{
    "items": "171",
    "sentiment_score_definition": "x <= -0.35: Bearish; -0.35 < x <= -0.15: Somewhat-Bearish; -0.15 < x < 0.15: Neutral; 0.15 <= x < 0.35: Somewhat_Bullish; x >= 0.35: Bullish",
    "relevance_score_definition": "0 < x <= 1, with a higher score indicating higher relevance.",
    "feed": [
        {
            "title": "Rally Gains Steam As Powell Signals No More Rate Hikes",
            "url": "https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-market-rally-gains-steam-as-fed-chief-powell-signals-no-more-rate-hikes/",
            "time_published": "20231101T205533",
            "authors": [
                "ED CARSON",
                "Investor's Business Daily"
            ],
            "summary": "Dow Jones futures were little changed hours, along with S&P 500 futures and Nasdaq futures, after Fed chief Jerome Powell signaled the rates will stay on hold into next year. Roku ( ROKU ) and MercadoLibre were among a slew of earnings Wednesday night, with Palantir Technologies ( PLTR ) , Eli ...",
            "banner_image": "https://www.investors.com/wp-content/uploads/2018/10/stock-Jerome-Powell-03-fed.jpg",
            "source": "Investors Business Daily",
            "category_within_source": "n/a",
            "source_domain": "www.investors.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.769861"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.928769"
                },
                {
                    "topic": "Real Estate & Construction",
                    "relevance_score": "0.166667"
                }
            ],
            "overall_sentiment_score": 0.142972,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "META",
                    "relevance_score": "0.080458",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ROKU",
                    "relevance_score": "0.107135",
                    "ticker_sentiment_score": "0.099701",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AAPL",
                    "relevance_score": "0.107135",
                    "ticker_sentiment_score": "0.012043",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.107135",
                    "ticker_sentiment_score": "-0.028084",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "COR",
                    "relevance_score": "0.107135",
                    "ticker_sentiment_score": "0.01197",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "IVZ",
                    "relevance_score": "0.02686",
                    "ticker_sentiment_score": "0.172995",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "MSFT",
                    "relevance_score": "0.263657",
                    "ticker_sentiment_score": "0.132174",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SHOP",
                    "relevance_score": "0.080458",
                    "ticker_sentiment_score": "0.056724",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MELI",
                    "relevance_score": "0.107135",
                    "ticker_sentiment_score": "0.071799",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TSLA",
                    "relevance_score": "0.02686",
                    "ticker_sentiment_score": "0.215006",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "MCK",
                    "relevance_score": "0.160099",
                    "ticker_sentiment_score": "-0.041109",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.133692",
                    "ticker_sentiment_score": "0.008339",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "REGN",
                    "relevance_score": "0.053689",
                    "ticker_sentiment_score": "-0.079734",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AMZN",
                    "relevance_score": "0.107135",
                    "ticker_sentiment_score": "0.053395",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MAR",
                    "relevance_score": "0.053689",
                    "ticker_sentiment_score": "-0.079734",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PLTR",
                    "relevance_score": "0.080458",
                    "ticker_sentiment_score": "-0.027407",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Earnings Due For These Stealth Weight-Loss Drug Plays",
            "url": "https://www.investors.com/news/mckesson-earnings-stealth-glp-1-weight-loss-drug-play-mckesson-rivals/",
            "time_published": "20231101T172402",
            "authors": [
                "Investor's Business Daily",
                "JED GRAHAM"
            ],
            "summary": "McKesson Earnings Due For Stealth GLP-1 Weight-Loss Drug Play ... Investor's Business Daily ...",
            "banner_image": "https://www.investors.com/wp-content/uploads/2022/08/Stock-McKesson-03-adobe.jpg",
            "source": "Investors Business Daily",
            "category_within_source": "n/a",
            "source_domain": "www.investors.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.999897"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.95493"
                },
                {
                    "topic": "Real Estate & Construction",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.25"
                }
            ],
            "overall_sentiment_score": 0.264294,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.160633",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "C",
                    "relevance_score": "0.160633",
                    "ticker_sentiment_score": "0.190892",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "CAH",
                    "relevance_score": "0.387674",
                    "ticker_sentiment_score": "0.298988",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "MCK",
                    "relevance_score": "0.735092",
                    "ticker_sentiment_score": "0.315229",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.160633",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "COR",
                    "relevance_score": "0.456884",
                    "ticker_sentiment_score": "0.340649",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "LLY: Eli Lilly & Co.  ( LLY )  Earnings Forecast",
            "url": "https://stocknews.com/news/lly-abbv-taro-rdy-eli-lilly-co-lly-earnings-forecast/",
            "time_published": "20231101T170704",
            "authors": [
                "StockNews.com Staff"
            ],
            "summary": "Pharmaceutical major Eli Lilly and Company ( LLY ) is scheduled to release its third-quarter results on November 2. While its earnings are expected to decline year-over-year, its revenue will likely improve. In this piece, I have discussed why waiting for an opportune entry point in the stock ...",
            "banner_image": "https://stocknews.com/wp-content/uploads/2021/03/shutterstock_530971462-1-scaled.jpg",
            "source": "Stocknews.com",
            "category_within_source": "n/a",
            "source_domain": "stocknews.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.998356"
                }
            ],
            "overall_sentiment_score": 0.126292,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.520477",
                    "ticker_sentiment_score": "0.098165",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TARO",
                    "relevance_score": "0.080458",
                    "ticker_sentiment_score": "0.023811",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ABBV",
                    "relevance_score": "0.080458",
                    "ticker_sentiment_score": "0.023811",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Curious about Lilly  ( LLY )  Q3 Performance? Explore Wall Street Estimates for Key Metrics",
            "url": "https://www.zacks.com/stock/news/2176355/curious-about-lilly-lly-q3-performance-explore-wall-street-estimates-for-key-metrics",
            "time_published": "20231101T125000",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Evaluate the expected performance of Lilly (LLY) for the quarter ended September 2023, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.",
            "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default199.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.95493"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.161647"
                }
            ],
            "overall_sentiment_score": 0.081403,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.356609",
                    "ticker_sentiment_score": "0.060128",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Should You Invest in the VanEck Pharmaceutical ETF  ( PPH ) ?",
            "url": "https://www.zacks.com/stock/news/2176034/should-you-invest-in-the-vaneck-pharmaceutical-etf-pph",
            "time_published": "20231101T102007",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Sector ETF report for PPH ...",
            "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default182.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.999999"
                }
            ],
            "overall_sentiment_score": 0.16198,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.132004",
                    "ticker_sentiment_score": "0.060139",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TEVA",
                    "relevance_score": "0.132004",
                    "ticker_sentiment_score": "0.060139",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "IVZ",
                    "relevance_score": "0.132004",
                    "ticker_sentiment_score": "0.042059",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.132004",
                    "ticker_sentiment_score": "0.060139",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Why Beam and Verve Therapeutics Shares Soared While Eli Lilly Soured Today",
            "url": "https://www.fool.com/investing/2023/10/31/why-beam-and-verve-therapeutics-stock-soared-while/",
            "time_published": "20231031T230902",
            "authors": [
                "Eric Volkman"
            ],
            "summary": "Lilly is putting its money where its mouth is with its purchase of cutting-edge medical technology.",
            "banner_image": "https://g.foolcdn.com/editorial/images/753180/person-in-a-lab-looking-through-a-microscope.jpg",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.161647"
                }
            ],
            "overall_sentiment_score": 0.210761,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "BEAM",
                    "relevance_score": "0.193465",
                    "ticker_sentiment_score": "0.383136",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.537474",
                    "ticker_sentiment_score": "0.269147",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "VERV",
                    "relevance_score": "0.193465",
                    "ticker_sentiment_score": "0.383136",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "CRYPTO:XCP",
                    "relevance_score": "0.097457",
                    "ticker_sentiment_score": "-0.146035",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Ozempic Supply Is Running Low: Here's Why That Can Be A Problem - Novo Nordisk  ( NYSE:NVO ) , Eli Lilly  ( NYSE:LLY ) ",
            "url": "https://www.benzinga.com/general/health-care/23/10/35522328/ozempic-supply-is-running-low-heres-why-that-can-be-a-problem",
            "time_published": "20231031T212345",
            "authors": [
                "Aaron Bry"
            ],
            "summary": "Ozempic, the diabetes drug also used as a so-called \"miracle\" weight-loss drug, has been sweeping through America and is now in limited supply. When used for weight loss, the drug, a GLP-1, helps patients manage their weight.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/10/31/opzemic.shutterstock_2172980959.jpg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.108179"
                }
            ],
            "overall_sentiment_score": -0.067732,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.231332",
                    "ticker_sentiment_score": "-0.017602",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WBD",
                    "relevance_score": "0.116914",
                    "ticker_sentiment_score": "-0.011291",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.231332",
                    "ticker_sentiment_score": "-0.217443",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                }
            ]
        },
        {
            "title": "Incyte  ( INCY )  Beats on Q3 Earnings, Misses Revenue Estimates",
            "url": "https://www.zacks.com/stock/news/2175739/incyte-incy-beats-on-q3-earnings-misses-revenue-estimates",
            "time_published": "20231031T161400",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Incyte's (INCY) third-quarter 2023 earnings beat estimates, while revenues miss the same. The company tightens Jakafi net product revenue guidance for 2023.",
            "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/37/2337.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.938238"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.141345,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.169378",
                    "ticker_sentiment_score": "0.047996",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DVAX",
                    "relevance_score": "0.25168",
                    "ticker_sentiment_score": "0.155569",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "INCY",
                    "relevance_score": "0.513062",
                    "ticker_sentiment_score": "0.125213",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Amgen's stock hit by expectations its obesity pipeline is facing a longer wait",
            "url": "https://www.marketwatch.com/story/amgens-stock-jumps-premarket-after-earnings-beat-and-company-again-raises-guidance-d4015936",
            "time_published": "20231031T155900",
            "authors": [
                "Ciara Linnane"
            ],
            "summary": "Amgen Inc.'s stock fell 3.3% Tuesday despite an earnings beat and raised guidance. Obesity drugs were to blame.",
            "banner_image": "https://images.mktw.net/im-814193/social",
            "source": "MarketWatch",
            "category_within_source": "Top Stories",
            "source_domain": "www.marketwatch.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.108179"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.980716"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.104098,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.146469",
                    "ticker_sentiment_score": "0.114297",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ABBV",
                    "relevance_score": "0.146469",
                    "ticker_sentiment_score": "-0.199329",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "AMGN",
                    "relevance_score": "0.288044",
                    "ticker_sentiment_score": "-0.031612",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MS",
                    "relevance_score": "0.073546",
                    "ticker_sentiment_score": "0.091052",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.146469",
                    "ticker_sentiment_score": "0.114297",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "5 Hot Earnings Charts",
            "url": "https://www.zacks.com/stock/news/2175700/5-hot-earnings-charts",
            "time_published": "20231031T155400",
            "authors": [
                "Tracey Ryniec"
            ],
            "summary": "These 5 companies have red hot charts and they have outstanding earnings surprise histories.",
            "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/66/49902.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.365926"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.890401"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.217484,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.344712",
                    "ticker_sentiment_score": "0.202108",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "HURN",
                    "relevance_score": "0.407844",
                    "ticker_sentiment_score": "0.205683",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "BKNG",
                    "relevance_score": "0.468029",
                    "ticker_sentiment_score": "0.141673",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BLDR",
                    "relevance_score": "0.344712",
                    "ticker_sentiment_score": "0.22045",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Eli Lilly Stock Has Quadrupled in 3 Years. Could a Weight-Loss Drug Approval Make It Happen Again?",
            "url": "https://www.fool.com/investing/2023/10/31/eli-lilly-stock-quadrupled-weight-loss-drug/",
            "time_published": "20231031T141233",
            "authors": [
                "James Brumley"
            ],
            "summary": "Mounjaro may be a winner, but all its upside is already priced in. An approval poses the risk of profit-taking.",
            "banner_image": "https://g.foolcdn.com/editorial/images/752576/investing-screen-analysis-investor-growth-stocks.jpg",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.996023"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.614606"
                },
                {
                    "topic": "Real Estate & Construction",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.25"
                }
            ],
            "overall_sentiment_score": 0.116269,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.33628",
                    "ticker_sentiment_score": "0.166002",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "PEP",
                    "relevance_score": "0.03468",
                    "ticker_sentiment_score": "-0.144117",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GS",
                    "relevance_score": "0.03468",
                    "ticker_sentiment_score": "0.074345",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MDNDF",
                    "relevance_score": "0.03468",
                    "ticker_sentiment_score": "-0.144117",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PNT",
                    "relevance_score": "0.03468",
                    "ticker_sentiment_score": "0.143011",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Why Beam Therapeutics Stock Is Getting Bought Today - Beam Therapeutics  ( NASDAQ:BEAM ) ",
            "url": "https://www.benzinga.com/news/23/10/35512455/why-beam-therapeutics-stock-is-getting-bought-today",
            "time_published": "20231031T125254",
            "authors": [
                "Adam Eckert"
            ],
            "summary": "Beam Therapeutics Inc BEAM shares are trading higher Tuesday after Eli Lilly And Co LLY agreed to acquire certain rights under Beam's agreement with Verve Therapeutics Inc VERV.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/10/31/stock-1863880_1920-34.jpg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "News",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.214378"
                }
            ],
            "overall_sentiment_score": 0.345564,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "BEAM",
                    "relevance_score": "0.528475",
                    "ticker_sentiment_score": "0.712861",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.528475",
                    "ticker_sentiment_score": "0.582183",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "VERV",
                    "relevance_score": "0.368773",
                    "ticker_sentiment_score": "0.68778",
                    "ticker_sentiment_label": "Bullish"
                }
            ]
        },
        {
            "title": "Pfizer  ( PFE )  Reports Q3 Loss, Lags Revenue Estimates",
            "url": "https://www.zacks.com/stock/news/2175168/pfizer-pfe-reports-q3-loss-lags-revenue-estimates",
            "time_published": "20231031T120508",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Pfizer (PFE) delivered earnings and revenue surprises of 46.88% and 3.93%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?",
            "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default26.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.999981"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.266143"
                }
            ],
            "overall_sentiment_score": 0.112098,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.140076",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.40348",
                    "ticker_sentiment_score": "0.074066",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Dow Jones Rises As Apple Climbs Ahead Of Earnings; GM Reportedly Settles With UAW",
            "url": "https://www.investors.com/market-trend/stock-market-today/dow-jones-rises-as-apple-climbs-ahead-of-earnings-gm-settles-with-uaw/",
            "time_published": "20231030T150805",
            "authors": [
                "Investor's Business Daily",
                "VIDYA RAMAKRISHNAN"
            ],
            "summary": "Dow Jones Rises As Apple Climbs Ahead Of Earnings. GM ... Investor's Business Daily ...",
            "banner_image": "https://www.investors.com/wp-content/uploads/2019/06/stock-WallStreet-06-adobe.jpg",
            "source": "Investors Business Daily",
            "category_within_source": "n/a",
            "source_domain": "www.investors.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.999896"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.904684"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.25"
                }
            ],
            "overall_sentiment_score": 0.069208,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "AAPL",
                    "relevance_score": "0.158868",
                    "ticker_sentiment_score": "-0.073442",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LSCC",
                    "relevance_score": "0.106305",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MDNDF",
                    "relevance_score": "0.053271",
                    "ticker_sentiment_score": "0.142686",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GM",
                    "relevance_score": "0.210731",
                    "ticker_sentiment_score": "0.050436",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.106305",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "RMBS",
                    "relevance_score": "0.106305",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CAH",
                    "relevance_score": "0.106305",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AMGN",
                    "relevance_score": "0.158868",
                    "ticker_sentiment_score": "-0.073442",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DTST",
                    "relevance_score": "0.053271",
                    "ticker_sentiment_score": "-0.047015",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "QCOM",
                    "relevance_score": "0.106305",
                    "ticker_sentiment_score": "0.076727",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CAT",
                    "relevance_score": "0.158868",
                    "ticker_sentiment_score": "-0.073442",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WDC",
                    "relevance_score": "0.106305",
                    "ticker_sentiment_score": "-0.052684",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AMD",
                    "relevance_score": "0.106305",
                    "ticker_sentiment_score": "0.076727",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.106305",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WOLF",
                    "relevance_score": "0.106305",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ON",
                    "relevance_score": "0.053271",
                    "ticker_sentiment_score": "0.032999",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Pre-Markets in Green to Start a Crucial Week of Events",
            "url": "https://www.zacks.com/stock/news/2174622/pre-markets-in-green-to-start-a-crucial-week-of-events",
            "time_published": "20231030T150600",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "It's the start of the busiest week of Q3 earnings season, and pre-market futures are up. Perhaps this is a sign of optimism for expected earnings, or perhaps it's looking favorably on a parade of economic reports out this week.",
            "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/01/36484.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.310843"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.538269"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.838487"
                }
            ],
            "overall_sentiment_score": 0.169225,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "MDNDF",
                    "relevance_score": "0.087185",
                    "ticker_sentiment_score": "0.20895",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "SBUX",
                    "relevance_score": "0.173333",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "COP",
                    "relevance_score": "0.173333",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CAT",
                    "relevance_score": "0.173333",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.173333",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.173333",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ON",
                    "relevance_score": "0.087185",
                    "ticker_sentiment_score": "0.129182",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Busy Week for Earnings, Fed, Reports; MCD, ON Beat in Q3",
            "url": "https://www.zacks.com/stock/news/2174606/busy-week-for-earnings-fed-reports-mcd-on-beat-in-q3",
            "time_published": "20231030T143500",
            "authors": [
                "Mark Vickery"
            ],
            "summary": "Mid-October near-term highs have given way to lower trading levels for the most part in the past couple weeks.",
            "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/59/2364.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.310843"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.538269"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.890401"
                }
            ],
            "overall_sentiment_score": 0.162295,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "MDNDF",
                    "relevance_score": "0.084127",
                    "ticker_sentiment_score": "0.154679",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "SBUX",
                    "relevance_score": "0.167322",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "COP",
                    "relevance_score": "0.167322",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CAT",
                    "relevance_score": "0.167322",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.167322",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.167322",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ON",
                    "relevance_score": "0.084127",
                    "ticker_sentiment_score": "0.154679",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "This Is What Whales Are Betting On Eli Lilly - Eli Lilly  ( NYSE:LLY ) ",
            "url": "https://www.benzinga.com/markets/options/23/10/35490808/this-is-what-whales-are-betting-on-eli-lilly",
            "time_published": "20231030T134615",
            "authors": [
                "Benzinga Insights"
            ],
            "summary": "Someone with a lot of money to spend has taken a bearish stance on Eli Lilly LLY. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "Markets",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.266143"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.09017,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.773597",
                    "ticker_sentiment_score": "0.015813",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "C",
                    "relevance_score": "0.096283",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WFC",
                    "relevance_score": "0.096283",
                    "ticker_sentiment_score": "-0.122172",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MS",
                    "relevance_score": "0.096283",
                    "ticker_sentiment_score": "-0.122172",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Apple, AMD, Palantir Earnings On Deck This Week As Market Seeks Positive Catalysts In Fed Decision Week - Lattice Semiconductor  ( NASDAQ:LSCC ) , Exact Sciences  ( NASDAQ:EXAS ) , Amgen  ( NASDAQ:AMGN ) , STMicroelectronics  ( NYSE:STM ) ",
            "url": "https://www.benzinga.com/analyst-ratings/analyst-color/23/10/35484208/apple-amd-palantir-earnings-on-deck-this-week-as-market-seeks-positive-catalysts-in",
            "time_published": "20231030T074015",
            "authors": [
                "Shanthi Rexaline"
            ],
            "summary": "The third-quarter earnings season has largely been mixed so far, reflecting the impact of the economic uncertainties on profit growth. That said, data suggests S&P 500 companies may be on track to break a fourth-quarter earnings-declining streak.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/Stocks_Photo_by_Phongphan_on_Shutterstock_16.jpeg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "News",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.891286"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.999813"
                },
                {
                    "topic": "Real Estate & Construction",
                    "relevance_score": "0.166667"
                }
            ],
            "overall_sentiment_score": 0.155659,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "DD",
                    "relevance_score": "0.0864",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MSTR",
                    "relevance_score": "0.0864",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MTH",
                    "relevance_score": "0.0864",
                    "ticker_sentiment_score": "0.195087",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "AAPL",
                    "relevance_score": "0.0864",
                    "ticker_sentiment_score": "0.026184",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LSCC",
                    "relevance_score": "0.0864",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MDNDF",
                    "relevance_score": "0.043264",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "EXAS",
                    "relevance_score": "0.0864",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "KHC",
                    "relevance_score": "0.0864",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CLX",
                    "relevance_score": "0.0864",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SBUX",
                    "relevance_score": "0.0864",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CHKP",
                    "relevance_score": "0.0864",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "VNO",
                    "relevance_score": "0.0864",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WDC",
                    "relevance_score": "0.0864",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AMD",
                    "relevance_score": "0.129284",
                    "ticker_sentiment_score": "-0.016206",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "YUMC",
                    "relevance_score": "0.0864",
                    "ticker_sentiment_score": "0.195087",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "EA",
                    "relevance_score": "0.0864",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DKNG",
                    "relevance_score": "0.0864",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "META",
                    "relevance_score": "0.0864",
                    "ticker_sentiment_score": "-0.10532",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BLCO",
                    "relevance_score": "0.0864",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CAH",
                    "relevance_score": "0.0864",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SIRI",
                    "relevance_score": "0.0864",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "FOX",
                    "relevance_score": "0.043264",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "YUM",
                    "relevance_score": "0.0864",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "FSLR",
                    "relevance_score": "0.0864",
                    "ticker_sentiment_score": "0.195087",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "CAR",
                    "relevance_score": "0.0864",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CAT",
                    "relevance_score": "0.0864",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "XOM",
                    "relevance_score": "0.0864",
                    "ticker_sentiment_score": "0.185074",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "EAT",
                    "relevance_score": "0.0864",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SOFI",
                    "relevance_score": "0.0864",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BHC",
                    "relevance_score": "0.0864",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MAR",
                    "relevance_score": "0.0864",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CVS",
                    "relevance_score": "0.0864",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WEN",
                    "relevance_score": "0.0864",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CVX",
                    "relevance_score": "0.0864",
                    "ticker_sentiment_score": "0.185074",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "D",
                    "relevance_score": "0.043264",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PARA",
                    "relevance_score": "0.0864",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PTON",
                    "relevance_score": "0.0864",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "EXPE",
                    "relevance_score": "0.0864",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "H",
                    "relevance_score": "0.0864",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MRO",
                    "relevance_score": "0.0864",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SRGRF",
                    "relevance_score": "0.043264",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TXN",
                    "relevance_score": "0.0864",
                    "ticker_sentiment_score": "0.284455",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "THC",
                    "relevance_score": "0.0864",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BUD",
                    "relevance_score": "0.0864",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MSFT",
                    "relevance_score": "0.0864",
                    "ticker_sentiment_score": "0.284455",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "NCLH",
                    "relevance_score": "0.0864",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "QCOM",
                    "relevance_score": "0.129284",
                    "ticker_sentiment_score": "0.104299",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.0864",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PINS",
                    "relevance_score": "0.0864",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SPWR",
                    "relevance_score": "0.0864",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ON",
                    "relevance_score": "0.043264",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PLTR",
                    "relevance_score": "0.0864",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PYPL",
                    "relevance_score": "0.0864",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GOOG",
                    "relevance_score": "0.0864",
                    "ticker_sentiment_score": "-0.10532",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JBLU",
                    "relevance_score": "0.0864",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LYV",
                    "relevance_score": "0.0864",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SWKS",
                    "relevance_score": "0.0864",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "INTC",
                    "relevance_score": "0.0864",
                    "ticker_sentiment_score": "0.284455",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "WOLF",
                    "relevance_score": "0.0864",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "REGN",
                    "relevance_score": "0.0864",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AMZN",
                    "relevance_score": "0.0864",
                    "ticker_sentiment_score": "0.284455",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Bulls And Bears: Tesla, Chevron, Eli Lilly And Dogecoin Co-founder's 3 Favorite Cryptos",
            "url": "https://www.benzinga.com/trading-ideas/long-ideas/23/10/35465080/benzinga-bulls-and-bears-tesla-chevron-eli-lilly-and-dogecoin-co-founders-3-favorite-cry",
            "time_published": "20231028T124902",
            "authors": [
                "Michael Cohen"
            ],
            "summary": "Benzinga examined the prospects for many investors' favorite stocks over the last week - here's a look at some of our top stories. This week saw significant declines in major averages, with the Dow, S&P 500, and Nasdaq dropping by 2.1%, 2.5%, and 2.6%, respectively.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/10/27/bulls_bears6.png?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "Trading",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.684621"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.310843"
                },
                {
                    "topic": "Mergers & Acquisitions",
                    "relevance_score": "0.158519"
                }
            ],
            "overall_sentiment_score": 0.1194,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "GOOG",
                    "relevance_score": "0.124164",
                    "ticker_sentiment_score": "-0.205346",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "META",
                    "relevance_score": "0.124164",
                    "ticker_sentiment_score": "-0.205346",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "NVDA",
                    "relevance_score": "0.124164",
                    "ticker_sentiment_score": "-0.205346",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "TSLA",
                    "relevance_score": "0.185306",
                    "ticker_sentiment_score": "-0.134878",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CVX",
                    "relevance_score": "0.185306",
                    "ticker_sentiment_score": "0.26513",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.124164",
                    "ticker_sentiment_score": "0.1605",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "HES",
                    "relevance_score": "0.303926",
                    "ticker_sentiment_score": "0.381027",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.124164",
                    "ticker_sentiment_score": "0.1605",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "CRYPTO:BTC",
                    "relevance_score": "0.185306",
                    "ticker_sentiment_score": "0.273737",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "CRYPTO:ETH",
                    "relevance_score": "0.124164",
                    "ticker_sentiment_score": "0.216949",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "CRYPTO:DOGE",
                    "relevance_score": "0.185306",
                    "ticker_sentiment_score": "0.273737",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Roche, Lilly or Pfizer: Who's the Winner in IBD Wars?",
            "url": "https://www.fool.com/investing/2023/10/28/roche-lilly-or-pfizer-whos-the-winner-in-ibd-wars/",
            "time_published": "20231028T124500",
            "authors": [
                "Jim Halley"
            ],
            "summary": "The three companies are spending big on IBD therapies.",
            "banner_image": "https://g.foolcdn.com/editorial/images/752299/group-of-medical-practitioners-having-a-seminar-in-board-room.jpg",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.413559"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.999975"
                }
            ],
            "overall_sentiment_score": 0.135664,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "BBY",
                    "relevance_score": "0.036532",
                    "ticker_sentiment_score": "0.138123",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.216537",
                    "ticker_sentiment_score": "0.11901",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ROIV",
                    "relevance_score": "0.036532",
                    "ticker_sentiment_score": "0.072581",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.353059",
                    "ticker_sentiment_score": "0.078417",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Eli Lilly and Company  ( NYSE:LLY )  Stock Rating Lowered by StockNews.com",
            "url": "https://www.defenseworld.net/2023/10/28/eli-lilly-and-company-nyselly-stock-rating-lowered-by-stocknews-com.html",
            "time_published": "20231028T054845",
            "authors": [
                "Defense World Staff"
            ],
            "summary": "Eli Lilly and Company ( NYSE:LLY ) Stock Rating Lowered by ... Defense World ...",
            "banner_image": "https://www.marketbeat.com/logos/logo_eli_lilly.jpg",
            "source": "Stocknews.com",
            "category_within_source": "n/a",
            "source_domain": "www.defenseworld.net",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.986564"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.223325,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.769861",
                    "ticker_sentiment_score": "0.36356",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "TFC",
                    "relevance_score": "0.039878",
                    "ticker_sentiment_score": "0.045582",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BCS",
                    "relevance_score": "0.039878",
                    "ticker_sentiment_score": "0.045582",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "C",
                    "relevance_score": "0.039878",
                    "ticker_sentiment_score": "0.045582",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WFC",
                    "relevance_score": "0.039878",
                    "ticker_sentiment_score": "0.045582",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Apple, Fed Meeting, Caterpillar, Jobs Report; Investing Action Plan",
            "url": "https://www.investors.com/research/investing-action-plan/apple-fed-meeting-caterpillar-jobs-report-investing-action-plan/",
            "time_published": "20231027T215300",
            "authors": [
                "ALAN R. ELLIOTT",
                "Investor's Business Daily"
            ],
            "summary": "Apple, Fed Meeting, Caterpillar, Jobs Report. Investing Action Plan Investor's Business Daily ...",
            "banner_image": "https://www.investors.com/wp-content/uploads/2023/10/Stock-mannequinapple-01-adobe.jpg",
            "source": "Investors Business Daily",
            "category_within_source": "n/a",
            "source_domain": "www.investors.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.576289"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.99999"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Real Estate & Construction",
                    "relevance_score": "0.166667"
                }
            ],
            "overall_sentiment_score": 0.100088,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "CVS",
                    "relevance_score": "0.052493",
                    "ticker_sentiment_score": "0.008988",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ROKU",
                    "relevance_score": "0.052493",
                    "ticker_sentiment_score": "0.075",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AAPL",
                    "relevance_score": "0.069951",
                    "ticker_sentiment_score": "0.015119",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ANET",
                    "relevance_score": "0.052493",
                    "ticker_sentiment_score": "0.003991",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MDNDF",
                    "relevance_score": "0.017509",
                    "ticker_sentiment_score": "0.117232",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CROX",
                    "relevance_score": "0.035009",
                    "ticker_sentiment_score": "0.066673",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AMGN",
                    "relevance_score": "0.104759",
                    "ticker_sentiment_score": "0.056462",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.069951",
                    "ticker_sentiment_score": "0.019329",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "UNH",
                    "relevance_score": "0.052493",
                    "ticker_sentiment_score": "0.093934",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BUD",
                    "relevance_score": "0.035009",
                    "ticker_sentiment_score": "0.121518",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MSFT",
                    "relevance_score": "0.104759",
                    "ticker_sentiment_score": "0.069871",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SHOP",
                    "relevance_score": "0.035009",
                    "ticker_sentiment_score": "0.012525",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SBUX",
                    "relevance_score": "0.035009",
                    "ticker_sentiment_score": "0.176478",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "QCOM",
                    "relevance_score": "0.035009",
                    "ticker_sentiment_score": "-0.017404",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AMD",
                    "relevance_score": "0.052493",
                    "ticker_sentiment_score": "-0.048998",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.035009",
                    "ticker_sentiment_score": "0.01861",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SHEN",
                    "relevance_score": "0.035009",
                    "ticker_sentiment_score": "-0.004844",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DBX",
                    "relevance_score": "0.052493",
                    "ticker_sentiment_score": "0.152599",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "PAYC",
                    "relevance_score": "0.035009",
                    "ticker_sentiment_score": "0.055611",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SQ",
                    "relevance_score": "0.035009",
                    "ticker_sentiment_score": "0.02226",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PYPL",
                    "relevance_score": "0.035009",
                    "ticker_sentiment_score": "0.045334",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "META",
                    "relevance_score": "0.052493",
                    "ticker_sentiment_score": "0.003991",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CF",
                    "relevance_score": "0.052493",
                    "ticker_sentiment_score": "0.016038",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SYK",
                    "relevance_score": "0.035009",
                    "ticker_sentiment_score": "0.055832",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "COR",
                    "relevance_score": "0.052493",
                    "ticker_sentiment_score": "0.006",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CBOE",
                    "relevance_score": "0.035009",
                    "ticker_sentiment_score": "0.250018",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "CAH",
                    "relevance_score": "0.052493",
                    "ticker_sentiment_score": "0.006",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SWKS",
                    "relevance_score": "0.035009",
                    "ticker_sentiment_score": "0.071169",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MCK",
                    "relevance_score": "0.052493",
                    "ticker_sentiment_score": "0.006",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ETSY",
                    "relevance_score": "0.052493",
                    "ticker_sentiment_score": "0.092997",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "FTNT",
                    "relevance_score": "0.035009",
                    "ticker_sentiment_score": "0.080794",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CAT",
                    "relevance_score": "0.104759",
                    "ticker_sentiment_score": "0.012288",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WMT",
                    "relevance_score": "0.052493",
                    "ticker_sentiment_score": "0.093934",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CRYPTO:BTC",
                    "relevance_score": "0.017509",
                    "ticker_sentiment_score": "0.020325",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Bears Roam Wall Street As Middle East Conflict, Earnings Outlook Raise Concerns Despite Strong Q3 US Economic Growth: This Week In Markets - CVS Health  ( NYSE:CVS ) , Enphase Energy  ( NASDAQ:ENPH ) , Alphabet  ( NASDAQ:GOOGL ) , Apple  ( NASDAQ:AAPL ) ",
            "url": "https://www.benzinga.com/news/earnings/23/10/35474151/bears-roam-wall-street-as-middle-east-conflict-earnings-outlook-raise-concerns-despite-strong-q3-us",
            "time_published": "20231027T203357",
            "authors": [
                "Piero Cingari"
            ],
            "summary": "It has been another week of volatility in the stock market, characterized by mounting fears of a wider Middle East conflict and a more cautious fourth-quarter earnings outlook announced by U.S. corporations.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/Bearish_stock_chart..jpeg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "Markets",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.682689"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.995921"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.795202"
                }
            ],
            "overall_sentiment_score": 0.151583,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "BLK",
                    "relevance_score": "0.046816",
                    "ticker_sentiment_score": "0.123827",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CVS",
                    "relevance_score": "0.09347",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MDLZ",
                    "relevance_score": "0.09347",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AAPL",
                    "relevance_score": "0.09347",
                    "ticker_sentiment_score": "-0.055253",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MDNDF",
                    "relevance_score": "0.046816",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ABNB",
                    "relevance_score": "0.09347",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ALGN",
                    "relevance_score": "0.09347",
                    "ticker_sentiment_score": "0.057667",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "IVZ",
                    "relevance_score": "0.046816",
                    "ticker_sentiment_score": "0.094925",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AMGN",
                    "relevance_score": "0.09347",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.09347",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PDD",
                    "relevance_score": "0.09347",
                    "ticker_sentiment_score": "0.204728",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "SBUX",
                    "relevance_score": "0.09347",
                    "ticker_sentiment_score": "-0.055253",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "QCOM",
                    "relevance_score": "0.09347",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AMD",
                    "relevance_score": "0.09347",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.09347",
                    "ticker_sentiment_score": "-0.055253",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SPGI",
                    "relevance_score": "0.09347",
                    "ticker_sentiment_score": "-0.055253",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WTW",
                    "relevance_score": "0.09347",
                    "ticker_sentiment_score": "0.204728",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "BKNG",
                    "relevance_score": "0.09347",
                    "ticker_sentiment_score": "-0.055253",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WHR",
                    "relevance_score": "0.09347",
                    "ticker_sentiment_score": "0.057667",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GOOG",
                    "relevance_score": "0.139804",
                    "ticker_sentiment_score": "0.004048",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "META",
                    "relevance_score": "0.09347",
                    "ticker_sentiment_score": "-0.119207",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "COP",
                    "relevance_score": "0.09347",
                    "ticker_sentiment_score": "-0.055253",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ROL",
                    "relevance_score": "0.09347",
                    "ticker_sentiment_score": "0.204728",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "MCD",
                    "relevance_score": "0.09347",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CAT",
                    "relevance_score": "0.09347",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AMZN",
                    "relevance_score": "0.09347",
                    "ticker_sentiment_score": "0.233308",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "CRYPTO:BTC",
                    "relevance_score": "0.27535",
                    "ticker_sentiment_score": "0.25509",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Is Ozempic Killing Liposuction? A Stock That Could Get Hit Hard From New Weight-Loss Drugs - Novo Nordisk  ( NYSE:NVO ) ",
            "url": "https://www.benzinga.com/general/health-care/23/10/35469218/is-ozempic-killing-liposuction-a-stock-that-could-get-hit-hard-from-new-weight-loss-drugs",
            "time_published": "20231027T191555",
            "authors": [
                "Aaron Bry"
            ],
            "summary": "Ozempic, Novo Nordisk's NVO diabetes drug, is now popular for weight loss. The rise of the drug could become a major headwind for other companies that provide weight-loss services such as liposuction and bariatric surgeries. Some companies are already seeing the impact of widespread Ozempic use.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/10/27/weightloss.shutterstock_2270507665.jpg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": -0.062611,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.316846",
                    "ticker_sentiment_score": "-0.116065",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.316846",
                    "ticker_sentiment_score": "-0.073174",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.316846",
                    "ticker_sentiment_score": "-0.31328",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                }
            ]
        },
        {
            "title": "FDA Gives Nod To Eli Lilly's First Treatment For Type Of Inflammatory Bowel Disease, To Compete With JNJ, Pfizer, AbbVie - Eli Lilly  ( NYSE:LLY ) ",
            "url": "https://www.benzinga.com/general/biotech/23/10/35465199/fda-gives-nod-to-eli-lillys-first-treatment-for-type-of-inflammatory-bowel-disease-to-compete-wit",
            "time_published": "20231027T142819",
            "authors": [
                "Vandana Singh"
            ],
            "summary": "The FDA approved Eli Lilly And Co's LLY Omvoh ( mirikizumab-mrkz ) for moderately to severely active ulcerative colitis ( UC ) in adults, marking Lilly's first approved treatment for a type of inflammatory bowel disease.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/10/27/lly.png?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.259077,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.642555",
                    "ticker_sentiment_score": "0.486525",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "ABBV",
                    "relevance_score": "0.2872",
                    "ticker_sentiment_score": "0.447515",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.2872",
                    "ticker_sentiment_score": "0.447515",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.2872",
                    "ticker_sentiment_score": "0.447515",
                    "ticker_sentiment_label": "Bullish"
                }
            ]
        },
        {
            "title": "Pharma Stock Roundup: SNY, MRK, NVS Report Q3 Earnings, FDA Okays PFE, LLY Products",
            "url": "https://www.zacks.com/stock/news/2173795/pharma-stock-roundup-sny-mrk-nvs-report-q3-earnings-fda-okays-pfe-lly-products",
            "time_published": "20231027T140500",
            "authors": [
                "Kinjel Shah"
            ],
            "summary": "Merck (MRK), Sanofi (SNY) and Novartis (NVS) report third-quarter results. FDA approves Pfizer's (PFE) Penbraya and Eli ...",
            "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/13/11325.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.9545"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.214378"
                }
            ],
            "overall_sentiment_score": 0.187911,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.149656",
                    "ticker_sentiment_score": "-0.049789",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ROIV",
                    "relevance_score": "0.075161",
                    "ticker_sentiment_score": "0.095328",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.294093",
                    "ticker_sentiment_score": "0.163231",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "BNTX",
                    "relevance_score": "0.037622",
                    "ticker_sentiment_score": "0.076864",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SNY",
                    "relevance_score": "0.149656",
                    "ticker_sentiment_score": "0.017879",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Weight-Loss Beating Continues For Devices Makers; Why It's Overdone",
            "url": "https://www.investors.com/news/technology/weight-loss-drugs-spook-medical-device-stocks-an-overreaction/",
            "time_published": "20231027T130000",
            "authors": [
                "ALLISON GATLIN",
                "Investor's Business Daily"
            ],
            "summary": "Weight-Loss Drugs Spooked Medical Device Stocks. Did Investors ... Investor's Business Daily ...",
            "banner_image": "https://www.investors.com/wp-content/uploads/2023/10/IT2c103023-300x171.jpg",
            "source": "Investors Business Daily",
            "category_within_source": "n/a",
            "source_domain": "www.investors.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.997405"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.538269"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.093424,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "INSP",
                    "relevance_score": "0.034907",
                    "ticker_sentiment_score": "-0.017925",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ZBH",
                    "relevance_score": "0.034907",
                    "ticker_sentiment_score": "0.125221",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BAC",
                    "relevance_score": "0.017458",
                    "ticker_sentiment_score": "-0.108231",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.087122",
                    "ticker_sentiment_score": "0.080517",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "RMD",
                    "relevance_score": "0.034907",
                    "ticker_sentiment_score": "0.125221",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MASI",
                    "relevance_score": "0.034907",
                    "ticker_sentiment_score": "0.23697",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "AMGN",
                    "relevance_score": "0.034907",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DVA",
                    "relevance_score": "0.087122",
                    "ticker_sentiment_score": "0.002112",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.034907",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "EW",
                    "relevance_score": "0.034907",
                    "ticker_sentiment_score": "0.23697",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "FSNUF",
                    "relevance_score": "0.017458",
                    "ticker_sentiment_score": "0.047327",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.069748",
                    "ticker_sentiment_score": "0.111489",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PODD",
                    "relevance_score": "0.034907",
                    "ticker_sentiment_score": "0.099119",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SLNO",
                    "relevance_score": "0.017458",
                    "ticker_sentiment_score": "0.014131",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ISRG",
                    "relevance_score": "0.05234",
                    "ticker_sentiment_score": "0.026937",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DXCM",
                    "relevance_score": "0.121738",
                    "ticker_sentiment_score": "0.072049",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Weight Loss Drugs Like Wegovy Would Not Impact Business - Healthcare Companies Tell Investors - Novo Nordisk  ( NYSE:NVO ) ",
            "url": "https://www.benzinga.com/general/biotech/23/10/35461521/weight-loss-drugs-like-wegovy-would-not-impact-business-healthcare-companies-tell-investors",
            "time_published": "20231027T115156",
            "authors": [
                "Vandana Singh"
            ],
            "summary": "Novo Nordisk A/S NVO investors and analysts eagerly await the company's third-quarter results, hoping for clarity on when supply limitations for its weight-loss drug, Wegovy, in the U.S. will be resolved.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/10/27/ozempic.png?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": -0.038857,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.269776",
                    "ticker_sentiment_score": "-0.435366",
                    "ticker_sentiment_label": "Bearish"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.395012",
                    "ticker_sentiment_score": "0.506218",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "BCS",
                    "relevance_score": "0.136888",
                    "ticker_sentiment_score": "-0.01004",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "FDA Approves Lilly's Omvoh  ( mirikizumab-mrkz ) , A First-in-Class Treatment for Adults with Moderately to Severely Active Ulcerative Colitis",
            "url": "https://www.prnewswire.com/news-releases/fda-approves-lillys-omvoh-mirikizumab-mrkz-a-first-in-class-treatment-for-adults-with-moderately-to-severely-active-ulcerative-colitis-301969505.html",
            "time_published": "20231026T222400",
            "authors": [
                "Eli Lilly and Company"
            ],
            "summary": "FDA Approves Lilly's Omvoh ( mirikizumab-mrkz ) , A First-in-Class Treatment for Adults with Moderately to Severely ... PR ...",
            "banner_image": "https://mma.prnewswire.com/media/133140/eli_lilly_and_company_logo.jpg?p=facebook",
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.310843"
                }
            ],
            "overall_sentiment_score": 0.007347,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.351558",
                    "ticker_sentiment_score": "0.235349",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "META",
                    "relevance_score": "0.018187",
                    "ticker_sentiment_score": "0.153865",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "NHPEF",
                    "relevance_score": "0.018187",
                    "ticker_sentiment_score": "-0.11338",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Weight Loss Drugs Wegovy, Ozempic Gain Traction With Millennials, High Earners: New Survey Results - Coca-Cola  ( NYSE:KO ) , Novo Nordisk  ( NYSE:NVO ) , Eli Lilly  ( NYSE:LLY ) , PepsiCo  ( NASDAQ:PEP ) ",
            "url": "https://www.benzinga.com/news/23/10/35449786/weight-loss-drugs-wegovy-ozempic-gain-traction-with-millennials-high-earners-new-survey-results",
            "time_published": "20231026T193958",
            "authors": [
                "Chris Katje"
            ],
            "summary": "Prescription weight loss drugs Ozempic, Wegovy and Mounjaro have dominated headlines in 2023 with increased interest and the impact being discussed by food and drink companies. Here's a look at the consumer segments that might be driving the enthusiasm and demand for these GLP-1 drugs.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/weight_loss_shutter.jpeg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "Trading",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.108179"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.075909,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.143843",
                    "ticker_sentiment_score": "0.158745",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "PEP",
                    "relevance_score": "0.143843",
                    "ticker_sentiment_score": "-0.073057",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "KO",
                    "relevance_score": "0.143843",
                    "ticker_sentiment_score": "-0.073057",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.143843",
                    "ticker_sentiment_score": "0.225997",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "WMT",
                    "relevance_score": "0.214304",
                    "ticker_sentiment_score": "-0.109201",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Earnings Preview: Eli Lilly  ( LLY )  Q3 Earnings Expected to Decline",
            "url": "https://www.zacks.com/stock/news/2172796/earnings-preview-eli-lilly-lly-q3-earnings-expected-to-decline",
            "time_published": "20231026T140225",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Lilly (LLY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.",
            "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default56.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.365926"
                }
            ],
            "overall_sentiment_score": 0.112273,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.260652",
                    "ticker_sentiment_score": "0.009872",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.175539",
                    "ticker_sentiment_score": "-0.025752",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Will Eli Lilly Stock Be Worth More Than Tesla Stock by 2030?",
            "url": "https://www.fool.com/investing/2023/10/26/will-eli-lilly-stock-be-worth-more-than-tesla-stoc/",
            "time_published": "20231026T130500",
            "authors": [
                "David Jagielski"
            ],
            "summary": "The difference in market cap between these two companies is approximately $150 billion right now.",
            "banner_image": "https://g.foolcdn.com/misc-assets/hp-sa-cumulative-growth-chart.png",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "IPO",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.108179"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.839681"
                }
            ],
            "overall_sentiment_score": 0.152907,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.559221",
                    "ticker_sentiment_score": "0.379866",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "TSLA",
                    "relevance_score": "0.479385",
                    "ticker_sentiment_score": "0.254853",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Merck  ( MRK )  Q3 Earnings and Revenues Beat Estimates",
            "url": "https://www.zacks.com/stock/news/2172414/merck-mrk-q3-earnings-and-revenues-beat-estimates",
            "time_published": "20231026T115013",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Merck (MRK) delivered earnings and revenue surprises of 9.79% and 3.80%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?",
            "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default78.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.999953"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.266143"
                }
            ],
            "overall_sentiment_score": 0.116826,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.139265",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Eli Lilly  ( LLY )  to Report Q3 Earnings: What's in the Cards?",
            "url": "https://www.zacks.com/stock/news/2172391/eli-lilly-lly-to-report-q3-earnings-whats-in-the-cards",
            "time_published": "20231026T114000",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "On Eli Lilly's (LLY) third-quarter conference call, investor focus is likely to be on the sales of its new diabetes drug, Mounjaro.",
            "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/ca/2357.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.999992"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.796627"
                }
            ],
            "overall_sentiment_score": 0.10472,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.417304",
                    "ticker_sentiment_score": "0.022949",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "VRTX",
                    "relevance_score": "0.173958",
                    "ticker_sentiment_score": "0.050098",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AZN",
                    "relevance_score": "0.216473",
                    "ticker_sentiment_score": "0.025286",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BIIB",
                    "relevance_score": "0.216473",
                    "ticker_sentiment_score": "-0.026882",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Eli Lilly  ( LLY )  Stock Moves -1.01%: What You Should Know",
            "url": "https://www.zacks.com/stock/news/2172042/eli-lilly-lly-stock-moves--101-what-you-should-know",
            "time_published": "20231025T214517",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Eli Lilly (LLY) closed at $586.46 in the latest trading session, marking a -1.01% move from the prior day.",
            "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default267.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.995921"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.266143"
                }
            ],
            "overall_sentiment_score": 0.130817,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.532556",
                    "ticker_sentiment_score": "0.203855",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Biogen and Eisai release new Alzheimer's drug data that may support wider uptake",
            "url": "https://www.marketwatch.com/story/biogen-and-eisai-release-new-alzheimers-drug-data-that-may-support-wider-uptake-40d2d151",
            "time_published": "20231025T212800",
            "authors": [
                "Eleanor Laise"
            ],
            "summary": "Eisai plans to apply for FDA approval of subcutaneous Leqembi by early next year.",
            "banner_image": "https://images.mktw.net/im-696087/social",
            "source": "MarketWatch",
            "category_within_source": "Top Stories",
            "source_domain": "www.marketwatch.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.083728,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.224903",
                    "ticker_sentiment_score": "0.003554",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ESALF",
                    "relevance_score": "0.524949",
                    "ticker_sentiment_score": "0.059391",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BIIB",
                    "relevance_score": "0.524949",
                    "ticker_sentiment_score": "0.059391",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Doug Kass: Investing in a Storm",
            "url": "https://realmoney.thestreet.com/investing/doug-kass-investing-in-a-storm-16136395",
            "time_published": "20231025T180000",
            "authors": [
                "Doug Kass"
            ],
            "summary": "If we have had one consistent message over the last two years, it is that there is a broadening list of uncertainties that could lead to a wide range of outcomes and result in lower stock market valuations.",
            "banner_image": "https://s.thestreet.com/files/tsc/v2008/photos/contrib/uploads/86042ef9-7321-11ee-b0ee-31878339afac_564x376.png",
            "source": "The Street",
            "category_within_source": "GoogleRSS",
            "source_domain": "realmoney.thestreet.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.142857"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.142857"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.142857"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.142857"
                },
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.972193"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.142857"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.142857"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.310843"
                },
                {
                    "topic": "Real Estate & Construction",
                    "relevance_score": "0.142857"
                }
            ],
            "overall_sentiment_score": 0.088054,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "PARA",
                    "relevance_score": "0.02671",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WOOF",
                    "relevance_score": "0.02671",
                    "ticker_sentiment_score": "-0.05074",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVEI",
                    "relevance_score": "0.02671",
                    "ticker_sentiment_score": "-0.05074",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SNBR",
                    "relevance_score": "0.02671",
                    "ticker_sentiment_score": "-0.05074",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "OXY",
                    "relevance_score": "0.02671",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TSLA",
                    "relevance_score": "0.02671",
                    "ticker_sentiment_score": "-0.05074",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SBUX",
                    "relevance_score": "0.02671",
                    "ticker_sentiment_score": "-0.05074",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DWAC",
                    "relevance_score": "0.02671",
                    "ticker_sentiment_score": "-0.05074",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GRBK",
                    "relevance_score": "0.02671",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MPW",
                    "relevance_score": "0.02671",
                    "ticker_sentiment_score": "-0.05074",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WFC",
                    "relevance_score": "0.02671",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "HRMY",
                    "relevance_score": "0.02671",
                    "ticker_sentiment_score": "-0.05074",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.02671",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CHGG",
                    "relevance_score": "0.02671",
                    "ticker_sentiment_score": "-0.05074",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BAC",
                    "relevance_score": "0.02671",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "FRHC",
                    "relevance_score": "0.02671",
                    "ticker_sentiment_score": "-0.05074",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MS",
                    "relevance_score": "0.02671",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "XPOF",
                    "relevance_score": "0.02671",
                    "ticker_sentiment_score": "-0.05074",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BRK-A",
                    "relevance_score": "0.013357",
                    "ticker_sentiment_score": "-0.04612",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NYT",
                    "relevance_score": "0.013357",
                    "ticker_sentiment_score": "-0.106941",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NKE",
                    "relevance_score": "0.02671",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GS",
                    "relevance_score": "0.02671",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LEE",
                    "relevance_score": "0.02671",
                    "ticker_sentiment_score": "-0.05074",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ROL",
                    "relevance_score": "0.02671",
                    "ticker_sentiment_score": "-0.05074",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "IOT",
                    "relevance_score": "0.02671",
                    "ticker_sentiment_score": "-0.05074",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "FRPT",
                    "relevance_score": "0.02671",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "FOREX:USD",
                    "relevance_score": "0.013357",
                    "ticker_sentiment_score": "0.116961",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": " ( LLY )  - Analyzing Eli Lilly's Short Interest - Eli Lilly  ( NYSE:LLY ) ",
            "url": "https://www.benzinga.com/short-sellers/23/10/35421538/lly-analyzing-eli-lillys-short-interest",
            "time_published": "20231025T171511",
            "authors": [
                "Benzinga Insights"
            ],
            "summary": "Eli Lilly's LLY short percent of float has risen 11.27% since its last report. The company recently reported that it has 6.27 million shares sold short, which is 0.79% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.84 days to cover their ...",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "Trading",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.365926"
                }
            ],
            "overall_sentiment_score": 0.265104,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.221819",
                    "ticker_sentiment_score": "0.15378",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Investors Scurry To Buy 14 Soaring Stocks As Market Sells Off",
            "url": "https://www.investors.com/etfs-and-funds/sectors/sp500-investors-scurry-to-buy-soaring-stocks-as-market-sells-off/",
            "time_published": "20231025T120000",
            "authors": [
                "Investor's Business Daily",
                "MATT KRANTZ"
            ],
            "summary": "Don't assume that all S&P 500 stocks are struggling. A small group are actually thriving, thank you.",
            "banner_image": "https://www.investors.com/wp-content/uploads/2016/07/IC_cash_071516_adobe.jpeg",
            "source": "Investors Business Daily",
            "category_within_source": "n/a",
            "source_domain": "www.investors.com",
            "topics": [
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.538269"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.298627,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.330876",
                    "ticker_sentiment_score": "0.297051",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "SPGI",
                    "relevance_score": "0.068112",
                    "ticker_sentiment_score": "0.103744",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PGR",
                    "relevance_score": "0.202366",
                    "ticker_sentiment_score": "0.315056",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "CEG",
                    "relevance_score": "0.202366",
                    "ticker_sentiment_score": "0.172375",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Is SPDR MSCI USA StrategicFactors ETF  ( QUS )  a Strong ETF Right Now?",
            "url": "https://www.zacks.com/stock/news/2171248/is-spdr-msci-usa-strategicfactors-etf-qus-a-strong-etf-right-now",
            "time_published": "20231025T102006",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Smart Beta ETF report for ...",
            "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default115.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.999998"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.216176,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.116067",
                    "ticker_sentiment_score": "0.05679",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MSFT",
                    "relevance_score": "0.116067",
                    "ticker_sentiment_score": "0.05679",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AAPL",
                    "relevance_score": "0.116067",
                    "ticker_sentiment_score": "0.05679",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "STT",
                    "relevance_score": "0.058188",
                    "ticker_sentiment_score": "0.035973",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Should Goldman Sachs Equal Weight U.S. Large Cap Equity ETF  ( GSEW )  Be on Your Investing Radar?",
            "url": "https://www.zacks.com/stock/news/2171252/should-goldman-sachs-equal-weight-us-large-cap-equity-etf-gsew-be-on-your-investing-radar",
            "time_published": "20231025T102005",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Style Box ETF report for ...",
            "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default333.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Real Estate & Construction",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.143095,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "GS",
                    "relevance_score": "0.186259",
                    "ticker_sentiment_score": "0.063387",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.124809",
                    "ticker_sentiment_score": "0.057405",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TPL",
                    "relevance_score": "0.124809",
                    "ticker_sentiment_score": "0.057405",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "This Is What Whales Are Betting On Eli Lilly - Eli Lilly  ( NYSE:LLY ) ",
            "url": "https://www.benzinga.com/markets/options/23/10/35396723/this-is-what-whales-are-betting-on-eli-lilly",
            "time_published": "20231024T150109",
            "authors": [
                "Benzinga Insights"
            ],
            "summary": "A whale with a lot of money to spend has taken a noticeably bearish stance on Eli Lilly. Looking at options history for Eli Lilly LLY we detected 21 strange trades. If we consider the specifics of each trade, it is accurate to state that 28% of the investors opened trades with bullish ...",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "Markets",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.266143"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.107079,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.718485",
                    "ticker_sentiment_score": "-0.030766",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WFC",
                    "relevance_score": "0.122269",
                    "ticker_sentiment_score": "-0.132548",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Eli Lilly and Company  ( LLY )  Is a Trending Stock: Facts to Know Before Betting on It",
            "url": "https://www.zacks.com/stock/news/2170716/eli-lilly-and-company-lly-is-a-trending-stock-facts-to-know-before-betting-on-it",
            "time_published": "20231024T130009",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Lilly (LLY) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.",
            "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default56.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.999998"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.5855"
                }
            ],
            "overall_sentiment_score": 0.237864,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.525907",
                    "ticker_sentiment_score": "0.112892",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Why Coke, others, may be spared, as a $100 billion opportunity in weight loss drugs unfolds says JPMorgan",
            "url": "https://www.marketwatch.com/story/the-weight-loss-drugs-are-coming-for-these-companies-but-heres-why-coke-others-may-be-spared-says-jpmorgan-c6c24538",
            "time_published": "20231024T104200",
            "authors": [
                "Barbara Kollmeyer"
            ],
            "summary": "JPMorgan says the weight-loss drug industry is now a \"$100 billion plus opportunity.\" Coke is one of the stocks they say is likely to get hit less hard.",
            "banner_image": "https://images.mktw.net/im-874075?width=700&height=763",
            "source": "MarketWatch",
            "category_within_source": "Top Stories",
            "source_domain": "www.marketwatch.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.929393"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.451494"
                }
            ],
            "overall_sentiment_score": 0.129162,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "KO",
                    "relevance_score": "0.126784",
                    "ticker_sentiment_score": "0.038342",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CTLT",
                    "relevance_score": "0.084722",
                    "ticker_sentiment_score": "0.067688",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GM",
                    "relevance_score": "0.084722",
                    "ticker_sentiment_score": "0.116945",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JPM",
                    "relevance_score": "0.126784",
                    "ticker_sentiment_score": "0.019258",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MS",
                    "relevance_score": "0.084722",
                    "ticker_sentiment_score": "-0.045214",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.126784",
                    "ticker_sentiment_score": "0.095915",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "HPNN",
                    "relevance_score": "0.042421",
                    "ticker_sentiment_score": "0.243126",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "TXN",
                    "relevance_score": "0.084722",
                    "ticker_sentiment_score": "0.116945",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AVTR",
                    "relevance_score": "0.084722",
                    "ticker_sentiment_score": "0.067688",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DASH",
                    "relevance_score": "0.084722",
                    "ticker_sentiment_score": "0.140662",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DHR",
                    "relevance_score": "0.084722",
                    "ticker_sentiment_score": "0.067688",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MSFT",
                    "relevance_score": "0.126784",
                    "ticker_sentiment_score": "0.182706",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "TSLA",
                    "relevance_score": "0.042421",
                    "ticker_sentiment_score": "0.243126",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "KDP",
                    "relevance_score": "0.084722",
                    "ticker_sentiment_score": "0.142685",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "V",
                    "relevance_score": "0.084722",
                    "ticker_sentiment_score": "0.116945",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.084722",
                    "ticker_sentiment_score": "0.083395",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "RGEN",
                    "relevance_score": "0.084722",
                    "ticker_sentiment_score": "0.067688",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PEP",
                    "relevance_score": "0.084722",
                    "ticker_sentiment_score": "-0.10898",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PODD",
                    "relevance_score": "0.084722",
                    "ticker_sentiment_score": "0.211781",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "SFM",
                    "relevance_score": "0.084722",
                    "ticker_sentiment_score": "0.142685",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "UBER",
                    "relevance_score": "0.084722",
                    "ticker_sentiment_score": "0.140662",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DXCM",
                    "relevance_score": "0.084722",
                    "ticker_sentiment_score": "0.211781",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "WMT",
                    "relevance_score": "0.084722",
                    "ticker_sentiment_score": "-0.10898",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Eli Lilly Unusual Options Activity For October 23 - Eli Lilly  ( NYSE:LLY ) ",
            "url": "https://www.benzinga.com/markets/options/23/10/35383700/eli-lilly-unusual-options-activity-for-october-23",
            "time_published": "20231023T204542",
            "authors": [
                "Benzinga Insights"
            ],
            "summary": "Someone with a lot of money to spend has taken a bearish stance on Eli Lilly LLY. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "Markets",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.214378"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.07335,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.805954",
                    "ticker_sentiment_score": "0.178416",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "WFC",
                    "relevance_score": "0.103331",
                    "ticker_sentiment_score": "-0.124574",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "C",
                    "relevance_score": "0.103331",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Should First Trust Capital Strength ETF  ( FTCS )  Be on Your Investing Radar?",
            "url": "https://www.zacks.com/stock/news/2170081/should-first-trust-capital-strength-etf-ftcs-be-on-your-investing-radar",
            "time_published": "20231023T102005",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Style Box ETF report for ...",
            "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default296.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.310843"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.262161,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.127795",
                    "ticker_sentiment_score": "0.060366",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CSCO",
                    "relevance_score": "0.127795",
                    "ticker_sentiment_score": "0.060366",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TJX",
                    "relevance_score": "0.127795",
                    "ticker_sentiment_score": "0.060366",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Amazon, Alphabet, Meta, Intel Q3 Earnings This Week: Will Mega-Caps Shatter Forecasts And Revive Market? - Alphabet  ( NASDAQ:GOOGL ) , Logitech International  ( NASDAQ:LOGI ) , Archer-Daniels Midland  ( NYSE:ADM ) , Novartis  ( NYSE:NVS ) ",
            "url": "https://www.benzinga.com/analyst-ratings/analyst-color/23/10/35367409/amazon-alphabet-meta-intel-q3-earnings-this-week-will-mega-caps-shatter-forecasts-a",
            "time_published": "20231023T071517",
            "authors": [
                "Shanthi Rexaline"
            ],
            "summary": "After the first week of earnings, analysts have tempered their expectations for profit growth, anticipating a continuation of the profit-declining trend.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/Q3_Earnings.jpeg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "News",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.142857"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.142857"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.142857"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.142857"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.142857"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.744043"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.142857"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.998645"
                },
                {
                    "topic": "Real Estate & Construction",
                    "relevance_score": "0.142857"
                }
            ],
            "overall_sentiment_score": 0.117862,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LOGI",
                    "relevance_score": "0.104228",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ADM",
                    "relevance_score": "0.104228",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "STM",
                    "relevance_score": "0.104228",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.104228",
                    "ticker_sentiment_score": "-0.100479",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DFS",
                    "relevance_score": "0.104228",
                    "ticker_sentiment_score": "-0.182444",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "TSLA",
                    "relevance_score": "0.104228",
                    "ticker_sentiment_score": "-0.182444",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "MA",
                    "relevance_score": "0.052226",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ORLY",
                    "relevance_score": "0.104228",
                    "ticker_sentiment_score": "-0.172658",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "STX",
                    "relevance_score": "0.104228",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NSC",
                    "relevance_score": "0.104228",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "XRX",
                    "relevance_score": "0.104228",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AA",
                    "relevance_score": "0.104228",
                    "ticker_sentiment_score": "-0.182444",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "META",
                    "relevance_score": "0.104228",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MO",
                    "relevance_score": "0.104228",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NOC",
                    "relevance_score": "0.104228",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SPOT",
                    "relevance_score": "0.104228",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BSX",
                    "relevance_score": "0.104228",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NOK",
                    "relevance_score": "0.104228",
                    "ticker_sentiment_score": "-0.182444",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "PKG",
                    "relevance_score": "0.104228",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "EW",
                    "relevance_score": "0.104228",
                    "ticker_sentiment_score": "-0.172658",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "XOM",
                    "relevance_score": "0.104228",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "RCL",
                    "relevance_score": "0.104228",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CHTR",
                    "relevance_score": "0.104228",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "HPE",
                    "relevance_score": "0.104228",
                    "ticker_sentiment_score": "-0.182444",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "VZ",
                    "relevance_score": "0.104228",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "F",
                    "relevance_score": "0.104228",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "HPQ",
                    "relevance_score": "0.052226",
                    "ticker_sentiment_score": "-0.16858",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "TXN",
                    "relevance_score": "0.104228",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BYD",
                    "relevance_score": "0.104228",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "HTZ",
                    "relevance_score": "0.104228",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MSFT",
                    "relevance_score": "0.155786",
                    "ticker_sentiment_score": "0.065554",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PHM",
                    "relevance_score": "0.104228",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "IBM",
                    "relevance_score": "0.104228",
                    "ticker_sentiment_score": "-0.172658",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.104228",
                    "ticker_sentiment_score": "-0.100479",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "COF",
                    "relevance_score": "0.104228",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GD",
                    "relevance_score": "0.104228",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GE",
                    "relevance_score": "0.104228",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "KLAC",
                    "relevance_score": "0.104228",
                    "ticker_sentiment_score": "-0.172658",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "GOOG",
                    "relevance_score": "0.104228",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "KO",
                    "relevance_score": "0.104228",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GM",
                    "relevance_score": "0.104228",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CL",
                    "relevance_score": "0.104228",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LUV",
                    "relevance_score": "0.104228",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SNAP",
                    "relevance_score": "0.104228",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CP",
                    "relevance_score": "0.104228",
                    "ticker_sentiment_score": "-0.172658",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "BMY",
                    "relevance_score": "0.104228",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TMUS",
                    "relevance_score": "0.104228",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "HAL",
                    "relevance_score": "0.104228",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SEDG",
                    "relevance_score": "0.104228",
                    "ticker_sentiment_score": "-0.182444",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "INTC",
                    "relevance_score": "0.104228",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CCZ",
                    "relevance_score": "0.052226",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AMZN",
                    "relevance_score": "0.104228",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ODFL",
                    "relevance_score": "0.104228",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "3 Unstoppable Stocks to Buy Sooner Rather Than Later",
            "url": "https://www.fool.com/investing/2023/10/22/3-unstoppable-stocks-to-buy-sooner-rather-than-lat/",
            "time_published": "20231022T105500",
            "authors": [
                "and Prosper Junior Bakiny",
                "David Jagielski",
                "Keith Speights"
            ],
            "summary": "Now is the time to invest in these great stocks.",
            "banner_image": "https://g.foolcdn.com/misc-assets/hp-sa-cumulative-growth-chart.png",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.796627"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.266143"
                }
            ],
            "overall_sentiment_score": 0.172773,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.287441",
                    "ticker_sentiment_score": "0.100872",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "VRTX",
                    "relevance_score": "0.166743",
                    "ticker_sentiment_score": "0.014889",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.326283",
                    "ticker_sentiment_score": "0.046633",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Is Your Weight-loss Medication Genuine? Demand For Drugs From Novo Nordisk And Eli Lilly Leads To Surge In Counterfeits - Novo Nordisk  ( NYSE:NVO ) , Eli Lilly  ( NYSE:LLY ) ",
            "url": "https://www.benzinga.com/markets/equities/23/10/35362605/is-your-weight-loss-medication-genuine-demand-for-drugs-from-novo-nordisk-and-eli-lilly-leads-to",
            "time_published": "20231022T015622",
            "authors": [
                "Nabaparna Bhattacharya"
            ],
            "summary": "As obesity rates climb worldwide, so does the demand for weight-loss medications like Novo Nordisk's NVO Ozempic and Eli Lilly And Company's LLY Mounjaro. This heightened demand, however, has spurred a troubling rise in counterfeit drugs, law enforcement and health officials reveal, according to ...",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/10/21/shutterstock_2309846461.jpg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": -0.084419,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.166169",
                    "ticker_sentiment_score": "-0.095993",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Lilly's Retevmo  ( selpercatinib )  Phase 3 Results in RET Fusion-Positive Non-Small Cell Lung Cancer and RET-Mutant Medullary Thyroid Cancer Both Published in The New England Journal of Medicine and Presented in a Presidential Symposium at ESMO Congress 2023",
            "url": "https://www.prnewswire.com/news-releases/lillys-retevmo-selpercatinib-phase-3-results-in-ret-fusion-positive-non-small-cell-lung-cancer-and-ret-mutant-medullary-thyroid-cancer-both-published-in-the-new-england-journal-of-medicine-and-presented-in-a-presidential-sympo-301963757.html",
            "time_published": "20231021T143100",
            "authors": [
                "Eli Lilly and Company"
            ],
            "summary": "Lilly's Retevmo ( selpercatinib ) Phase 3 Results in RET Fusion-Positive Non-Small Cell Lung Cancer and RET-Mutant ... PR ...",
            "banner_image": "https://mma.prnewswire.com/media/133140/eli_lilly_and_company_logo.jpg?p=facebook",
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.310843"
                }
            ],
            "overall_sentiment_score": 0.02431,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.077125",
                    "ticker_sentiment_score": "0.080031",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "META",
                    "relevance_score": "0.009655",
                    "ticker_sentiment_score": "0.147458",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Eli Lilly Says Lebrikizumab Monthly Maintenance Dosing At Two Years Demonstrated Efficacy For Patients With Eczema - Eli Lilly  ( NYSE:LLY ) ",
            "url": "https://www.benzinga.com/markets/equities/23/10/35349114/eli-lilly-says-lebrikizumab-monthly-maintenance-dosing-at-two-years-demonstrated-efficacy-for-pa",
            "time_published": "20231020T150730",
            "authors": [
                "Shivani Kumaresan"
            ],
            "summary": "Eli Lilly And Company LLY said patients with moderate-to-severe atopic dermatitis who continued treatment with investigational lebrikizumab for up to two years experienced sustained skin clearance.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/10/20/lly_1.png?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.108179"
                }
            ],
            "overall_sentiment_score": -0.0704,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.657566",
                    "ticker_sentiment_score": "0.037523",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "The top 10 things to watch in the stock market Friday",
            "url": "https://www.cnbc.com/2023/10/20/the-top-10-things-to-watch-in-the-stock-market-friday.html",
            "time_published": "20231020T131905",
            "authors": [
                "Jeff Marks"
            ],
            "summary": "Will the yield on the 10-year Treasury breach 5% Friday, and how will markets react?",
            "banner_image": "https://image.cnbcfm.com/api/v1/image/107123736-1663957784492-gettyimages-482832746-000070312695_Unapproved.jpeg?v=1697807945&w=1920&h=1080",
            "source": "CNBC",
            "category_within_source": "Top News",
            "source_domain": "www.cnbc.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.997405"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.995015"
                }
            ],
            "overall_sentiment_score": 0.173123,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "F",
                    "relevance_score": "0.13459",
                    "ticker_sentiment_score": "0.176393",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "GM",
                    "relevance_score": "0.13459",
                    "ticker_sentiment_score": "0.176393",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JPM",
                    "relevance_score": "0.067536",
                    "ticker_sentiment_score": "0.145206",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MS",
                    "relevance_score": "0.13459",
                    "ticker_sentiment_score": "-0.06791",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "UNP",
                    "relevance_score": "0.13459",
                    "ticker_sentiment_score": "0.174759",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.200688",
                    "ticker_sentiment_score": "0.159599",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "SLB",
                    "relevance_score": "0.067536",
                    "ticker_sentiment_score": "0.07438",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AXP",
                    "relevance_score": "0.13459",
                    "ticker_sentiment_score": "0.123096",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GS",
                    "relevance_score": "0.067536",
                    "ticker_sentiment_score": "-0.114966",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ISRG",
                    "relevance_score": "0.13459",
                    "ticker_sentiment_score": "0.012275",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AMZN",
                    "relevance_score": "0.200688",
                    "ticker_sentiment_score": "0.229",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Pharma Stock Roundup: JNJ Posts Upbeat Q3 Earnings, PFE, NVO Revise 2023 View",
            "url": "https://www.zacks.com/stock/news/2169495/pharma-stock-roundup-jnj-posts-upbeat-q3-earnings-pfe-nvo-revise-2023-view",
            "time_published": "20231020T130200",
            "authors": [
                "Kinjel Shah"
            ],
            "summary": "J&J (JNJ) reports strong third-quarter results. Merck's (MRK) new deal with Japan's Daiichi Sankyo to jointly develop the latter's three DXd ADC candidates.",
            "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/f5/952.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.994953"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.214378"
                }
            ],
            "overall_sentiment_score": 0.102884,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.064362",
                    "ticker_sentiment_score": "-0.153214",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "SKXJF",
                    "relevance_score": "0.128306",
                    "ticker_sentiment_score": "-0.016733",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DSKYF",
                    "relevance_score": "0.128306",
                    "ticker_sentiment_score": "-0.016733",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AZN",
                    "relevance_score": "0.032207",
                    "ticker_sentiment_score": "-0.277037",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.222546",
                    "ticker_sentiment_score": "0.12752",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.253316",
                    "ticker_sentiment_score": "-0.128908",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Should iShares MSCI USA Min Vol Factor ETF  ( USMV )  Be on Your Investing Radar?",
            "url": "https://www.zacks.com/stock/news/2169370/should-ishares-msci-usa-min-vol-factor-etf-usmv-be-on-your-investing-radar",
            "time_published": "20231020T102004",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Style Box ETF report for ...",
            "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default94.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.150986,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "BLK",
                    "relevance_score": "0.064449",
                    "ticker_sentiment_score": "0.050028",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.128478",
                    "ticker_sentiment_score": "0.058182",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "VMW",
                    "relevance_score": "0.128478",
                    "ticker_sentiment_score": "0.058182",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "IBM",
                    "relevance_score": "0.128478",
                    "ticker_sentiment_score": "0.058182",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Eli Lilly and Company  ( NYSE:LLY )  Rating Lowered to Hold at StockNews.com",
            "url": "https://www.defenseworld.net/2023/10/20/eli-lilly-and-company-nyselly-rating-lowered-to-hold-at-stocknews-com.html",
            "time_published": "20231020T064041",
            "authors": [
                "Defense World Staff"
            ],
            "summary": "Eli Lilly and Company ( NYSE:LLY ) Rating Lowered to Hold at ... Defense World ...",
            "banner_image": "https://www.marketbeat.com/logos/logo_eli_lilly.jpg",
            "source": "Stocknews.com",
            "category_within_source": "n/a",
            "source_domain": "www.defenseworld.net",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.999999"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.988915"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.203596,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.794507",
                    "ticker_sentiment_score": "0.33678",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "XXII",
                    "relevance_score": "0.043898",
                    "ticker_sentiment_score": "0.024569",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "RBCPF",
                    "relevance_score": "0.043898",
                    "ticker_sentiment_score": "0.024569",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WFC",
                    "relevance_score": "0.043898",
                    "ticker_sentiment_score": "0.024569",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JPM",
                    "relevance_score": "0.043898",
                    "ticker_sentiment_score": "0.024569",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Pressure Mounts As Yields Flirt With 5%; Fear Gauge Offers Hope",
            "url": "https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-pressure-mounts-as-yields-flirt-with-5-tesla-dives-this-market-gauge-offers-hope/",
            "time_published": "20231019T203200",
            "authors": [
                "Investor's Business Daily",
                "ED CARSON"
            ],
            "summary": "Pressure Mounts As Yields Flirt With 5%. Fear Gauge Offers Hope Investor's Business Daily ...",
            "banner_image": "https://www.investors.com/wp-content/uploads/2018/01/FAB-fear-020518-shutterstock.jpg",
            "source": "Investors Business Daily",
            "category_within_source": "n/a",
            "source_domain": "www.investors.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.95493"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.25"
                }
            ],
            "overall_sentiment_score": -0.053454,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "MSFT",
                    "relevance_score": "0.236588",
                    "ticker_sentiment_score": "0.089875",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "META",
                    "relevance_score": "0.079921",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ANET",
                    "relevance_score": "0.159043",
                    "ticker_sentiment_score": "-0.05506",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TSLA",
                    "relevance_score": "0.210961",
                    "ticker_sentiment_score": "0.005183",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.05333",
                    "ticker_sentiment_score": "-0.271887",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "UNP",
                    "relevance_score": "0.05333",
                    "ticker_sentiment_score": "-0.159029",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "ADBE",
                    "relevance_score": "0.185103",
                    "ticker_sentiment_score": "0.021017",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.05333",
                    "ticker_sentiment_score": "-0.271887",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "SLB",
                    "relevance_score": "0.106423",
                    "ticker_sentiment_score": "0.112494",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ISRG",
                    "relevance_score": "0.106423",
                    "ticker_sentiment_score": "-0.230299",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "PLTR",
                    "relevance_score": "0.106423",
                    "ticker_sentiment_score": "0.010019",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Stock Market Erases Gains And Here Comes Powell; Tesla Stock Has This Problem",
            "url": "https://www.investors.com/market-trend/stock-market-today/stock-market-erases-gains-here-comes-powell-teslas-chart-becomes-deformed/",
            "time_published": "20231019T144700",
            "authors": [
                "JUAN CARLOS ARANCIBIA",
                "Investor's Business Daily"
            ],
            "summary": "Stock Market Erases Gains And Here Comes Powell. Tesla Stock ... Investor's Business Daily ...",
            "banner_image": "https://www.investors.com/wp-content/uploads/2022/06/Stock-jeromepowell2022-03-gov.jpg",
            "source": "Investors Business Daily",
            "category_within_source": "n/a",
            "source_domain": "www.investors.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.795202"
                },
                {
                    "topic": "Real Estate & Construction",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.25"
                }
            ],
            "overall_sentiment_score": 0.055338,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "NFLX",
                    "relevance_score": "0.175009",
                    "ticker_sentiment_score": "0.326468",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "TSLA",
                    "relevance_score": "0.175009",
                    "ticker_sentiment_score": "-0.021979",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BX",
                    "relevance_score": "0.1172",
                    "ticker_sentiment_score": "-0.076821",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.1172",
                    "ticker_sentiment_score": "-0.089813",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.175009",
                    "ticker_sentiment_score": "0.012121",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LVS",
                    "relevance_score": "0.1172",
                    "ticker_sentiment_score": "0.244611",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "AMGN",
                    "relevance_score": "0.1172",
                    "ticker_sentiment_score": "-0.089813",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "UNH",
                    "relevance_score": "0.1172",
                    "ticker_sentiment_score": "-0.089813",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "1 Market-Beating Stock to Buy Near Its 52-Week High",
            "url": "https://www.fool.com/investing/2023/10/19/1-market-beating-stock-to-buy-near-52-week-high/",
            "time_published": "20231019T133000",
            "authors": [
                "Prosper Junior Bakiny"
            ],
            "summary": "This stock has been firing on all cylinders -- and it isn't about to stop.",
            "banner_image": "https://media.ycharts.com/charts/a1505ef731280b97dff5e5bf069c8c9a.png",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.77141"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.161647"
                }
            ],
            "overall_sentiment_score": 0.282021,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.268",
                    "ticker_sentiment_score": "0.214712",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "ACCD",
                    "relevance_score": "0.054607",
                    "ticker_sentiment_score": "-0.063291",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.108958",
                    "ticker_sentiment_score": "0.011564",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "4 Ways to Grow $100,000 Into $1 Million for Retirement",
            "url": "https://www.fool.com/investing/2023/10/19/4-ways-to-grow-100000-into-1-million-for-retiremen/",
            "time_published": "20231019T131300",
            "authors": [
                "Jim Halley"
            ],
            "summary": "Investing for big-time growth doesn't have to be risky.",
            "banner_image": "https://g.foolcdn.com/misc-assets/hp-sa-cumulative-growth-chart.png",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "IPO",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.962106"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.999966"
                },
                {
                    "topic": "Real Estate & Construction",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.206499,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.115787",
                    "ticker_sentiment_score": "0.122393",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "VRTX",
                    "relevance_score": "0.077343",
                    "ticker_sentiment_score": "0.050792",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GOOG",
                    "relevance_score": "0.077343",
                    "ticker_sentiment_score": "0.055791",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.115787",
                    "ticker_sentiment_score": "0.097293",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "O",
                    "relevance_score": "0.115787",
                    "ticker_sentiment_score": "0.0852",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "1 Thing You'd Better Know Before You Invest in the Stocks Behind Ozempic and Mounjaro",
            "url": "https://www.fool.com/investing/2023/10/19/1-thing-you-better-know-before-invest-in-ozempic/",
            "time_published": "20231019T130000",
            "authors": [
                "Adam Spatacco"
            ],
            "summary": "Eli Lilly and Novo Nordisk are both battling demand issues for flagship treatments.",
            "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F750321%2Fgettyimages-1404901940.jpg&op=resize&w=700",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.614606"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.87644"
                }
            ],
            "overall_sentiment_score": 0.215497,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.52706",
                    "ticker_sentiment_score": "0.344682",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "WBD",
                    "relevance_score": "0.038162",
                    "ticker_sentiment_score": "0.041449",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.58401",
                    "ticker_sentiment_score": "0.334632",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Is Invesco Pharmaceuticals ETF  ( PJP )  a Strong ETF Right Now?",
            "url": "https://www.zacks.com/stock/news/2168544/is-invesco-pharmaceuticals-etf-pjp-a-strong-etf-right-now",
            "time_published": "20231019T102005",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Smart Beta ETF report for ...",
            "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default265.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.999999"
                }
            ],
            "overall_sentiment_score": 0.258671,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.115509",
                    "ticker_sentiment_score": "0.055568",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ABBV",
                    "relevance_score": "0.115509",
                    "ticker_sentiment_score": "0.055568",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "IVZ",
                    "relevance_score": "0.172507",
                    "ticker_sentiment_score": "0.240144",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "AMGN",
                    "relevance_score": "0.115509",
                    "ticker_sentiment_score": "0.055568",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Eli Lilly Unusual Options Activity - Eli Lilly  ( NYSE:LLY ) ",
            "url": "https://www.benzinga.com/markets/options/23/10/35310788/eli-lilly-unusual-options-activity",
            "time_published": "20231018T144640",
            "authors": [
                "Benzinga Insights"
            ],
            "summary": "A whale with a lot of money to spend has taken a noticeably bullish stance on Eli Lilly. Looking at options history for Eli Lilly LLY we detected 25 strange trades. If we consider the specifics of each trade, it is accurate to state that 52% of the investors opened trades with bullish ...",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "Markets",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.266143"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.132907,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.767534",
                    "ticker_sentiment_score": "0.094594",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WFC",
                    "relevance_score": "0.118647",
                    "ticker_sentiment_score": "-0.130868",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MS",
                    "relevance_score": "0.118647",
                    "ticker_sentiment_score": "-0.130868",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Eli Lilly  ( LLY )  Registers a Bigger Fall Than the Market: Important Facts to Note",
            "url": "https://www.zacks.com/stock/news/2167524/eli-lilly-lly-registers-a-bigger-fall-than-the-market-important-facts-to-note",
            "time_published": "20231017T214518",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Eli Lilly (LLY) reachead $608.31 at the closing of the latest trading day, reflecting a -1.35% change compared to its last close.",
            "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default147.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.961735"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.266143"
                }
            ],
            "overall_sentiment_score": 0.093858,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.52949",
                    "ticker_sentiment_score": "0.142668",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "$100 Invested In This Stock 10 Years Ago Would Be Worth $1,200 Today - Eli Lilly  ( NYSE:LLY ) ",
            "url": "https://www.benzinga.com/news/23/10/35293445/100-invested-in-this-stock-10-years-ago-would-be-worth-1-200-today",
            "time_published": "20231017T163033",
            "authors": [
                "Benzinga Insights"
            ],
            "summary": "Eli Lilly LLY has outperformed the market over the past 10 years by 18.71% on an annualized basis producing an average annual return of 28.29%. Currently, Eli Lilly has a market capitalization of $575.21 billion.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/valuestock_image_1.jpeg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "Trading",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.108179"
                }
            ],
            "overall_sentiment_score": 0.158543,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.980595",
                    "ticker_sentiment_score": "0.375984",
                    "ticker_sentiment_label": "Bullish"
                }
            ]
        },
        {
            "title": "Here's what Ozempic, ASML and India's fintech industry all have in common - and how one ETF takes advantage of all three",
            "url": "https://www.marketwatch.com/story/heres-what-ozempic-asml-and-indias-fintech-industry-all-have-in-common-and-how-one-etf-takes-advantage-of-all-three-70d1260a",
            "time_published": "20231017T125500",
            "authors": [
                "Philip van Doorn"
            ],
            "summary": "C Worldwide Thematic Specialist Morten Springborg says his firm has outperformed by taking a much longer-term approach than is usual for money managers.",
            "banner_image": "https://images.mktw.net/im-869481/social",
            "source": "MarketWatch",
            "category_within_source": "Top Stories",
            "source_domain": "www.marketwatch.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.996718"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.576289"
                }
            ],
            "overall_sentiment_score": 0.140845,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "SMAWF",
                    "relevance_score": "0.030958",
                    "ticker_sentiment_score": "0.104133",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "KO",
                    "relevance_score": "0.030958",
                    "ticker_sentiment_score": "-0.170054",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.061869",
                    "ticker_sentiment_score": "0.046002",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "HDB",
                    "relevance_score": "0.123367",
                    "ticker_sentiment_score": "0.048738",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.061869",
                    "ticker_sentiment_score": "0.068006",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ATLKY",
                    "relevance_score": "0.030958",
                    "ticker_sentiment_score": "0.020023",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ASML",
                    "relevance_score": "0.153863",
                    "ticker_sentiment_score": "0.054463",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WMT",
                    "relevance_score": "0.092688",
                    "ticker_sentiment_score": "-0.029482",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Ozempic Sales Are Skyrocketing Faster Than Expected. Here's Why That's Great News for Eli Lilly Stock.",
            "url": "https://www.fool.com/investing/2023/10/17/ozempic-sales-are-skyrocketing-faster-than-expecte/",
            "time_published": "20231017T095000",
            "authors": [
                "Keith Speights"
            ],
            "summary": "What's good for Novo Nordisk's Ozempic is also good for Eli Lilly's Mounjaro.",
            "banner_image": "https://g.foolcdn.com/misc-assets/hp-sa-cumulative-growth-chart.png",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.614606"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.161647"
                }
            ],
            "overall_sentiment_score": 0.309608,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.455525",
                    "ticker_sentiment_score": "0.390074",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.350564",
                    "ticker_sentiment_score": "0.462387",
                    "ticker_sentiment_label": "Bullish"
                }
            ]
        },
        {
            "title": "Lilly's tirzepatide shows additional 21.1% weight loss after 12 weeks of intensive lifestyle intervention, for a total mean weight loss of 26.6% from study entry over 84 weeks",
            "url": "https://www.prnewswire.com/news-releases/lillys-tirzepatide-shows-additional-21-1-weight-loss-after-12-weeks-of-intensive-lifestyle-intervention-for-a-total-mean-weight-loss-of-26-6-from-study-entry-over-84-weeks-301956883.html",
            "time_published": "20231015T220000",
            "authors": [
                "Eli Lilly and Company"
            ],
            "summary": "Lilly's tirzepatide shows additional 21.1% weight loss after 12 weeks of intensive lifestyle intervention, for a total mean ... PR ...",
            "banner_image": "https://mma.prnewswire.com/media/133140/eli_lilly_and_company_logo.jpg?p=facebook",
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.310843"
                }
            ],
            "overall_sentiment_score": -0.088862,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.136985",
                    "ticker_sentiment_score": "0.06524",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "META",
                    "relevance_score": "0.017207",
                    "ticker_sentiment_score": "0.15408",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "When is it OK to violate your cost basis to buy more shares of a company?",
            "url": "https://www.cnbc.com/2023/10/15/when-is-it-ok-to-violate-your-cost-basis-to-buy-more-shares-of-a-company.html",
            "time_published": "20231015T140101",
            "authors": [
                "Zev Fima"
            ],
            "summary": "Here's how to determine a good buying point when a stock doesn't look ready to come down anytime soon.",
            "banner_image": "https://image.cnbcfm.com/api/v1/image/107278560-1690555294515-gettyimages-1258356004-TAIWAN-COMPUTEX2023-01062023-152JPG.jpeg?v=1697378461&w=1920&h=1080",
            "source": "CNBC",
            "category_within_source": "Top News",
            "source_domain": "www.cnbc.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.538269"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.24399,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.629492",
                    "ticker_sentiment_score": "0.573475",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "NVDA",
                    "relevance_score": "0.629492",
                    "ticker_sentiment_score": "0.573475",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "TSLA",
                    "relevance_score": "0.629492",
                    "ticker_sentiment_score": "0.573475",
                    "ticker_sentiment_label": "Bullish"
                }
            ]
        },
        {
            "title": "Are Ozempic and Similar Treatments Impacting Food and Beverage Stocks? Here's What Pepsi's CFO Said About It",
            "url": "https://www.fool.com/investing/2023/10/14/are-ozempic-and-similar-treatments-impacting-food/",
            "time_published": "20231014T120300",
            "authors": [
                "Adam Spatacco"
            ],
            "summary": "PepsiCo's Q3 earnings may have shed some light on the long-standing speculation about Ozempic's impact on consumer staples.",
            "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F750584%2Fgettyimages-1630177922.jpg&op=resize&w=700",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.161647"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.875462"
                }
            ],
            "overall_sentiment_score": 0.185148,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.066784",
                    "ticker_sentiment_score": "0.065477",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PEP",
                    "relevance_score": "0.38489",
                    "ticker_sentiment_score": "0.263266",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "KO",
                    "relevance_score": "0.066784",
                    "ticker_sentiment_score": "0.025221",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.198493",
                    "ticker_sentiment_score": "0.103525",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "3 Dividend Growth Stocks You Can Buy and Hold Forever",
            "url": "https://www.fool.com/investing/2023/10/14/3-dividend-growth-stocks-you-can-buy-and-hold-fore/",
            "time_published": "20231014T105200",
            "authors": [
                "Keith Speights",
                "and Prosper Junior Bakiny",
                "David Jagielski"
            ],
            "summary": "Investors can sit back and let the dividends flow in with these great stocks.",
            "banner_image": "https://g.foolcdn.com/misc-assets/hp-sa-cumulative-growth-chart.png",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.538269"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.803643"
                }
            ],
            "overall_sentiment_score": 0.201977,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.353338",
                    "ticker_sentiment_score": "0.11404",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ABBV",
                    "relevance_score": "0.278561",
                    "ticker_sentiment_score": "0.130001",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.316337",
                    "ticker_sentiment_score": "0.229411",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Improved Alzheimer's Diagnosis Access: CMS Expands Amyloid PET Scan Usage - Eisai Co  ( OTC:ESALF ) , Biogen  ( NASDAQ:BIIB ) ",
            "url": "https://www.benzinga.com/government/23/10/35245698/improved-alzheimers-diagnosis-access-cms-expands-amyloid-pet-scan-usage",
            "time_published": "20231013T191042",
            "authors": [
                "Vandana Singh"
            ],
            "summary": "The U.S. Centers for Medicare and Medicaid Services has revised its policy permitting multiple uses of amyloid positron emission tomography ( PET ) scans, a non-invasive brain scan crucial for identifying amyloid plaques, a telltale sign of Alzheimer's.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/10/13/dementia-photo_by_gerd_altmann_via_pixabay.jpg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.132291,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.254307",
                    "ticker_sentiment_score": "0.182864",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "ESALF",
                    "relevance_score": "0.128822",
                    "ticker_sentiment_score": "0.114567",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BIIB",
                    "relevance_score": "0.254307",
                    "ticker_sentiment_score": "0.182864",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Jamie Dimon says it's 'the most dangerous time the world has seen in decades.' Here are all the ripple effects.",
            "url": "https://www.marketwatch.com/story/how-to-find-financial-opportunities-in-what-jamie-dimon-calls-the-most-dangerous-time-the-world-has-seen-in-decades-8a363023",
            "time_published": "20231013T163000",
            "authors": [
                "Philip van Doorn"
            ],
            "summary": "Also, hope for housing, close looks at choices for bond investors, a busted IPO and sound advice from the Moneyist.",
            "banner_image": "https://images.mktw.net/im-867562?width=700&height=466",
            "source": "MarketWatch",
            "category_within_source": "Top Stories",
            "source_domain": "www.marketwatch.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.682689"
                },
                {
                    "topic": "IPO",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Economy - Fiscal",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.310843"
                },
                {
                    "topic": "Mergers & Acquisitions",
                    "relevance_score": "0.310843"
                },
                {
                    "topic": "Real Estate & Construction",
                    "relevance_score": "0.166667"
                }
            ],
            "overall_sentiment_score": 0.079738,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "JPM",
                    "relevance_score": "0.06623",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.06623",
                    "ticker_sentiment_score": "0.136302",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "XOM",
                    "relevance_score": "0.06623",
                    "ticker_sentiment_score": "0.253983",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.06623",
                    "ticker_sentiment_score": "0.136302",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PEP",
                    "relevance_score": "0.099202",
                    "ticker_sentiment_score": "0.103922",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "RDFN",
                    "relevance_score": "0.033144",
                    "ticker_sentiment_score": "0.199051",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "PXD",
                    "relevance_score": "0.06623",
                    "ticker_sentiment_score": "0.253983",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "WMT",
                    "relevance_score": "0.06623",
                    "ticker_sentiment_score": "-0.027173",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Eli Lilly's  ( LLY )  Mirikizumab Meets Crohn's Disease Study Goals",
            "url": "https://www.zacks.com/stock/news/2165822/eli-lillys-lly-mirikizumab-meets-crohns-disease-study-goals",
            "time_published": "20231013T162900",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Based on this data, Eli Lilly (LLY) will initiate regulatory submissions worldwide next year seeking regulatory approval for mirikizumab in Crohn's disease.",
            "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/fc/588.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.769861"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.155568,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.601928",
                    "ticker_sentiment_score": "0.327734",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "CORT",
                    "relevance_score": "0.387875",
                    "ticker_sentiment_score": "0.254298",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "ABBV",
                    "relevance_score": "0.387875",
                    "ticker_sentiment_score": "0.276863",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "What exactly are patients taking new weight-loss drugs eating and what are they avoiding? Bernstein asked them.",
            "url": "https://www.marketwatch.com/story/what-exactly-are-patients-taking-new-weight-loss-drugs-eating-and-what-are-they-avoiding-bernstein-asked-them-3d523d3d",
            "time_published": "20231013T153400",
            "authors": [
                "Ciara Linnane"
            ],
            "summary": "Bernstein analyzed online data to determine what people taking Ozempic and Wegovy are eating and what are they cutting out of their diets.",
            "banner_image": "https://images.mktw.net/im-868112?width=700&height=415",
            "source": "MarketWatch",
            "category_within_source": "Top Stories",
            "source_domain": "www.marketwatch.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.451494"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.109403,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "GIS",
                    "relevance_score": "0.085476",
                    "ticker_sentiment_score": "0.098113",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SMPL",
                    "relevance_score": "0.085476",
                    "ticker_sentiment_score": "0.10844",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MDLZ",
                    "relevance_score": "0.085476",
                    "ticker_sentiment_score": "0.098113",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CPB",
                    "relevance_score": "0.085476",
                    "ticker_sentiment_score": "-0.047627",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MS",
                    "relevance_score": "0.0428",
                    "ticker_sentiment_score": "-0.123497",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.085476",
                    "ticker_sentiment_score": "0.109358",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "KHC",
                    "relevance_score": "0.085476",
                    "ticker_sentiment_score": "0.098113",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TWNK",
                    "relevance_score": "0.085476",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.169975",
                    "ticker_sentiment_score": "0.093824",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "K",
                    "relevance_score": "0.085476",
                    "ticker_sentiment_score": "0.098113",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "IVZ",
                    "relevance_score": "0.0428",
                    "ticker_sentiment_score": "-0.059562",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TSN",
                    "relevance_score": "0.085476",
                    "ticker_sentiment_score": "-0.047627",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Market Rallies, Hits Resistance: Weekly Review",
            "url": "https://www.investors.com/news/stock-market-rallies-hits-resistance-novo-nordisk-jpmorgan-exxon-in-focus/",
            "time_published": "20231013T152200",
            "authors": [
                "IBD STAFF",
                "Investor's Business Daily"
            ],
            "summary": "Stock Market Rallies, Hits Resistance. Novo Nordisk, JPMorgan ... Investor's Business Daily ...",
            "banner_image": "https://www.investors.com/wp-content/uploads/2016/03/BIGPIC-032316-shutterstock.jpg",
            "source": "Investors Business Daily",
            "category_within_source": "n/a",
            "source_domain": "www.investors.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.576289"
                },
                {
                    "topic": "IPO",
                    "relevance_score": "0.451494"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.99793"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.999819"
                }
            ],
            "overall_sentiment_score": -0.049165,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "C",
                    "relevance_score": "0.146916",
                    "ticker_sentiment_score": "0.069711",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "F",
                    "relevance_score": "0.073773",
                    "ticker_sentiment_score": "0.178146",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JPM",
                    "relevance_score": "0.288893",
                    "ticker_sentiment_score": "-0.020212",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.146916",
                    "ticker_sentiment_score": "-0.029637",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DAL",
                    "relevance_score": "0.110462",
                    "ticker_sentiment_score": "-0.157722",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "DVA",
                    "relevance_score": "0.073773",
                    "ticker_sentiment_score": "-0.067843",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "UNH",
                    "relevance_score": "0.288893",
                    "ticker_sentiment_score": "-0.108098",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "FSNUF",
                    "relevance_score": "0.036926",
                    "ticker_sentiment_score": "-0.06527",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WFC",
                    "relevance_score": "0.146916",
                    "ticker_sentiment_score": "0.069711",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WBA",
                    "relevance_score": "0.073773",
                    "ticker_sentiment_score": "-0.160534",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "XOM",
                    "relevance_score": "0.218817",
                    "ticker_sentiment_score": "0.093971",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.146916",
                    "ticker_sentiment_score": "-0.029637",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PXD",
                    "relevance_score": "0.110462",
                    "ticker_sentiment_score": "0.085682",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Momo Buys On Iran Hinting At Second Front And Israel Issuing An Impossible Evacuation Order - JPMorgan Chase  ( NYSE:JPM ) ",
            "url": "https://www.benzinga.com/markets/23/10/35242061/momo-buys-on-iran-hinting-at-second-front-and-israel-issuing-an-impossible-evacuation-order",
            "time_published": "20231013T143030",
            "authors": [
                "The Arora Report"
            ],
            "summary": "To gain an edge, this is what you need to know today. Please click here for a chart of SPDR S&P 500 ETF Trust SPY which represents the benchmark stock market index S&P 500 ( SPX ) . The chart shows that the stock market pulled back to the top band of the top support zone on rising yields.",
            "banner_image": "https://cdn.benzinga.com/files/nicholas-cappello-wb63zqj5gne-unsplash_11_22.jpg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "Trading",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.576289"
                }
            ],
            "overall_sentiment_score": 0.245115,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "GOOG",
                    "relevance_score": "0.070002",
                    "ticker_sentiment_score": "0.126617",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "META",
                    "relevance_score": "0.070002",
                    "ticker_sentiment_score": "0.126617",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVDA",
                    "relevance_score": "0.070002",
                    "ticker_sentiment_score": "0.126617",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AAPL",
                    "relevance_score": "0.070002",
                    "ticker_sentiment_score": "0.126617",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "C",
                    "relevance_score": "0.104835",
                    "ticker_sentiment_score": "0.203487",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "PNC",
                    "relevance_score": "0.070002",
                    "ticker_sentiment_score": "0.243734",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JPM",
                    "relevance_score": "0.139467",
                    "ticker_sentiment_score": "0.171594",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.070002",
                    "ticker_sentiment_score": "0.154912",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "IVZ",
                    "relevance_score": "0.035035",
                    "ticker_sentiment_score": "0.3556",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "UNH",
                    "relevance_score": "0.070002",
                    "ticker_sentiment_score": "0.243734",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "MSFT",
                    "relevance_score": "0.070002",
                    "ticker_sentiment_score": "0.126617",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TSLA",
                    "relevance_score": "0.070002",
                    "ticker_sentiment_score": "0.126617",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WFC",
                    "relevance_score": "0.070002",
                    "ticker_sentiment_score": "0.243734",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.070002",
                    "ticker_sentiment_score": "0.154912",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Pharma Stock Roundup: LLY Meets IBD Study Goal, PFE, MRK Give Cancer Pipeline Updates",
            "url": "https://www.zacks.com/stock/news/2165526/pharma-stock-roundup-lly-meets-ibd-study-goal-pfe-mrk-give-cancer-pipeline-updates",
            "time_published": "20231013T134100",
            "authors": [
                "Kinjel Shah"
            ],
            "summary": "Eli Lilly's (LLY) mirikizumab meets the main goals in a Crohn's disease study. PFE, MRK and JNJ provide updates on cancer drugs in their pipeline.",
            "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/07/905.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.214378"
                }
            ],
            "overall_sentiment_score": 0.09506,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.158519",
                    "ticker_sentiment_score": "-0.068286",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.079656",
                    "ticker_sentiment_score": "-0.10015",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.119235",
                    "ticker_sentiment_score": "-0.11971",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "The Zacks Analyst Blog Highlights Meta Platforms, Eli Lilly, Caterpillar, Citigroup and Micron Technology",
            "url": "https://www.zacks.com/stock/news/2165420/the-zacks-analyst-blog-highlights-meta-platforms-eli-lilly-caterpillar-citigroup-and-micron-technology",
            "time_published": "20231013T110400",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Meta Platforms, Eli Lilly, Caterpillar, Citigroup and Micron Technology are part of the Zacks top Analyst Blog.",
            "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/fc/588.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.161647"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.714479"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.25"
                }
            ],
            "overall_sentiment_score": 0.278022,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.429671",
                    "ticker_sentiment_score": "0.175974",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "MU",
                    "relevance_score": "0.128822",
                    "ticker_sentiment_score": "0.034897",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "META",
                    "relevance_score": "0.429671",
                    "ticker_sentiment_score": "0.378135",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "C",
                    "relevance_score": "0.128822",
                    "ticker_sentiment_score": "0.034897",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CAT",
                    "relevance_score": "0.31482",
                    "ticker_sentiment_score": "0.216191",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Ozempic Ingredient Gives Maker Novo Nordisk's Kidney Outcomes Trial A Positive Result: How Will This Affect the Industry? - Novo Nordisk  ( NYSE:NVO ) ",
            "url": "https://www.benzinga.com/general/biotech/23/10/35223055/novo-nordisks-kidney-outcomes-trial-has-broad-industry-implications",
            "time_published": "20231012T162353",
            "authors": [
                "Adam Eckert"
            ],
            "summary": "Novo Nordisk A/S NVO shares got a boost this week after the drugmaker halted trials testing potential treatment for kidney failure on early signs of efficacy. The study has implications for other drugmakers including Eli Lilly And Co LLY and DaVita Inc DVA.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/10/12/original-2.jpeg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.141322,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.531326",
                    "ticker_sentiment_score": "0.447428",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "BCS",
                    "relevance_score": "0.115232",
                    "ticker_sentiment_score": "0.220472",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "DVA",
                    "relevance_score": "0.689652",
                    "ticker_sentiment_score": "0.155398",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.531326",
                    "ticker_sentiment_score": "0.423775",
                    "ticker_sentiment_label": "Bullish"
                }
            ]
        },
        {
            "title": "Lilly  ( LLY )  Up on NVO's Ozempic Early Success in Kidney Study",
            "url": "https://www.zacks.com/stock/news/2165095/lilly-lly-up-on-nvos-ozempic-early-success-in-kidney-study",
            "time_published": "20231012T161300",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Eli Lilly's (LLY) Mounjaro is also being evaluated in clinical studies for patients who are obese or overweight and have CKD. Investors are probably expecting similar success with Mounjaro's CKD study.",
            "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/cc/389.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.576289"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.156478,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.43494",
                    "ticker_sentiment_score": "0.235223",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "AUPH",
                    "relevance_score": "0.318897",
                    "ticker_sentiment_score": "0.15358",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.130571",
                    "ticker_sentiment_score": "-0.039629",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ALPN",
                    "relevance_score": "0.257668",
                    "ticker_sentiment_score": "0.217631",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Top Research Reports for Meta Platforms, Eli Lilly & Caterpillar",
            "url": "https://www.zacks.com/research-daily/2164849/top-research-reports-for-meta-platforms-eli-lilly-caterpillar",
            "time_published": "20231012T144800",
            "authors": [
                "Sheraz Mian"
            ],
            "summary": "Today's Research Daily features new research reports on 16 major stocks, including Meta Platforms, Inc. (META), Eli Lilly and Company (LLY) and Caterpillar Inc. (CAT).",
            "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default261.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.108179"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.714479"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.339006,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.338582",
                    "ticker_sentiment_score": "0.215333",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "META",
                    "relevance_score": "0.338582",
                    "ticker_sentiment_score": "0.563225",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "CAT",
                    "relevance_score": "0.173333",
                    "ticker_sentiment_score": "0.269458",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Eli Lilly Treatment For Crohn's Tops Placebo In Latest Study, Makes Plans For 2024 - Eli Lilly  ( NYSE:LLY ) ",
            "url": "https://www.benzinga.com/general/biotech/23/10/35220123/eli-lilly-treatment-for-crohns-tops-placebo-in-latest-study-makes-plans-for-2024",
            "time_published": "20231012T142658",
            "authors": [
                "Vandana Singh"
            ],
            "summary": "Eli Lilly And Co LLY plans to submit a marketing application for a drug that treats Crohn's disease to the Food and Drug Administration ( FDA ) in 2024.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/10/12/aapharma_3.png?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.105062,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.401331",
                    "ticker_sentiment_score": "0.122858",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "This Is What Whales Are Betting On Eli Lilly - Eli Lilly  ( NYSE:LLY ) ",
            "url": "https://www.benzinga.com/markets/options/23/10/35221521/this-is-what-whales-are-betting-on-eli-lilly",
            "time_published": "20231012T141720",
            "authors": [
                "Benzinga Insights"
            ],
            "summary": "A whale with a lot of money to spend has taken a noticeably bearish stance on Eli Lilly. Looking at options history for Eli Lilly LLY we detected 43 strange trades. If we consider the specifics of each trade, it is accurate to state that 46% of the investors opened trades with bullish ...",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "Markets",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.266143"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.090713,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.767534",
                    "ticker_sentiment_score": "-0.094486",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WFC",
                    "relevance_score": "0.118647",
                    "ticker_sentiment_score": "-0.130868",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MS",
                    "relevance_score": "0.118647",
                    "ticker_sentiment_score": "-0.130868",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "3 Super Safe Dividend Stocks That Have Been Making Payments for Decades",
            "url": "https://www.fool.com/investing/2023/10/12/3-super-safe-dividend-stocks-that-have-been-making/",
            "time_published": "20231012T131500",
            "authors": [
                "David Jagielski"
            ],
            "summary": "These are income-generating investments that you can buy and forget about.",
            "banner_image": "https://g.foolcdn.com/misc-assets/hp-sa-cumulative-growth-chart.png",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.623304"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.744043"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.357903,
            "overall_sentiment_label": "Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "ATVI",
                    "relevance_score": "0.055492",
                    "ticker_sentiment_score": "0.169913",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.323785",
                    "ticker_sentiment_score": "0.411306",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "MSFT",
                    "relevance_score": "0.272181",
                    "ticker_sentiment_score": "0.190477",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "KO",
                    "relevance_score": "0.323785",
                    "ticker_sentiment_score": "0.332113",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Lilly  ( LLY )  Moves 4.5% Higher: Will This Strength Last?",
            "url": "https://www.zacks.com/stock/news/2164784/lilly-lly-moves-45-higher-will-this-strength-last",
            "time_published": "20231012T130400",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Lilly (LLY) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.",
            "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default52.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.972476"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.365926"
                }
            ],
            "overall_sentiment_score": 0.156527,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.551295",
                    "ticker_sentiment_score": "0.13081",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.120431",
                    "ticker_sentiment_score": "0.045165",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SNY",
                    "relevance_score": "0.551295",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Futures Rise With CPI Inflation Due",
            "url": "https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-market-rally-at-key-levels-as-inflation-data-looms-novo-nordisk-soars/",
            "time_published": "20231012T120700",
            "authors": [
                "Investor's Business Daily",
                "ED CARSON"
            ],
            "summary": "Dow Jones Futures Rise: Market Rally At Key Levels As Inflation ... Investor's Business Daily ...",
            "banner_image": "https://www.investors.com/wp-content/uploads/2019/12/FAP2020-bull-123019-shutter.jpg",
            "source": "Investors Business Daily",
            "category_within_source": "n/a",
            "source_domain": "www.investors.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.998626"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.650727"
                },
                {
                    "topic": "Real Estate & Construction",
                    "relevance_score": "0.166667"
                }
            ],
            "overall_sentiment_score": 0.002419,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "DKNG",
                    "relevance_score": "0.108222",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVDA",
                    "relevance_score": "0.188193",
                    "ticker_sentiment_score": "0.038691",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TSLA",
                    "relevance_score": "0.027134",
                    "ticker_sentiment_score": "0.215241",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "F",
                    "relevance_score": "0.081276",
                    "ticker_sentiment_score": "-0.035159",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.108222",
                    "ticker_sentiment_score": "0.014356",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ADBE",
                    "relevance_score": "0.135043",
                    "ticker_sentiment_score": "0.057918",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.16171",
                    "ticker_sentiment_score": "0.006935",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "IVZ",
                    "relevance_score": "0.027134",
                    "ticker_sentiment_score": "0.071256",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "STRL",
                    "relevance_score": "0.054236",
                    "ticker_sentiment_score": "0.134779",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DAL",
                    "relevance_score": "0.108222",
                    "ticker_sentiment_score": "-0.158279",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "DVA",
                    "relevance_score": "0.054236",
                    "ticker_sentiment_score": "-0.161835",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "FOREX:GBP",
                    "relevance_score": "0.027134",
                    "ticker_sentiment_score": "0.125029",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Lilly's Mirikizumab Helped Patients with Crohn's Disease Achieve Long-Term Remission in Phase 3 Trial",
            "url": "https://www.prnewswire.com/news-releases/lillys-mirikizumab-helped-patients-with-crohns-disease-achieve-long-term-remission-in-phase-3-trial-301954471.html",
            "time_published": "20231012T104500",
            "authors": [
                "Eli Lilly and Company"
            ],
            "summary": "Mirikizumab demonstrated clinical remission and endoscopic response for patients with moderately to severely active Crohn's disease through 52 weeks The study achieved the coprimary endpoints and all major secondary endpoints versus placebo",
            "banner_image": "https://mma.prnewswire.com/media/133140/eli_lilly_and_company_logo.jpg?p=facebook",
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.310843"
                }
            ],
            "overall_sentiment_score": 0.082731,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.23008",
                    "ticker_sentiment_score": "0.130884",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "META",
                    "relevance_score": "0.033328",
                    "ticker_sentiment_score": "0.164115",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Why Eli Lilly Stock's Dream Run May Not Be Over Yet - The Future Fund Active ETF  ( ARCA:FFND ) , Novo Nordisk  ( NYSE:NVO ) , Eli Lilly  ( NYSE:LLY ) ",
            "url": "https://www.benzinga.com/analyst-ratings/analyst-color/23/10/35213501/eli-lilly-to-fly-higher-fund-manager-gary-black-envisions-blockbuster-potential-for",
            "time_published": "20231012T084057",
            "authors": [
                "Shanthi Rexaline"
            ],
            "summary": "Eli Lilly & Co. LLY has been a high-flier among the mega-cap pharma stocks this year, as the company leverages the obesity drug craze. Prominent Tesla investor and Future Fund Manager Gary Black weighed in on the stock's run-up and its future trajectory.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/Eli_Lilly_1.jpeg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "Trading",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.744043"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.120341,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.68471",
                    "ticker_sentiment_score": "0.144027",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TSLA",
                    "relevance_score": "0.09989",
                    "ticker_sentiment_score": "0.016091",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MS",
                    "relevance_score": "0.09989",
                    "ticker_sentiment_score": "0.03599",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.198221",
                    "ticker_sentiment_score": "0.133554",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Dow Jones Rises After Fed Minutes As House Vote On New Speaker Looms; Meta Breaks Out",
            "url": "https://www.investors.com/market-trend/stock-market-today/dow-jones-rises-after-fed-minutes-as-house-vote-on-new-speaker-looms-meta-breaks-out/",
            "time_published": "20231011T195200",
            "authors": [
                "VIDYA RAMAKRISHNAN",
                "Investor's Business Daily"
            ],
            "summary": "Dow Jones Rises After Fed Minutes As House Vote On New ... Investor's Business Daily ...",
            "banner_image": "https://www.investors.com/wp-content/uploads/2019/01/stock-FederalReserve-snow-11-shutter.jpg",
            "source": "Investors Business Daily",
            "category_within_source": "n/a",
            "source_domain": "www.investors.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.769861"
                },
                {
                    "topic": "IPO",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.999981"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.451494"
                }
            ],
            "overall_sentiment_score": 0.062531,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "META",
                    "relevance_score": "0.100308",
                    "ticker_sentiment_score": "0.04817",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CAVA",
                    "relevance_score": "0.100308",
                    "ticker_sentiment_score": "-0.081807",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "HZNP",
                    "relevance_score": "0.050254",
                    "ticker_sentiment_score": "0.236385",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JPM",
                    "relevance_score": "0.100308",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MS",
                    "relevance_score": "0.050254",
                    "ticker_sentiment_score": "-0.076389",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ADBE",
                    "relevance_score": "0.100308",
                    "ticker_sentiment_score": "0.197599",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.149966",
                    "ticker_sentiment_score": "0.235216",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "FAST",
                    "relevance_score": "0.100308",
                    "ticker_sentiment_score": "0.032902",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AMGN",
                    "relevance_score": "0.199037",
                    "ticker_sentiment_score": "0.209207",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "DXCM",
                    "relevance_score": "0.100308",
                    "ticker_sentiment_score": "0.04772",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Is There A Blood Test for Alzheimer's? Progress Underway, But Not Quite Ready - Roche Holding  ( OTC:RHHBF ) , Roche Holding  ( OTC:RHHVF ) , Roche Holding  ( OTC:RHHBY ) ",
            "url": "https://www.benzinga.com/news/large-cap/23/10/35199963/is-there-a-blood-test-for-alzheimers-progress-underway-but-not-quite-ready",
            "time_published": "20231011T182704",
            "authors": [
                "Vandana Singh"
            ],
            "summary": "Blood tests for diagnosing Alzheimer's disease are eagerly awaited, but it may be a couple of years before they become a routine diagnostic tool. While several blood tests for Alzheimer's diagnosis are in development, none are approved by regulators or insurance reimbursement.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/10/11/dementia-photo_by_gerd_altmann_via_pixabay.jpg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.004782,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.229149",
                    "ticker_sentiment_score": "-0.005294",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DGX",
                    "relevance_score": "0.229149",
                    "ticker_sentiment_score": "-0.012987",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LH",
                    "relevance_score": "0.229149",
                    "ticker_sentiment_score": "-0.012987",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ESALF",
                    "relevance_score": "0.115787",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BIIB",
                    "relevance_score": "0.229149",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "QTRX",
                    "relevance_score": "0.115787",
                    "ticker_sentiment_score": "-0.0034",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "What's Going On With Eli Lilly Stock Wednesday? - Eli Lilly  ( NYSE:LLY ) ",
            "url": "https://www.benzinga.com/news/23/10/35197403/whats-going-on-with-eli-lilly-stock-wednesday",
            "time_published": "20231011T161603",
            "authors": [
                "Adam Eckert"
            ],
            "summary": "Eli Lilly And Co LLY shares are trading higher Wednesday. The stock appears to be moving alongside Novo Nordisk NVO shares after the drugmaker halted trials on early signs of efficiency.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/10/11/us_devicefront_5.png?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "News",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.161647"
                }
            ],
            "overall_sentiment_score": 0.096302,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.810649",
                    "ticker_sentiment_score": "0.159772",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "MS",
                    "relevance_score": "0.426225",
                    "ticker_sentiment_score": "0.014121",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.426225",
                    "ticker_sentiment_score": "0.433376",
                    "ticker_sentiment_label": "Bullish"
                }
            ]
        },
        {
            "title": "Why Eli Lilly Stock Is Jumping Today",
            "url": "https://www.fool.com/investing/2023/10/11/why-eli-lilly-stock-is-jumping-today/",
            "time_published": "20231011T154531",
            "authors": [
                "Keith Speights"
            ],
            "summary": "Good news for Novo Nordisk's Ozempic could be good news for Lilly's Mounjaro.",
            "banner_image": "https://g.foolcdn.com/misc-assets/hp-sa-cumulative-growth-chart.png",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.272474,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.407844",
                    "ticker_sentiment_score": "0.101806",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.279015",
                    "ticker_sentiment_score": "0.085592",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Lexicon's  ( LXRX )  Inpefa Gets Preferred Status at Express Scripts",
            "url": "https://www.zacks.com/stock/news/2164477/lexicons-lxrx-inpefa-gets-preferred-status-at-express-scripts",
            "time_published": "20231011T151300",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "A pharmacy benefit manager decides to place Lexicon's (LXRX) heart failure drug as a preferred product on Medicare national formularies on Nov. 1. The stock jumped 12% post this announcement.",
            "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/21/594.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.118925,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.419733",
                    "ticker_sentiment_score": "0.103863",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AZN",
                    "relevance_score": "0.419733",
                    "ticker_sentiment_score": "0.103863",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LXRX",
                    "relevance_score": "0.510588",
                    "ticker_sentiment_score": "0.299286",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Stock Market Shrugs Off Inflation Numbers; Exxon Shares Sink On Deal News",
            "url": "https://www.investors.com/market-trend/stock-market-today/stock-market-shrugs-off-inflation-numbers-exxon-shares-sink-on-deal-news/",
            "time_published": "20231011T150500",
            "authors": [
                "Investor's Business Daily",
                "KIMBERLEY KOENIG"
            ],
            "summary": "Stock Market Shrugs Off Inflation Numbers. Exxon Shares Sink On ... Investor's Business Daily ...",
            "banner_image": "https://www.investors.com/wp-content/uploads/2023/02/Stock-Exxon-05-shutt.jpg",
            "source": "Investors Business Daily",
            "category_within_source": "n/a",
            "source_domain": "www.investors.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Mergers & Acquisitions",
                    "relevance_score": "0.158519"
                }
            ],
            "overall_sentiment_score": 0.224936,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "BAC",
                    "relevance_score": "0.057215",
                    "ticker_sentiment_score": "-0.02308",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.170475",
                    "ticker_sentiment_score": "0.266934",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "IVZ",
                    "relevance_score": "0.057215",
                    "ticker_sentiment_score": "0.124963",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DVA",
                    "relevance_score": "0.170475",
                    "ticker_sentiment_score": "0.057648",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SSNLF",
                    "relevance_score": "0.057215",
                    "ticker_sentiment_score": "0.063943",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "FSNUF",
                    "relevance_score": "0.057215",
                    "ticker_sentiment_score": "0.039171",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WBA",
                    "relevance_score": "0.114137",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "XOM",
                    "relevance_score": "0.114137",
                    "ticker_sentiment_score": "-0.01351",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.114137",
                    "ticker_sentiment_score": "0.349647",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "BAX",
                    "relevance_score": "0.114137",
                    "ticker_sentiment_score": "0.045651",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TKR",
                    "relevance_score": "0.114137",
                    "ticker_sentiment_score": "-0.026795",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PXD",
                    "relevance_score": "0.170475",
                    "ticker_sentiment_score": "-0.016892",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TTWO",
                    "relevance_score": "0.114137",
                    "ticker_sentiment_score": "0.344067",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "What's Going On With Kidney Dialysis Provider Stocks Today? - Novo Nordisk  ( NYSE:NVO ) , DaVita  ( NYSE:DVA ) ",
            "url": "https://www.benzinga.com/news/large-cap/23/10/35190991/whats-going-on-with-kidney-dialysis-provider-stocks-today",
            "time_published": "20231011T135258",
            "authors": [
                "Vandana Singh"
            ],
            "summary": "DaVita Inc DVA, Fresenius Medical Care AG FMS, and Baxter International Inc BAX shares fell sharply in reaction to Novo Nordisk A/S's NVO stopping semaglutide kidney outcomes trial FLOW based on early signs of efficacy.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/10/11/dva.png?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.108179"
                }
            ],
            "overall_sentiment_score": 0.028791,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "C",
                    "relevance_score": "0.162802",
                    "ticker_sentiment_score": "0.173793",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "FSNUF",
                    "relevance_score": "0.162802",
                    "ticker_sentiment_score": "-0.187398",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.462395",
                    "ticker_sentiment_score": "-0.352277",
                    "ticker_sentiment_label": "Bearish"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.318897",
                    "ticker_sentiment_score": "0.039516",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BAX",
                    "relevance_score": "0.462395",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "FMS",
                    "relevance_score": "0.462395",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DVA",
                    "relevance_score": "0.462395",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Ozempic Is Moving a Bunch of Stocks Wednesday Morning",
            "url": "https://www.fool.com/investing/2023/10/11/ozempic-is-moving-a-bunch-of-stocks-wednesday-morn/",
            "time_published": "20231011T133737",
            "authors": [
                "Dan Caplinger"
            ],
            "summary": "Find out who the winners and losers are.",
            "banner_image": "https://g.foolcdn.com/misc-assets/hp-sa-cumulative-growth-chart.png",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.576289"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.918141"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.236141,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.24847",
                    "ticker_sentiment_score": "0.440239",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "PEP",
                    "relevance_score": "0.125789",
                    "ticker_sentiment_score": "0.113953",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "FSNUF",
                    "relevance_score": "0.187705",
                    "ticker_sentiment_score": "0.132755",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DVA",
                    "relevance_score": "0.24847",
                    "ticker_sentiment_score": "0.164807",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.307731",
                    "ticker_sentiment_score": "0.23569",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "9 'Unstoppable' Stocks Deliver Big Gains And No Pain To Investors",
            "url": "https://www.investors.com/etfs-and-funds/sectors/sp500-unstoppable-stocks-deliver-big-gains-and-no-pain-to-investors/",
            "time_published": "20231011T120000",
            "authors": [
                "Investor's Business Daily",
                "MATT KRANTZ"
            ],
            "summary": "Risk and reward are supposed to be attached at the hip for S&P 500 stocks. But a small group of stocks are delivering all gain and no pain.",
            "banner_image": "https://www.investors.com/wp-content/uploads/2021/04/Stock-moneypile-03-adobe.jpg",
            "source": "Investors Business Daily",
            "category_within_source": "n/a",
            "source_domain": "www.investors.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.234598,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.313817",
                    "ticker_sentiment_score": "0.318471",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "META",
                    "relevance_score": "0.238133",
                    "ticker_sentiment_score": "0.148118",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PANW",
                    "relevance_score": "0.313817",
                    "ticker_sentiment_score": "0.269171",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "The Zacks Analyst Blog Highlights Bristol Myers Squibb, Mirati Therapeutics, Eli Lilly, POINT Biopharma and Pfizer",
            "url": "https://www.zacks.com/stock/news/2164151/the-zacks-analyst-blog-highlights-bristol-myers-squibb-mirati-therapeutics-eli-lilly-point-biopharma-and-pfizer",
            "time_published": "20231011T115600",
            "authors": [
                "Zacks Investment Research"
            ],
            "summary": "Bristol Myers Squibb, Mirati Therapeutics, Eli Lilly, POINT Biopharma and Pfizer are part of the Zacks top Analyst Blog.",
            "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/89/447.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Mergers & Acquisitions",
                    "relevance_score": "0.769861"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.108179"
                }
            ],
            "overall_sentiment_score": 0.115081,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "HZNP",
                    "relevance_score": "0.059488",
                    "ticker_sentiment_score": "-0.061009",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.290952",
                    "ticker_sentiment_score": "0.078791",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SGEN",
                    "relevance_score": "0.118647",
                    "ticker_sentiment_score": "0.044477",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "RXDX",
                    "relevance_score": "0.059488",
                    "ticker_sentiment_score": "-0.061009",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MRTX",
                    "relevance_score": "0.17715",
                    "ticker_sentiment_score": "0.092045",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.234684",
                    "ticker_sentiment_score": "0.048244",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BMY",
                    "relevance_score": "0.17715",
                    "ticker_sentiment_score": "0.092045",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Could Visa Be the Next Company to Join the Trillion-Dollar Market Cap Club?",
            "url": "https://www.fool.com/investing/2023/10/11/could-visa-be-the-next-company-to-join-the-trillio/",
            "time_published": "20231011T101500",
            "authors": [
                "Brett Schafer"
            ],
            "summary": "The leading payments network has a dominant market position and multiple tailwinds at its back.",
            "banner_image": "https://media.ycharts.com/charts/69d5d477ea3f1cb7afb2b0bbedb0fbf2.png",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.451494"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.214378"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.997874"
                }
            ],
            "overall_sentiment_score": 0.213948,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "MSFT",
                    "relevance_score": "0.044469",
                    "ticker_sentiment_score": "0.052358",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "META",
                    "relevance_score": "0.044469",
                    "ticker_sentiment_score": "0.052358",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVDA",
                    "relevance_score": "0.044469",
                    "ticker_sentiment_score": "0.052358",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AAPL",
                    "relevance_score": "0.044469",
                    "ticker_sentiment_score": "0.052358",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TSLA",
                    "relevance_score": "0.044469",
                    "ticker_sentiment_score": "0.052358",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "V",
                    "relevance_score": "0.800342",
                    "ticker_sentiment_score": "0.362684",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "BRK-A",
                    "relevance_score": "0.088799",
                    "ticker_sentiment_score": "0.026428",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.088799",
                    "ticker_sentiment_score": "0.026428",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AMZN",
                    "relevance_score": "0.044469",
                    "ticker_sentiment_score": "0.052358",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TSM",
                    "relevance_score": "0.044469",
                    "ticker_sentiment_score": "0.139733",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Dialysis company shares plunge after Ozempic trial success vs. kidney trouble",
            "url": "https://www.marketwatch.com/story/dialysis-company-shares-plunge-after-ozempic-trial-success-vs-kidney-trouble-84c67de3",
            "time_published": "20231011T075900",
            "authors": [
                "Steve Goldstein"
            ],
            "summary": "The trial success of Novo Nordisk's hit drug against kidney failure sent shares of a German kidney dialysis services firm plummeting on Wednesday.",
            "banner_image": "https://images.mktw.net/im-654904/social",
            "source": "MarketWatch",
            "category_within_source": "Top Stories",
            "source_domain": "www.marketwatch.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.024052,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.272788",
                    "ticker_sentiment_score": "-0.01837",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "C",
                    "relevance_score": "0.138464",
                    "ticker_sentiment_score": "-0.011177",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "FSNUF",
                    "relevance_score": "0.272788",
                    "ticker_sentiment_score": "0.010646",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NSRGF",
                    "relevance_score": "0.138464",
                    "ticker_sentiment_score": "-0.011177",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.272788",
                    "ticker_sentiment_score": "-0.012377",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Wegovy Maker Novo Nordisk, Akero Therapeutics, Eli Lilly, Athena Consumer Acquisition, Tesla: Why These 5 Stocks Are Trending Today - Tesla  ( NASDAQ:TSLA ) , Novo Nordisk  ( NYSE:NVO ) , Eli Lilly  ( NYSE:LLY ) , Akero Therapeutics  ( NASDAQ:AKRO ) ",
            "url": "https://www.benzinga.com/markets/equities/23/10/35178000/wegovy-maker-novo-nordisk-akero-therapeutics-eli-lilly-athena-consumer-acquisition-tesla-why-the",
            "time_published": "20231011T015658",
            "authors": [
                "Benzinga Neuro"
            ],
            "summary": "U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining around 130 points on Tuesday. The Dow traded up 0.4% to 33,739.30 while the NASDAQ rose 0.58% to 13,562.84. The S&P 500 also rose, gaining 0.52% to 4,358.24.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/Stocks_Photo_by_Phongphan_on_Shutterstock_13.jpeg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "Markets",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.161647"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.11519,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.301933",
                    "ticker_sentiment_score": "0.138261",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AKRO",
                    "relevance_score": "0.204072",
                    "ticker_sentiment_score": "-0.117251",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TSLA",
                    "relevance_score": "0.204072",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ACCD",
                    "relevance_score": "0.102888",
                    "ticker_sentiment_score": "0.034115",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.204072",
                    "ticker_sentiment_score": "0.050935",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Oprah Winfrey Stock Aces New High After More Than Tripling",
            "url": "https://www.investors.com/news/ww-stock-soars-high-highsweight-loss-drug-play-oprah-winfrey-effect/",
            "time_published": "20231010T201800",
            "authors": [
                "APARNA NARAYANAN",
                "Investor's Business Daily"
            ],
            "summary": "WW Stock Soars To High. New Weight-Loss Drug Play Enjoys ... Investor's Business Daily ...",
            "banner_image": "https://www.investors.com/wp-content/uploads/2023/10/BIZ04oprah101023ap.jpg",
            "source": "Investors Business Daily",
            "category_within_source": "n/a",
            "source_domain": "www.investors.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.962106"
                }
            ],
            "overall_sentiment_score": 0.066486,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.208464",
                    "ticker_sentiment_score": "-0.235462",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "WW",
                    "relevance_score": "0.491255",
                    "ticker_sentiment_score": "0.136312",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MS",
                    "relevance_score": "0.105141",
                    "ticker_sentiment_score": "0.051616",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.208464",
                    "ticker_sentiment_score": "-0.235462",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                }
            ]
        },
        {
            "title": "Weight-Loss Drugs Aren't To Blame For The Snack Pullback. Pepsi Offers This Reason.",
            "url": "https://www.investors.com/news/weight-loss-drugs-blame-snack-pullback-pepsi-reason/",
            "time_published": "20231010T191900",
            "authors": [
                "Investor's Business Daily",
                "MIKE JUANG"
            ],
            "summary": "Weight-Loss Drugs Aren't To Blame For The Snack Pullback. Pepsi ... Investor's Business Daily ...",
            "banner_image": "https://www.investors.com/wp-content/uploads/2021/09/Stock-pepsico-01-adobe.jpg",
            "source": "Investors Business Daily",
            "category_within_source": "n/a",
            "source_domain": "www.investors.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.214378"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.904684"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.25"
                }
            ],
            "overall_sentiment_score": -0.002395,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "GOOG",
                    "relevance_score": "0.069094",
                    "ticker_sentiment_score": "0.031013",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MDLZ",
                    "relevance_score": "0.205225",
                    "ticker_sentiment_score": "-0.118387",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "KO",
                    "relevance_score": "0.137671",
                    "ticker_sentiment_score": "-0.090393",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.205225",
                    "ticker_sentiment_score": "0.16512",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "KHC",
                    "relevance_score": "0.137671",
                    "ticker_sentiment_score": "-0.090393",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.205225",
                    "ticker_sentiment_score": "0.16512",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "PEP",
                    "relevance_score": "0.397098",
                    "ticker_sentiment_score": "-0.065275",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WMT",
                    "relevance_score": "0.205225",
                    "ticker_sentiment_score": "0.006449",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "RayzeBio Is A New Contender in Radiopharmaceutical Arena, Will Attract Prominent Entities: JP Morgan - RayzeBio  ( NASDAQ:RYZB ) ",
            "url": "https://www.benzinga.com/analyst-ratings/analyst-color/23/10/35168194/rayzebio-is-a-new-contender-in-radiopharmaceutical-arena-will-attract-prominent-ent",
            "time_published": "20231010T190648",
            "authors": [
                "Vandana Singh"
            ],
            "summary": "JP Morgan has initiated coverage on RayzeBio Inc RYZB, representing a pure-play opportunity in the radiopharmaceutical space. Analysts Jessica Fye, Nick Lenard, and Na Sun see a relatively de-risked lead asset in RYZ101 currently in phase 3 and an earlier-stage pipeline that could offer further ...",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/10/10/ryzb.png?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.264234,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.305058",
                    "ticker_sentiment_score": "0.383972",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "RYZB",
                    "relevance_score": "0.567144",
                    "ticker_sentiment_score": "0.427051",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "JPM",
                    "relevance_score": "0.305058",
                    "ticker_sentiment_score": "0.382039",
                    "ticker_sentiment_label": "Bullish"
                }
            ]
        },
        {
            "title": "LuMind CEO At Odds With Neurologists Over Alzheimer's Drugs Made By Biogen, Eli Lilly - Eisai Co  ( OTC:ESALF ) , Biogen  ( NASDAQ:BIIB ) ",
            "url": "https://www.benzinga.com/general/biotech/23/10/35164150/lumind-ceo-at-odds-with-neurologists-over-alzheimers-drugs-made-by-biogen-eli-lilly",
            "time_published": "20231010T163526",
            "authors": [
                "Vandana Singh"
            ],
            "summary": "Hampus Hillerstrom, CEO of the Down syndrome research organization LuMind IDSC, is advocating for access to Alzheimer's drugs made by Eisai Co Ltd ESALY/ Biogen Inc's BIIB and Eli Lilly And Co's LLY. The former biotech executive is also hoping to include people with Down syndrome in Alzheimer's ...",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/10/10/aapharma_4.png?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.066268,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.405651",
                    "ticker_sentiment_score": "0.14946",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ESALF",
                    "relevance_score": "0.277433",
                    "ticker_sentiment_score": "0.112842",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BIIB",
                    "relevance_score": "0.277433",
                    "ticker_sentiment_score": "0.033717",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Cancer Biotechs Pique Buyout Interest: Recent Deals in Focus",
            "url": "https://www.zacks.com/stock/news/2163363/cancer-biotechs-pique-buyout-interest-recent-deals-in-focus",
            "time_published": "20231010T153700",
            "authors": [
                "Kinjel Shah"
            ],
            "summary": "The M&A trend of 2023 shows that there is an increasing interest in biotech companies making innovative cancer treatments.",
            "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/96/702.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Mergers & Acquisitions",
                    "relevance_score": "0.769861"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.122645,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "HZNP",
                    "relevance_score": "0.065685",
                    "ticker_sentiment_score": "-0.058151",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.258351",
                    "ticker_sentiment_score": "0.095096",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SGEN",
                    "relevance_score": "0.130926",
                    "ticker_sentiment_score": "0.04543",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "RXDX",
                    "relevance_score": "0.065685",
                    "ticker_sentiment_score": "-0.058151",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MRTX",
                    "relevance_score": "0.130926",
                    "ticker_sentiment_score": "0.134455",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.195287",
                    "ticker_sentiment_score": "0.059242",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BMY",
                    "relevance_score": "0.130926",
                    "ticker_sentiment_score": "0.134455",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Obesity Medication Insurance Coverage? Employers Embrace the Inclusion of Novo Nordisk's Wegovy in Health Coverage - Novo Nordisk  ( NYSE:NVO ) ",
            "url": "https://www.benzinga.com/general/biotech/23/10/35157108/obesity-medication-insurance-coverage-employers-embrace-the-inclusion-of-novo-nordisks-wegovy-in-",
            "time_published": "20231010T120614",
            "authors": [
                "Vandana Singh"
            ],
            "summary": "Coverage for obesity medications, including Novo Nordisk A/S's NVO Wegovy, is expected to expand among U.S. employers, according to a new survey conducted by healthcare program provider Accolade Inc ACCD and research firm Savanta.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/10/10/wegovy_.png?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.24522,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "AON",
                    "relevance_score": "0.280615",
                    "ticker_sentiment_score": "0.191788",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.280615",
                    "ticker_sentiment_score": "0.104575",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ACCD",
                    "relevance_score": "0.410059",
                    "ticker_sentiment_score": "0.272484",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.410059",
                    "ticker_sentiment_score": "0.231083",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Should You Invest in the Fidelity MSCI Health Care Index ETF  ( FHLC ) ?",
            "url": "https://www.zacks.com/stock/news/2163168/should-you-invest-in-the-fidelity-msci-health-care-index-etf-fhlc",
            "time_published": "20231010T102006",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Sector ETF report for ...",
            "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default268.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.304478,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.12546",
                    "ticker_sentiment_score": "0.049458",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "UNH",
                    "relevance_score": "0.12546",
                    "ticker_sentiment_score": "0.049458",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.12546",
                    "ticker_sentiment_score": "0.049458",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Should You Invest in the iShares U.S. Pharmaceuticals ETF  ( IHE ) ?",
            "url": "https://www.zacks.com/stock/news/2163169/should-you-invest-in-the-ishares-us-pharmaceuticals-etf-ihe",
            "time_published": "20231010T102005",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Sector ETF report for ...",
            "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default268.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.150003,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "BLK",
                    "relevance_score": "0.06623",
                    "ticker_sentiment_score": "0.031033",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.132004",
                    "ticker_sentiment_score": "0.063692",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ZTS",
                    "relevance_score": "0.132004",
                    "ticker_sentiment_score": "0.063692",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "IVZ",
                    "relevance_score": "0.132004",
                    "ticker_sentiment_score": "0.043293",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.132004",
                    "ticker_sentiment_score": "0.063692",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Why Eli Lilly Stock Crawled Higher Today",
            "url": "https://www.fool.com/investing/2023/10/09/why-eli-lilly-stock-crawled-higher-today/",
            "time_published": "20231009T222400",
            "authors": [
                "Eric Volkman"
            ],
            "summary": "The pharmaceutical giant gets a lift from some good news on insurance coverage and a prognosticator's price-target lift.",
            "banner_image": "https://g.foolcdn.com/misc-assets/hp-sa-cumulative-growth-chart.png",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.684621"
                }
            ],
            "overall_sentiment_score": 0.285883,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.592095",
                    "ticker_sentiment_score": "0.59086",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "ACCD",
                    "relevance_score": "0.163909",
                    "ticker_sentiment_score": "0.072265",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WFC",
                    "relevance_score": "0.163909",
                    "ticker_sentiment_score": "0.297545",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Jim Cramer's Take on Vertex: Tackling Opioid Addiction with New Drug in Pipeline - Vertex Pharmaceuticals  ( NASDAQ:VRTX ) ",
            "url": "https://www.benzinga.com/general/biotech/23/10/35149268/jim-cramers-take-on-vertex-tackling-opioid-addiction-with-new-drug-in-pipeline",
            "time_published": "20231009T182824",
            "authors": [
                "Vandana Singh"
            ],
            "summary": "CNBC's Jim Cramer has drawn investors' attention to Vertex Pharmaceuticals VRTX, a biotechnology company currently in the late stages of developing a non-opioid drug to treat acute pain. The company's potential candidate, known as VX-548, is being positioned to address the critical issue of ...",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/10/09/vrtx.png?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.684621"
                }
            ],
            "overall_sentiment_score": 0.168745,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.392948",
                    "ticker_sentiment_score": "0.571781",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "VRTX",
                    "relevance_score": "0.507107",
                    "ticker_sentiment_score": "0.089971",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Weight-Loss Drug Boom Has Another Ripple Effect - Rapid Growth Expected In Fill-Finish Market - Novo Nordisk  ( NYSE:NVO ) ",
            "url": "https://www.benzinga.com/general/biotech/23/10/35142181/weight-loss-drug-boom-has-another-ripple-effect-rapid-growth-expected-in-fill-finish-market",
            "time_published": "20231009T152129",
            "authors": [
                "Vandana Singh"
            ],
            "summary": "Contract drug manufacturers are investing billions of dollars in expanding or constructing facilities that fill the injection pens used for weight-loss drugs like Novo Nordisk A/S's NVO Wegovy.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/10/09/wegovy_.png?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.495866"
                }
            ],
            "overall_sentiment_score": 0.058462,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.272788",
                    "ticker_sentiment_score": "0.108883",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WXXWY",
                    "relevance_score": "0.272788",
                    "ticker_sentiment_score": "-0.097014",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CTLT",
                    "relevance_score": "0.514619",
                    "ticker_sentiment_score": "0.32029",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.272788",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.272788",
                    "ticker_sentiment_score": "0.091076",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TMO",
                    "relevance_score": "0.272788",
                    "ticker_sentiment_score": "0.503288",
                    "ticker_sentiment_label": "Bullish"
                }
            ]
        },
        {
            "title": "Peering Into Eli Lilly's Recent Short Interest - Eli Lilly  ( NYSE:LLY ) ",
            "url": "https://www.benzinga.com/short-sellers/23/10/35147167/peering-into-eli-lillys-recent-short-interest",
            "time_published": "20231009T150021",
            "authors": [
                "Benzinga Insights"
            ],
            "summary": "Eli Lilly's LLY short percent of float has risen 11.27% since its last report. The company recently reported that it has 6.27 million shares sold short, which is 0.79% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.84 days to cover their ...",
            "banner_image": "https://www.benzinga.com/files/images/story/2023/1696863618_0.png",
            "source": "Benzinga",
            "category_within_source": "Trading",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.365926"
                }
            ],
            "overall_sentiment_score": 0.265104,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.221819",
                    "ticker_sentiment_score": "0.15378",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "This Dividend Stock Just Got Hit With a Short Report. Is Now a Buying Opportunity?",
            "url": "https://www.fool.com/investing/2023/10/08/this-dividend-stock-just-got-hit-with-a-short-repo/",
            "time_published": "20231008T114500",
            "authors": [
                "Adam Spatacco"
            ],
            "summary": "Coca-Cola is the latest subject of the Bear Cave, an online publisher of reports on stock to sell short.",
            "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F749343%2Fgettyimages-1135420212.jpg&op=resize&w=700",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.266143"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.451494"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.067672,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.059415",
                    "ticker_sentiment_score": "0.033065",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CELH",
                    "relevance_score": "0.089019",
                    "ticker_sentiment_score": "-0.007551",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GOOG",
                    "relevance_score": "0.029728",
                    "ticker_sentiment_score": "-0.087974",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "KO",
                    "relevance_score": "0.497657",
                    "ticker_sentiment_score": "0.177699",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "MNST",
                    "relevance_score": "0.029728",
                    "ticker_sentiment_score": "-0.031027",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.089019",
                    "ticker_sentiment_score": "0.022185",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "What To Do After Bullish Reversal; 11 Stocks In Buy Areas",
            "url": "https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-what-to-do-after-bullish-upside-reversal-nvidia-leads-11-new-buys/",
            "time_published": "20231007T152400",
            "authors": [
                "Investor's Business Daily",
                "ED CARSON"
            ],
            "summary": "Dow Jones Futures: What To Do After Bullish Move. Nvidia Leads 11 ... Investor's Business Daily ...",
            "banner_image": "https://www.investors.com/wp-content/uploads/2023/09/Stock-bullsstampede-01-adobe.jpg",
            "source": "Investors Business Daily",
            "category_within_source": "n/a",
            "source_domain": "www.investors.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.310843"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.158519"
                }
            ],
            "overall_sentiment_score": 0.097665,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "META",
                    "relevance_score": "0.096769",
                    "ticker_sentiment_score": "0.065197",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVDA",
                    "relevance_score": "0.215574",
                    "ticker_sentiment_score": "0.06704",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ANET",
                    "relevance_score": "0.16849",
                    "ticker_sentiment_score": "0.087305",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CRWD",
                    "relevance_score": "0.144708",
                    "ticker_sentiment_score": "0.074294",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JPM",
                    "relevance_score": "0.048474",
                    "ticker_sentiment_score": "-0.105995",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DAL",
                    "relevance_score": "0.048474",
                    "ticker_sentiment_score": "-0.105995",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "UNH",
                    "relevance_score": "0.048474",
                    "ticker_sentiment_score": "-0.105995",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MSFT",
                    "relevance_score": "0.048474",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "QLYS",
                    "relevance_score": "0.120794",
                    "ticker_sentiment_score": "0.050776",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TSLA",
                    "relevance_score": "0.329551",
                    "ticker_sentiment_score": "-0.048394",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.215574",
                    "ticker_sentiment_score": "0.120202",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CDNS",
                    "relevance_score": "0.120794",
                    "ticker_sentiment_score": "0.053142",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "VRT",
                    "relevance_score": "0.120794",
                    "ticker_sentiment_score": "0.10785",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CME",
                    "relevance_score": "0.096769",
                    "ticker_sentiment_score": "0.132936",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PANW",
                    "relevance_score": "0.144708",
                    "ticker_sentiment_score": "0.04702",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "FOREX:USD",
                    "relevance_score": "0.024248",
                    "ticker_sentiment_score": "0.087163",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "3 No-Brainer Growth Stocks to Buy in October",
            "url": "https://www.fool.com/investing/2023/10/07/3-no-brainer-growth-stocks-to-buy-in-october/",
            "time_published": "20231007T105300",
            "authors": [
                "David Jagielski",
                "and Prosper Junior Bakiny",
                "Keith Speights"
            ],
            "summary": "The time is right to invest in these great stocks.",
            "banner_image": "https://g.foolcdn.com/misc-assets/hp-sa-cumulative-growth-chart.png",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.996718"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.413559"
                }
            ],
            "overall_sentiment_score": 0.274002,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.232439",
                    "ticker_sentiment_score": "0.217617",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "VRTX",
                    "relevance_score": "0.156207",
                    "ticker_sentiment_score": "0.168497",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.269776",
                    "ticker_sentiment_score": "0.307637",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Shutdown Averted, Treasury Yields Flirt With 5%, Strong Payrolls Add to Fed Tightening Risk: The Week In The Markets - BlackRock  ( NYSE:BLK ) , Alphabet  ( NASDAQ:GOOGL ) , Citigroup  ( NYSE:C ) , PNC Finl Servs Gr  ( NYSE:PNC ) ",
            "url": "https://www.benzinga.com/markets/equities/23/10/35132440/shutdown-averted-treasury-yields-flirt-with-5-strong-payrolls-add-to-fed-tightening-risk-the-wee",
            "time_published": "20231006T201449",
            "authors": [
                "Piero Cingari"
            ],
            "summary": "A week filled with significant events impacting the markets culminated in an unexpectedly strong September jobs report. Government Shutdown Averted. House Ousts McCarthy: The U.S. Congress managed to avoid a dramatic government shutdown just hours before the midnight deadline Oct. 1 by passing a ...",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/Wall_Street_subway_sign_1.jpeg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "Markets",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.682689"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.993856"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Economy - Macro",
                    "relevance_score": "0.158519"
                }
            ],
            "overall_sentiment_score": 0.185601,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "BLK",
                    "relevance_score": "0.096477",
                    "ticker_sentiment_score": "-0.038825",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "C",
                    "relevance_score": "0.096477",
                    "ticker_sentiment_score": "-0.038825",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PNC",
                    "relevance_score": "0.096477",
                    "ticker_sentiment_score": "-0.038825",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JPM",
                    "relevance_score": "0.096477",
                    "ticker_sentiment_score": "-0.038825",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.096477",
                    "ticker_sentiment_score": "-0.013809",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "IVZ",
                    "relevance_score": "0.048327",
                    "ticker_sentiment_score": "0.161895",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "UNH",
                    "relevance_score": "0.096477",
                    "ticker_sentiment_score": "-0.038825",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DPZ",
                    "relevance_score": "0.096477",
                    "ticker_sentiment_score": "-0.038825",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WFC",
                    "relevance_score": "0.096477",
                    "ticker_sentiment_score": "-0.038825",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WBA",
                    "relevance_score": "0.096477",
                    "ticker_sentiment_score": "-0.038825",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.096477",
                    "ticker_sentiment_score": "0.154064",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "INFY",
                    "relevance_score": "0.096477",
                    "ticker_sentiment_score": "-0.038825",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GOOG",
                    "relevance_score": "0.096477",
                    "ticker_sentiment_score": "0.154064",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "META",
                    "relevance_score": "0.096477",
                    "ticker_sentiment_score": "0.154064",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "NVDA",
                    "relevance_score": "0.096477",
                    "ticker_sentiment_score": "0.154064",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "KO",
                    "relevance_score": "0.096477",
                    "ticker_sentiment_score": "-0.013809",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "USEG",
                    "relevance_score": "0.048327",
                    "ticker_sentiment_score": "0.160857",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "DAL",
                    "relevance_score": "0.096477",
                    "ticker_sentiment_score": "-0.038825",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NEE",
                    "relevance_score": "0.096477",
                    "ticker_sentiment_score": "0.154064",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "DMPZF",
                    "relevance_score": "0.048327",
                    "ticker_sentiment_score": "-0.036489",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "XOM",
                    "relevance_score": "0.144275",
                    "ticker_sentiment_score": "0.201446",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "PEP",
                    "relevance_score": "0.144275",
                    "ticker_sentiment_score": "-0.029978",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PGR",
                    "relevance_score": "0.096477",
                    "ticker_sentiment_score": "-0.038825",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "FAST",
                    "relevance_score": "0.096477",
                    "ticker_sentiment_score": "-0.038825",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PXD",
                    "relevance_score": "0.144275",
                    "ticker_sentiment_score": "0.201446",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "WMT",
                    "relevance_score": "0.096477",
                    "ticker_sentiment_score": "-0.013809",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Snacks In The Ozempic Era: Food, Beverage Stocks Crash With Weight Loss Drugs On The Rise - Molson Coors Beverage  ( NYSE:TAP ) , Coca-Cola  ( NYSE:KO ) , Novo Nordisk  ( NYSE:NVO ) , WK Kellogg  ( NYSE:KLG ) ",
            "url": "https://www.benzinga.com/analyst-ratings/analyst-color/23/10/35132150/snacks-in-the-ozempic-era-food-beverage-stocks-crash-with-weight-loss-drugs-on-the-",
            "time_published": "20231006T200138",
            "authors": [
                "Piero Cingari"
            ],
            "summary": "Stocks in the food and beverage industry experienced their most challenging week since May 2022, further extending the declines seen in the preceding weeks. The First Trust Nasdaq Food & Beverage ETF FTXG plummeted by over 5% this week, marking its third consecutive week of losses and the ninth ...",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/snacks.jpeg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "Markets",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.77141"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Mergers & Acquisitions",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Real Estate & Construction",
                    "relevance_score": "0.2"
                }
            ],
            "overall_sentiment_score": -0.126327,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "MDLZ",
                    "relevance_score": "0.141726",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TAP",
                    "relevance_score": "0.141726",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BAC",
                    "relevance_score": "0.141726",
                    "ticker_sentiment_score": "0.021497",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "KO",
                    "relevance_score": "0.211191",
                    "ticker_sentiment_score": "0.051214",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.211191",
                    "ticker_sentiment_score": "-0.008491",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BF-A",
                    "relevance_score": "0.071145",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CAG",
                    "relevance_score": "0.141726",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "K",
                    "relevance_score": "0.071145",
                    "ticker_sentiment_score": "-0.165273",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "HSY",
                    "relevance_score": "0.141726",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CPB",
                    "relevance_score": "0.141726",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "KDP",
                    "relevance_score": "0.141726",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.141726",
                    "ticker_sentiment_score": "0.103082",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "STZ",
                    "relevance_score": "0.141726",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PEP",
                    "relevance_score": "0.071145",
                    "ticker_sentiment_score": "0.067274",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "UTZ",
                    "relevance_score": "0.141726",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BRBR",
                    "relevance_score": "0.211191",
                    "ticker_sentiment_score": "-0.159026",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "WMT",
                    "relevance_score": "0.141726",
                    "ticker_sentiment_score": "-0.183403",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                }
            ]
        },
        {
            "title": "Dow Jones Vaults 400 Points, Led By Disney Stock; Nasdaq 100 Movers Include Zscaler, CrowdStrike",
            "url": "https://www.investors.com/market-trend/stock-market-today/dow-jones-vaults-400-points-disney-stock-nasdaq-100-movers-zscaler-crowdstrike/",
            "time_published": "20231006T193200",
            "authors": [
                "KEN SHREVE",
                "Investor's Business Daily"
            ],
            "summary": "Dow Jones Vaults 400 Points, Led By Disney Stock. Nasdaq 100 ... Investor's Business Daily ...",
            "banner_image": "https://www.investors.com/wp-content/uploads/2018/05/Stock-dow-04-adobe.jpg",
            "source": "Investors Business Daily",
            "category_within_source": "n/a",
            "source_domain": "www.investors.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.451494"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.999921"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.2"
                }
            ],
            "overall_sentiment_score": 0.239795,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "META",
                    "relevance_score": "0.167322",
                    "ticker_sentiment_score": "0.306618",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "NVDA",
                    "relevance_score": "0.167322",
                    "ticker_sentiment_score": "0.306618",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "CRWD",
                    "relevance_score": "0.112008",
                    "ticker_sentiment_score": "0.269434",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "GM",
                    "relevance_score": "0.167322",
                    "ticker_sentiment_score": "0.151306",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "HON",
                    "relevance_score": "0.112008",
                    "ticker_sentiment_score": "0.166409",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.112008",
                    "ticker_sentiment_score": "0.166409",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "MANH",
                    "relevance_score": "0.112008",
                    "ticker_sentiment_score": "0.071483",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MSFT",
                    "relevance_score": "0.112008",
                    "ticker_sentiment_score": "0.166409",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "PDD",
                    "relevance_score": "0.112008",
                    "ticker_sentiment_score": "0.296174",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "CAT",
                    "relevance_score": "0.112008",
                    "ticker_sentiment_score": "0.166409",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "XOM",
                    "relevance_score": "0.112008",
                    "ticker_sentiment_score": "0.213681",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.167322",
                    "ticker_sentiment_score": "0.206178",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "CDNS",
                    "relevance_score": "0.167322",
                    "ticker_sentiment_score": "0.144204",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CYBR",
                    "relevance_score": "0.112008",
                    "ticker_sentiment_score": "0.269434",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "VRT",
                    "relevance_score": "0.167322",
                    "ticker_sentiment_score": "0.238072",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "ZS",
                    "relevance_score": "0.112008",
                    "ticker_sentiment_score": "0.269434",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "PANW",
                    "relevance_score": "0.112008",
                    "ticker_sentiment_score": "0.269434",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "WMT",
                    "relevance_score": "0.167322",
                    "ticker_sentiment_score": "0.206178",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Stock Market Ends On High Note; Tesla In Focus: Weekly Review",
            "url": "https://www.investors.com/news/stock-market-ends-on-high-note-even-as-yields-soar-tesla-in-focus/",
            "time_published": "20231006T165100",
            "authors": [
                "IBD STAFF",
                "Investor's Business Daily"
            ],
            "summary": "Stock Market Ends On High Note. Tesla In Focus: Weekly Review Investor's Business Daily ...",
            "banner_image": "https://www.investors.com/wp-content/uploads/2020/10/A1MAIN-bullsbears-100220-adobe.jpg",
            "source": "Investors Business Daily",
            "category_within_source": "n/a",
            "source_domain": "www.investors.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.796627"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.161647"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": -0.070958,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "AEHR",
                    "relevance_score": "0.063933",
                    "ticker_sentiment_score": "-0.112094",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "XPEV",
                    "relevance_score": "0.063933",
                    "ticker_sentiment_score": "0.047383",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TSLA",
                    "relevance_score": "0.25168",
                    "ticker_sentiment_score": "-0.025746",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LNTH",
                    "relevance_score": "0.095771",
                    "ticker_sentiment_score": "-0.003391",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NIO",
                    "relevance_score": "0.063933",
                    "ticker_sentiment_score": "0.047383",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GM",
                    "relevance_score": "0.095771",
                    "ticker_sentiment_score": "-0.13469",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "XOM",
                    "relevance_score": "0.063933",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.095771",
                    "ticker_sentiment_score": "-0.003391",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LI",
                    "relevance_score": "0.063933",
                    "ticker_sentiment_score": "0.047383",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PXD",
                    "relevance_score": "0.063933",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Here's The Point This Obesity-Focused Stock Of The Day Becomes Actionable",
            "url": "https://www.investors.com/research/ibd-stock-of-the-day/eli-lilly-stock-the-point-at-which-this-ibd-stock-of-the-day-could-become-actionable-again/",
            "time_published": "20231006T163700",
            "authors": [
                "ALLISON GATLIN",
                "Investor's Business Daily"
            ],
            "summary": "Eli Lilly Stock: The Point At Which This IBD Stock Of The Day Could ... Investor's Business Daily ...",
            "banner_image": "https://www.investors.com/wp-content/uploads/2023/10/sotd-10-6-23-1.png",
            "source": "Investors Business Daily",
            "category_within_source": "n/a",
            "source_domain": "www.investors.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.999897"
                }
            ],
            "overall_sentiment_score": 0.108716,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.828099",
                    "ticker_sentiment_score": "0.211705",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "BAC",
                    "relevance_score": "0.043579",
                    "ticker_sentiment_score": "0.037994",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LNTH",
                    "relevance_score": "0.215319",
                    "ticker_sentiment_score": "0.048003",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BIIB",
                    "relevance_score": "0.087027",
                    "ticker_sentiment_score": "0.066449",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Eli Lilly's Upcoming Obesity Drugs Highlight Bright Future, Says Optimistic Analyst - Eli Lilly  ( NYSE:LLY ) ",
            "url": "https://www.benzinga.com/analyst-ratings/analyst-color/23/10/35128539/eli-lillys-upcoming-obesity-drugs-highlight-bright-future-says-optimistic-analyst",
            "time_published": "20231006T162347",
            "authors": [
                "Priya Nigam"
            ],
            "summary": "Shares of Eli Lilly And Co LLY were climbing during Friday's trading session. The stock has been under pressure for the past three months, due to macro uncertainties and not fundamental concerns, according to BofA Securities.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/10/06/eli_lilly_shutter.jpg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "Trading",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.684621"
                }
            ],
            "overall_sentiment_score": 0.179843,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.930964",
                    "ticker_sentiment_score": "0.441033",
                    "ticker_sentiment_label": "Bullish"
                }
            ]
        },
        {
            "title": "These IBD 50 Companies Set To Report Blowout Earnings Growth Of Up To 320%",
            "url": "https://www.investors.com/stock-lists/ibd-50/growth-stocks-in-the-ibd-50-set-to-report-blowout-earnings-growth-of-up-to-320/",
            "time_published": "20231006T151400",
            "authors": [
                "Investor's Business Daily",
                "VIDYA RAMAKRISHNAN"
            ],
            "summary": "These IBD 50 Companies Set To Report Blowout Earnings Growth ... Investor's Business Daily ...",
            "banner_image": "https://www.investors.com/wp-content/uploads/2023/08/Stock-Meta-zuckerberg-01-shutt.jpg",
            "source": "Investors Business Daily",
            "category_within_source": "n/a",
            "source_domain": "www.investors.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.858979"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.999997"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.25"
                }
            ],
            "overall_sentiment_score": 0.196789,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "META",
                    "relevance_score": "0.190167",
                    "ticker_sentiment_score": "0.02906",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "IBKR",
                    "relevance_score": "0.127456",
                    "ticker_sentiment_score": "0.047573",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MOD",
                    "relevance_score": "0.127456",
                    "ticker_sentiment_score": "0.092994",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TSLA",
                    "relevance_score": "0.127456",
                    "ticker_sentiment_score": "-0.092944",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.127456",
                    "ticker_sentiment_score": "0.103737",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.127456",
                    "ticker_sentiment_score": "0.103737",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SNPS",
                    "relevance_score": "0.25168",
                    "ticker_sentiment_score": "0.223661",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "CDNS",
                    "relevance_score": "0.127456",
                    "ticker_sentiment_score": "0.140811",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AMPH",
                    "relevance_score": "0.127456",
                    "ticker_sentiment_score": "0.103737",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "APOS",
                    "relevance_score": "0.063933",
                    "ticker_sentiment_score": "0.040134",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DUOL",
                    "relevance_score": "0.127456",
                    "ticker_sentiment_score": "0.279301",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Looking At Eli Lilly's Recent Unusual Options Activity - Eli Lilly  ( NYSE:LLY ) ",
            "url": "https://www.benzinga.com/markets/options/23/10/35127079/looking-at-eli-lillys-recent-unusual-options-activity",
            "time_published": "20231006T143057",
            "authors": [
                "Benzinga Insights"
            ],
            "summary": "Someone with a lot of money to spend has taken a bullish stance on Eli Lilly LLY. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "Markets",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.266143"
                }
            ],
            "overall_sentiment_score": 0.183058,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.68039",
                    "ticker_sentiment_score": "0.334566",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Pharma Stock Roundup: LLY Offers to Buy POINT Biopharma & Other Updates",
            "url": "https://www.zacks.com/stock/news/2161488/pharma-stock-roundup-lly-offers-to-buy-point-biopharma-other-updates",
            "time_published": "20231006T133000",
            "authors": [
                "Kinjel Shah"
            ],
            "summary": "Eli Lilly (LLY) offers to buy POINT Biopharma for approximately $1.4 billion. Sanofi (SNY) partners with Teva for co-developing immunology candidate.",
            "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/cc/389.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.214378"
                }
            ],
            "overall_sentiment_score": 0.108891,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.220522",
                    "ticker_sentiment_score": "0.077117",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ABBV",
                    "relevance_score": "0.158519",
                    "ticker_sentiment_score": "0.095413",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AZN",
                    "relevance_score": "0.158519",
                    "ticker_sentiment_score": "-0.036263",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.063763",
                    "ticker_sentiment_score": "-0.122104",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SNY",
                    "relevance_score": "0.251032",
                    "ticker_sentiment_score": "0.060059",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CRYPTO:NXC",
                    "relevance_score": "0.127119",
                    "ticker_sentiment_score": "-0.03195",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Investors Heavily Search Eli Lilly and Company  ( LLY ) : Here is What You Need to Know",
            "url": "https://www.zacks.com/stock/news/2161417/investors-heavily-search-eli-lilly-and-company-lly-here-is-what-you-need-to-know",
            "time_published": "20231006T130011",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Lilly (LLY) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.",
            "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default257.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.999999"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.5855"
                }
            ],
            "overall_sentiment_score": 0.237233,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.524949",
                    "ticker_sentiment_score": "0.137715",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Structure Therapeutics  ( GPCR )  Stock Up 9% This Week: Here's Why",
            "url": "https://www.zacks.com/stock/news/2161548/structure-therapeutics-gpcr-stock-up-9-this-week-heres-why",
            "time_published": "20231006T124500",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Structure Therapeutics (GPCR) rises 9% on encouraging initial data from the early-stage study of its pipeline candidate, GSBR-1290, in healthy overweight or obese individuals.",
            "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/37/2337.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Economy - Macro",
                    "relevance_score": "0.158519"
                }
            ],
            "overall_sentiment_score": 0.107026,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.192694",
                    "ticker_sentiment_score": "0.064498",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ANIK",
                    "relevance_score": "0.129168",
                    "ticker_sentiment_score": "0.081787",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GPCR",
                    "relevance_score": "0.374312",
                    "ticker_sentiment_score": "0.201286",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.192694",
                    "ticker_sentiment_score": "0.213236",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "2 Reasons Why Eli Lilly's Mounjaro Might Beat Novo Nordisk's Ozempic, and 2 Reasons Why It Might Not",
            "url": "https://www.fool.com/investing/2023/10/06/2-reasons-eli-lillys-mounjaro-might-beat-ozempic/",
            "time_published": "20231006T121500",
            "authors": [
                "Alex Carchidi"
            ],
            "summary": "Eli Lilly's drug looks better on paper, but Ozempic was on the market first.",
            "banner_image": "https://g.foolcdn.com/misc-assets/hp-sa-cumulative-growth-chart.png",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.211302,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.170878",
                    "ticker_sentiment_score": "0.158832",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.226477",
                    "ticker_sentiment_score": "0.157269",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Lilly Announces Details of Presentations at ESMO Congress 2023",
            "url": "https://www.prnewswire.com/news-releases/lilly-announces-details-of-presentations-at-esmo-congress-2023-301949075.html",
            "time_published": "20231006T114500",
            "authors": [
                "Eli Lilly and Company"
            ],
            "summary": "INDIANAPOLIS, Oct. 6, 2023 /PRNewswire/ -- Eli Lilly and Company ( NYSE: LLY ) today announced that data from studies of Verzenio ( abemaciclib. a CDK4/6 inhibitor ) , Retevmo ( selpercatinib.",
            "banner_image": "https://mma.prnewswire.com/media/133140/eli_lilly_and_company_logo.jpg?p=facebook",
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.310843"
                }
            ],
            "overall_sentiment_score": -0.062935,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.085535",
                    "ticker_sentiment_score": "0.014759",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "META",
                    "relevance_score": "0.006592",
                    "ticker_sentiment_score": "0.144469",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Should You Sell This Stock After Another Regulatory Headwind?",
            "url": "https://www.fool.com/investing/2023/10/06/should-you-sell-this-stock-after-another-regulator/",
            "time_published": "20231006T100900",
            "authors": [
                "Prosper Junior Bakiny"
            ],
            "summary": "This company has grabbed plenty of headlines this year, and they haven't all been good.",
            "banner_image": "https://g.foolcdn.com/misc-assets/hp-sa-cumulative-growth-chart.png",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.310843"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.161647"
                }
            ],
            "overall_sentiment_score": 0.036239,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.451494",
                    "ticker_sentiment_score": "-0.054592",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Futures: Jobs Report Looms; 7 Stocks Boasting This Bullish Trait",
            "url": "https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-stocks-slash-sharp-losses-with-jobs-report-due-nvidia-meta-at-key-levels/",
            "time_published": "20231005T220200",
            "authors": [
                "Investor's Business Daily",
                "ED CARSON"
            ],
            "summary": "Dow Jones Futures: Stocks Slash Losses With Jobs Report Due ... Investor's Business Daily ...",
            "banner_image": "https://www.investors.com/wp-content/uploads/2016/03/BIGPIC-032316-shutterstock.jpg",
            "source": "Investors Business Daily",
            "category_within_source": "n/a",
            "source_domain": "www.investors.com",
            "topics": [
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.088702,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "AEHR",
                    "relevance_score": "0.134741",
                    "ticker_sentiment_score": "-0.107243",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "QLYS",
                    "relevance_score": "0.161349",
                    "ticker_sentiment_score": "0.130037",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "META",
                    "relevance_score": "0.081092",
                    "ticker_sentiment_score": "0.043715",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVDA",
                    "relevance_score": "0.213988",
                    "ticker_sentiment_score": "0.063194",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ANET",
                    "relevance_score": "0.187775",
                    "ticker_sentiment_score": "0.057362",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TSLA",
                    "relevance_score": "0.291077",
                    "ticker_sentiment_score": "0.134277",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.161349",
                    "ticker_sentiment_score": "0.086501",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "VRTX",
                    "relevance_score": "0.081092",
                    "ticker_sentiment_score": "0.047788",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Why Point BioPharma Global Stock Skyrocketed 86% This Week",
            "url": "https://www.fool.com/investing/2023/10/05/why-point-biopharma-global-stock-skyrocketed-86-th/",
            "time_published": "20231005T205042",
            "authors": [
                "Steve Symington"
            ],
            "summary": "Point Biopharma is being acquired by Eli Lilly. Here's what investors need to know.",
            "banner_image": "https://g.foolcdn.com/misc-assets/hp-sa-cumulative-growth-chart.png",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Mergers & Acquisitions",
                    "relevance_score": "0.495866"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Real Estate & Construction",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.319261,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.530253",
                    "ticker_sentiment_score": "0.492775",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "SPGI",
                    "relevance_score": "0.143415",
                    "ticker_sentiment_score": "0.251666",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "PNT",
                    "relevance_score": "0.282234",
                    "ticker_sentiment_score": "0.399606",
                    "ticker_sentiment_label": "Bullish"
                }
            ]
        },
        {
            "title": "LLY: Which Pharma Stock Has More Potential Gains This Month: Pfizer  ( PFE )  or Eli Lilly & Co.  ( LLY ) ?",
            "url": "https://stocknews.com/news/lly-pfe-dna-which-pharma-stock-has-more-potential-gains-this-month-pfizer/",
            "time_published": "20231005T160624",
            "authors": [
                "StockNews.com Staff"
            ],
            "summary": "LLY: Which Pharma Stock Has More Potential Gains This Month ... ...",
            "banner_image": "https://stocknews.com/wp-content/uploads/2021/01/cvs-rad-wba-scaled.jpg",
            "source": "Stocknews.com",
            "category_within_source": "n/a",
            "source_domain": "stocknews.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.999701"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.365926"
                }
            ],
            "overall_sentiment_score": 0.225284,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.623194",
                    "ticker_sentiment_score": "0.372587",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "DNA",
                    "relevance_score": "0.117104",
                    "ticker_sentiment_score": "0.071413",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.47672",
                    "ticker_sentiment_score": "0.330028",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Biggest Oil Drop In A Year On Biden Security Plan, Magnificent 7 Stocks Do Not Like The New Data - Walmart  ( NYSE:WMT ) ",
            "url": "https://www.benzinga.com/markets/23/10/35111357/biggest-oil-drop-in-a-year-on-biden-security-plan-magnificent-7-stocks-do-not-like-the-new-data",
            "time_published": "20231005T151532",
            "authors": [
                "The Arora Report"
            ],
            "summary": "To gain an edge, this is what you need to know today. Please click here for a chart of oil futures. The chart shows a big run up in oil. When oil crossed over $90, $100 oil became the consensus in the marketplace. As the chart shows, the $100 consensus caused a short squeeze.",
            "banner_image": "https://cdn.benzinga.com/files/maxim-hopman-fixlqxahcfk-unsplash_7_0.jpg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.310843"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.999981"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.2"
                }
            ],
            "overall_sentiment_score": 0.200532,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "MSFT",
                    "relevance_score": "0.070725",
                    "ticker_sentiment_score": "-0.150908",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "GOOG",
                    "relevance_score": "0.070725",
                    "ticker_sentiment_score": "-0.150908",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "META",
                    "relevance_score": "0.070725",
                    "ticker_sentiment_score": "-0.150908",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "NVDA",
                    "relevance_score": "0.070725",
                    "ticker_sentiment_score": "0.218613",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "AAPL",
                    "relevance_score": "0.070725",
                    "ticker_sentiment_score": "-0.150908",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "TSLA",
                    "relevance_score": "0.070725",
                    "ticker_sentiment_score": "0.218613",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.070725",
                    "ticker_sentiment_score": "0.075357",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.070725",
                    "ticker_sentiment_score": "0.075357",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "IVZ",
                    "relevance_score": "0.035397",
                    "ticker_sentiment_score": "0.241279",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "WMT",
                    "relevance_score": "0.070725",
                    "ticker_sentiment_score": "0.075357",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "What Are The Best Stocks To Invest In? 2 Healthcare Stocks To Know",
            "url": "https://stockmarket.com/featured/what-are-the-best-stocks-to-invest-in-2-healthcare-stocks-to-know-2023-10-05",
            "time_published": "20231005T143817",
            "authors": [
                "Brandon Michael"
            ],
            "summary": "The healthcare sector is an expansive domain that entails a wide range of companies. These companies are involved in the provision of medical services, the manufacture of medical equipment, and the development of pharmaceuticals. This sector plays a pivotal role in the well-being of society.",
            "banner_image": "https://u3j7m9h7.rocketcdn.me/wp-content/uploads/2023/10/LLY-stock.jpg",
            "source": "StockMarket.com",
            "category_within_source": "n/a",
            "source_domain": "stockmarket.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.858979"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.999921"
                }
            ],
            "overall_sentiment_score": 0.215872,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.259727",
                    "ticker_sentiment_score": "-0.021809",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ISRG",
                    "relevance_score": "0.321393",
                    "ticker_sentiment_score": "0.230452",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "HCSG",
                    "relevance_score": "0.066047",
                    "ticker_sentiment_score": "0.16363",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Here are 18 stocks I am watching in the market, including Clorox, Rivian and Airbnb",
            "url": "https://www.cnbc.com/2023/10/05/here-are-18-stocks-jim-cramer-is-watching-including-clorox-rivian-airbnb.html",
            "time_published": "20231005T140123",
            "authors": [
                "Jim Cramer"
            ],
            "summary": "Here are some of the tickers on Cramer's radar for Thursday, Oct. 5, taken directly from his reporter's notebook.",
            "banner_image": "https://image.cnbcfm.com/api/v1/image/106984350-1638556308191-bottles-of-clorox-bleach-on-store-shelves_t20_gLoQyN.jpg?v=1696514483&w=1920&h=1080",
            "source": "CNBC",
            "category_within_source": "Top News",
            "source_domain": "www.cnbc.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.839681"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.166667"
                }
            ],
            "overall_sentiment_score": -0.063116,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "CARR",
                    "relevance_score": "0.162802",
                    "ticker_sentiment_score": "-0.235658",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "MPC",
                    "relevance_score": "0.162802",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "C",
                    "relevance_score": "0.162802",
                    "ticker_sentiment_score": "-0.096352",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WING",
                    "relevance_score": "0.162802",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BAC",
                    "relevance_score": "0.08183",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JPM",
                    "relevance_score": "0.08183",
                    "ticker_sentiment_score": "-0.1302",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.162802",
                    "ticker_sentiment_score": "-0.108538",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CAKE",
                    "relevance_score": "0.162802",
                    "ticker_sentiment_score": "-0.108538",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "RIVN",
                    "relevance_score": "0.162802",
                    "ticker_sentiment_score": "-0.223261",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "ABNB",
                    "relevance_score": "0.162802",
                    "ticker_sentiment_score": "-0.057832",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TSCO",
                    "relevance_score": "0.162802",
                    "ticker_sentiment_score": "-0.059846",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CLX",
                    "relevance_score": "0.162802",
                    "ticker_sentiment_score": "-0.089037",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BCS",
                    "relevance_score": "0.162802",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ELAN",
                    "relevance_score": "0.162802",
                    "ticker_sentiment_score": "-0.117652",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PSX",
                    "relevance_score": "0.162802",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WFC",
                    "relevance_score": "0.162802",
                    "ticker_sentiment_score": "-0.057832",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.162802",
                    "ticker_sentiment_score": "-0.108538",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ZTS",
                    "relevance_score": "0.162802",
                    "ticker_sentiment_score": "-0.117652",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BKNG",
                    "relevance_score": "0.162802",
                    "ticker_sentiment_score": "-0.057832",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JACK",
                    "relevance_score": "0.162802",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "These diabetes stocks, pummeled by the Ozempic craze, now look like bargains, analysts say",
            "url": "https://www.marketwatch.com/story/these-diabetes-stocks-pummeled-by-the-ozempic-craze-now-look-like-bargains-analysts-say-30906b51",
            "time_published": "20231005T133100",
            "authors": [
                "Eleanor Laise"
            ],
            "summary": "DexCom could be the first stock to break out of 'GLP jail,' analysts say, as market continues to punish device makers ...",
            "banner_image": "https://images.mktw.net/im-852331/social",
            "source": "MarketWatch",
            "category_within_source": "Top Stories",
            "source_domain": "www.marketwatch.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.161647"
                }
            ],
            "overall_sentiment_score": 0.133373,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "INSP",
                    "relevance_score": "0.105836",
                    "ticker_sentiment_score": "0.104689",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.105836",
                    "ticker_sentiment_score": "-0.013472",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PODD",
                    "relevance_score": "0.260559",
                    "ticker_sentiment_score": "0.154043",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "ABT",
                    "relevance_score": "0.105836",
                    "ticker_sentiment_score": "0.023242",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TNDM",
                    "relevance_score": "0.105836",
                    "ticker_sentiment_score": "0.138579",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DXCM",
                    "relevance_score": "0.405378",
                    "ticker_sentiment_score": "0.22407",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Here's the Best Big Pharma Stock of the Decade so Far  ( and It's Not Even Close ) ",
            "url": "https://www.fool.com/investing/2023/10/05/heres-the-best-big-pharma-stock-of-the-decade-so-f/",
            "time_published": "20231005T095000",
            "authors": [
                "Keith Speights"
            ],
            "summary": "This stock puts the \"big\" in big pharma after massive gains in recent years.",
            "banner_image": "https://g.foolcdn.com/misc-assets/hp-sa-cumulative-growth-chart.png",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.451494"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.980922"
                }
            ],
            "overall_sentiment_score": 0.257867,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.391486",
                    "ticker_sentiment_score": "0.447177",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "REGN",
                    "relevance_score": "0.116348",
                    "ticker_sentiment_score": "0.285979",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.230235",
                    "ticker_sentiment_score": "0.258954",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Eli Lilly  ( LLY )  Surpasses Market Returns: Some Facts Worth Knowing",
            "url": "https://www.zacks.com/stock/news/2160336/eli-lilly-lly-surpasses-market-returns-some-facts-worth-knowing",
            "time_published": "20231004T214517",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Eli Lilly (LLY) concluded the recent trading session at $531.46, signifying a +1.19% move from its prior day's close.",
            "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default271.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.995921"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.365926"
                }
            ],
            "overall_sentiment_score": 0.155745,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.584103",
                    "ticker_sentiment_score": "0.306572",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Here's How Much $100 Invested In Eli Lilly 5 Years Ago Would Be Worth Today - Eli Lilly  ( NYSE:LLY ) ",
            "url": "https://www.benzinga.com/news/earnings/23/10/35098621/heres-how-much-100-invested-in-eli-lilly-5-years-ago-would-be-worth-today",
            "time_published": "20231004T213042",
            "authors": [
                "Benzinga Insights"
            ],
            "summary": "Eli Lilly LLY has outperformed the market over the past 5 years by 27.59% on an annualized basis producing an average annual return of 35.71%. Currently, Eli Lilly has a market capitalization of $504.51 billion.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/valuestock_image_1.jpeg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "News",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.108179"
                }
            ],
            "overall_sentiment_score": 0.158543,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.980595",
                    "ticker_sentiment_score": "0.375984",
                    "ticker_sentiment_label": "Bullish"
                }
            ]
        },
        {
            "title": "ALX Oncology  ( ALXO )  Up 56% on Upbeat Gastric Cancer Study Data",
            "url": "https://www.zacks.com/stock/news/2160251/alx-oncology-alxo-up-56-on-upbeat-gastric-cancer-study-data",
            "time_published": "20231004T153900",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Interim data from a mid-stage study shows that a combination regimen of ALX Oncology's (ALXO) lead candidate achieved 52% ORR in certain gastric cancer patients.",
            "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/2a/3899.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.928139"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.098205,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.109455",
                    "ticker_sentiment_score": "0.010137",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "VAXX",
                    "relevance_score": "0.163539",
                    "ticker_sentiment_score": "0.068133",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ALXO",
                    "relevance_score": "0.508593",
                    "ticker_sentiment_score": "0.138526",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ANVS",
                    "relevance_score": "0.163539",
                    "ticker_sentiment_score": "0.037885",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Check Out What Whales Are Doing With LLY - Eli Lilly  ( NYSE:LLY ) ",
            "url": "https://www.benzinga.com/markets/options/23/10/35091248/check-out-what-whales-are-doing-with-lly",
            "time_published": "20231004T144718",
            "authors": [
                "Benzinga Insights"
            ],
            "summary": "Someone with a lot of money to spend has taken a bullish stance on Eli Lilly LLY. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "Markets",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.214378"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.113107,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.815635",
                    "ticker_sentiment_score": "0.30677",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "MS",
                    "relevance_score": "0.105604",
                    "ticker_sentiment_score": "-0.125418",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Lilly  ( LLY )  to Buy POINT Biopharma, Strengthen Cancer Portfolio",
            "url": "https://www.zacks.com/stock/news/2159864/lilly-lly-to-buy-point-biopharma-strengthen-cancer-portfolio",
            "time_published": "20231004T122100",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Eli Lilly's (LLY) acquisition of POINT Biopharma, if successfully closed, is likely to bolster its portfolio of cancer drugs.",
            "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/86/1981.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.310843"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.161647"
                }
            ],
            "overall_sentiment_score": 0.095777,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.202932",
                    "ticker_sentiment_score": "0.095028",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ALPN",
                    "relevance_score": "0.268294",
                    "ticker_sentiment_score": "0.245629",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Lilly Announces Leadership Transitions",
            "url": "https://markets.businessinsider.com/news/stocks/lilly-announces-leadership-transitions-1032677321",
            "time_published": "20231004T104500",
            "authors": [
                "markets.businessinsider.com"
            ],
            "summary": "INDIANAPOLIS, Oct. 4, 2023 /PRNewswire/ -- Eli Lilly and Company ( NYSE: LLY ) today announced changes to its executive leadership team. Mike Mason, executive vice president and president of Lilly Diabetes and Obesity, will retire from Lilly at the end of 2023 after 34 years with the company.",
            "banner_image": "https://mma.prnewswire.com/media/133140/eli_lilly_and_company_logo.jpg",
            "source": "Business Insider",
            "category_within_source": "RSS",
            "source_domain": "markets.businessinsider.com",
            "topics": [
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.451494"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.360215"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.145632,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.600823",
                    "ticker_sentiment_score": "0.193581",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "CURN",
                    "relevance_score": "0.028023",
                    "ticker_sentiment_score": "0.005719",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "META",
                    "relevance_score": "0.028023",
                    "ticker_sentiment_score": "0.160467",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "GILD",
                    "relevance_score": "0.028023",
                    "ticker_sentiment_score": "-0.049462",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Lilly Announces Leadership Transitions",
            "url": "https://www.prnewswire.com/news-releases/lilly-announces-leadership-transitions-301946467.html",
            "time_published": "20231004T104500",
            "authors": [
                "Eli Lilly and Company"
            ],
            "summary": "INDIANAPOLIS, Oct. 4, 2023 /PRNewswire/ -- Eli Lilly and Company ( NYSE: LLY ) today announced changes to its executive leadership team. Mike Mason, executive vice president and president of Lilly Diabetes and Obesity, will retire from Lilly at the end of 2023 after 34 years with the company.",
            "banner_image": "https://mma.prnewswire.com/media/133140/eli_lilly_and_company_logo.jpg?p=facebook",
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.451494"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.360215"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.152655,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.5948",
                    "ticker_sentiment_score": "0.192587",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "CURN",
                    "relevance_score": "0.027667",
                    "ticker_sentiment_score": "0.00571",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "META",
                    "relevance_score": "0.027667",
                    "ticker_sentiment_score": "0.159271",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "GILD",
                    "relevance_score": "0.027667",
                    "ticker_sentiment_score": "-0.049386",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Why Eli Lilly Stock Was Looking Sickly Today",
            "url": "https://www.fool.com/investing/2023/10/03/why-eli-lilly-stock-was-looking-sickly-today/",
            "time_published": "20231003T223322",
            "authors": [
                "Eric Volkman"
            ],
            "summary": "Investors weren't necessarily satisfied with their company's latest asset buy.",
            "banner_image": "https://g.foolcdn.com/misc-assets/hp-sa-cumulative-growth-chart.png",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Real Estate & Construction",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.031303,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.669433",
                    "ticker_sentiment_score": "0.048972",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PNT",
                    "relevance_score": "0.254307",
                    "ticker_sentiment_score": "0.03732",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Crude Oil Moves Higher; POINT Biopharma Global Shares Jump - Eli Lilly  ( NYSE:LLY ) , ALX Oncology Holdings  ( NASDAQ:ALXO ) ",
            "url": "https://www.benzinga.com/news/earnings/23/10/35070704/crude-oil-moves-higher-point-biopharma-global-shares-jump",
            "time_published": "20231003T183639",
            "authors": [
                "Lisa Levin"
            ],
            "summary": "U.S. stocks extended losses toward the end of trading, with the S&P 500 falling around 1.5% on Tuesday. The Dow traded down 1.43% to 32,954.84 while the NASDAQ fell 1.98% to 13,044.24. The S&P 500 also fell, dropping, 1.53% to 4,222.58. Utilities shares rose by 0.6% on Tuesday.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/10/03/crude_oil_6-_logo.jpg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "Trading",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Economy - Fiscal",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.161647"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Real Estate & Construction",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": -0.031619,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "SDC",
                    "relevance_score": "0.138066",
                    "ticker_sentiment_score": "0.210098",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "OCEA",
                    "relevance_score": "0.138066",
                    "ticker_sentiment_score": "-0.020108",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "IAFNF",
                    "relevance_score": "0.069294",
                    "ticker_sentiment_score": "0.168847",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "PNT",
                    "relevance_score": "0.205807",
                    "ticker_sentiment_score": "0.383353",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.138066",
                    "ticker_sentiment_score": "0.299965",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "SPGI",
                    "relevance_score": "0.069294",
                    "ticker_sentiment_score": "-0.010074",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WEWOW",
                    "relevance_score": "0.138066",
                    "ticker_sentiment_score": "0.045802",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ALXO",
                    "relevance_score": "0.138066",
                    "ticker_sentiment_score": "0.092743",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "VERY",
                    "relevance_score": "0.069294",
                    "ticker_sentiment_score": "0.168847",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Why Eli Lilly Stock Is Trading Lower Today - Eli Lilly  ( NYSE:LLY ) ",
            "url": "https://www.benzinga.com/news/23/10/35070101/why-eli-lilly-stock-is-trading-lower-today",
            "time_published": "20231003T181649",
            "authors": [
                "Ryan Gustafson"
            ],
            "summary": "Eli Lilly and Company LLY shares are trading lower Tuesday after the company announced the acquisition of POINT Biopharma for an aggregate purchase price of approximately $1.4 billion.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/10/03/medications-1853400_12802.jpg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "News",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Mergers & Acquisitions",
                    "relevance_score": "0.451494"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.108179"
                }
            ],
            "overall_sentiment_score": 0.229366,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.911269",
                    "ticker_sentiment_score": "0.427428",
                    "ticker_sentiment_label": "Bullish"
                }
            ]
        },
        {
            "title": "Why Shares of Point Biopharma Global Are Soaring Tuesday",
            "url": "https://www.fool.com/investing/2023/10/03/why-shares-of-point-biopharma-global-are-soaring-t/",
            "time_published": "20231003T175218",
            "authors": [
                "Jim Halley"
            ],
            "summary": "The company entered into a buyout agreement with Eli Lilly.",
            "banner_image": "https://g.foolcdn.com/misc-assets/hp-sa-cumulative-growth-chart.png",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Real Estate & Construction",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": -0.009736,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.305058",
                    "ticker_sentiment_score": "0.011631",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LNTH",
                    "relevance_score": "0.155451",
                    "ticker_sentiment_score": "-0.133577",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PNT",
                    "relevance_score": "0.305058",
                    "ticker_sentiment_score": "0.300529",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Drugmakers Agree To Participate For Medicare Drug Price Negotiation With Biden Administration - Novo Nordisk  ( NYSE:NVO ) ",
            "url": "https://www.benzinga.com/general/biotech/23/10/35068559/drugmakers-agree-to-participate-for-medicare-drug-price-negotiation-with-biden-administration",
            "time_published": "20231003T173519",
            "authors": [
                "Vandana Singh"
            ],
            "summary": "All ten manufacturers of the first drugs selected for Medicare price negotiations will be participating, the White House said, even though many of them are suing the administration to halt the process.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/10/03/pills-image_by_steve_buissinne_from_pixabay.jpg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": -0.08438,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "AZN",
                    "relevance_score": "0.262522",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.262522",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.262522",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.262522",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVS",
                    "relevance_score": "0.262522",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AMGN",
                    "relevance_score": "0.262522",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BMY",
                    "relevance_score": "0.262522",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Nasdaq Down Over 200 Points; US Job Openings Rise In August - Eli Lilly  ( NYSE:LLY ) , Femasys  ( NASDAQ:FEMY ) ",
            "url": "https://www.benzinga.com/news/earnings/23/10/35068428/nasdaq-down-over-200-points-us-job-openings-rise-in-august",
            "time_published": "20231003T162053",
            "authors": [
                "Lisa Levin"
            ],
            "summary": "U.S. stocks extended losses midway through trading, with the Nasdaq Composite falling more than 200 points on Tuesday. The Dow traded down 1.06% to 33,078.27 while the NASDAQ fell 1.60% to 13,094.83. The S&P 500 also fell, dropping, 1.27% to 4,233.76. Materials shares fell by just 0.1% on Tuesday.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/10/03/image49.jpg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "Trading",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Economy - Fiscal",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.161647"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Real Estate & Construction",
                    "relevance_score": "0.25"
                }
            ],
            "overall_sentiment_score": -0.029242,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "SDC",
                    "relevance_score": "0.144275",
                    "ticker_sentiment_score": "0.21516",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "OCEA",
                    "relevance_score": "0.144275",
                    "ticker_sentiment_score": "-0.020654",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "IAFNF",
                    "relevance_score": "0.072435",
                    "ticker_sentiment_score": "0.169389",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "PNT",
                    "relevance_score": "0.214937",
                    "ticker_sentiment_score": "0.395006",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.144275",
                    "ticker_sentiment_score": "0.306941",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "SPRC",
                    "relevance_score": "0.144275",
                    "ticker_sentiment_score": "0.310635",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "SPGI",
                    "relevance_score": "0.072435",
                    "ticker_sentiment_score": "-0.010113",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "FEMY",
                    "relevance_score": "0.144275",
                    "ticker_sentiment_score": "0.090726",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "VERY",
                    "relevance_score": "0.072435",
                    "ticker_sentiment_score": "0.169389",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Vericity, Inc.  ( Nasdaq - VERY ) , POINT Biopharma Global, Inc.  ( Nasdaq - PNT ) , Blue Apron Holdings, Inc.  ( Nasdaq - APRN ) , Chico's FAS, Inc.  ( NYSE - CHS ) ",
            "url": "https://www.benzinga.com/pressreleases/23/10/g35067468/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-vericity-inc-",
            "time_published": "20231003T153742",
            "authors": [
                "Globe Newswire"
            ],
            "summary": "BALA CYNWYD, Pa., Oct. 03, 2023 ( GLOBE NEWSWIRE ) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky ( jbrodsky@brodskysmith.com ) or Marc Ackerman ( mackerman@brodskysmith.com ) at 855-576-4847.",
            "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png",
            "source": "Benzinga",
            "category_within_source": "News",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Mergers & Acquisitions",
                    "relevance_score": "0.796627"
                },
                {
                    "topic": "Real Estate & Construction",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.25"
                }
            ],
            "overall_sentiment_score": 0.233891,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "APRN",
                    "relevance_score": "0.348103",
                    "ticker_sentiment_score": "0.432176",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "DSSMY",
                    "relevance_score": "0.264897",
                    "ticker_sentiment_score": "0.076198",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "IAFNF",
                    "relevance_score": "0.089797",
                    "ticker_sentiment_score": "0.125311",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PNT",
                    "relevance_score": "0.089797",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.264897",
                    "ticker_sentiment_score": "0.206003",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "VERY",
                    "relevance_score": "0.348103",
                    "ticker_sentiment_score": "0.265255",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "CHS",
                    "relevance_score": "0.348103",
                    "ticker_sentiment_score": "0.296895",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Dow Jones Sinks After Strong Jobs Data; Warren Buffett Sells More Stock",
            "url": "https://www.investors.com/market-trend/stock-market-today/dow-jones-falls-after-strong-jobs-data-yields-spook-stocks-as-warren-buffett-sells-more-stock/",
            "time_published": "20231003T145600",
            "authors": [
                "Investor's Business Daily",
                "VIDYA RAMAKRISHNAN"
            ],
            "summary": "Dow Jones Sinks After Strong Jobs Data. Warren Buffett Sells More ... Investor's Business Daily ...",
            "banner_image": "https://www.investors.com/wp-content/uploads/2020/08/Stock-WallStreetSign-flag08-adobe.jpg",
            "source": "Investors Business Daily",
            "category_within_source": "n/a",
            "source_domain": "www.investors.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.999896"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.451494"
                },
                {
                    "topic": "Real Estate & Construction",
                    "relevance_score": "0.166667"
                }
            ],
            "overall_sentiment_score": -0.062796,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "MSFT",
                    "relevance_score": "0.120733",
                    "ticker_sentiment_score": "-0.0151",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WMG",
                    "relevance_score": "0.120733",
                    "ticker_sentiment_score": "0.174497",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "FVRR",
                    "relevance_score": "0.120733",
                    "ticker_sentiment_score": "0.174497",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "AAPL",
                    "relevance_score": "0.120733",
                    "ticker_sentiment_score": "-0.0151",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BAC",
                    "relevance_score": "0.060541",
                    "ticker_sentiment_score": "0.208085",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "INTC",
                    "relevance_score": "0.120733",
                    "ticker_sentiment_score": "-0.0151",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PNT",
                    "relevance_score": "0.180236",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.120733",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NKE",
                    "relevance_score": "0.120733",
                    "ticker_sentiment_score": "-0.0151",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ABNB",
                    "relevance_score": "0.180236",
                    "ticker_sentiment_score": "-0.285442",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "LBRT",
                    "relevance_score": "0.120733",
                    "ticker_sentiment_score": "-0.109773",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "FOREX:USD",
                    "relevance_score": "0.060541",
                    "ticker_sentiment_score": "-0.01501",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Top Stories Tuesday, Oct 3: 'Airbnb Has Foundational Cracks', Disney+ Follows Netflix On Subscription Sharing Crackdown, Microsoft's Nadella Criticizes Google's Exclusive Content Deals - Apple  ( NASDAQ:AAPL ) , ALX Oncology Holdings  ( NASDAQ:ALXO ) ",
            "url": "https://www.benzinga.com/news/23/10/35064552/airbnb-has-foundational-cracks-disney-follows-netflix-on-subscription-sharing-crackdown-microsofts-n",
            "time_published": "20231003T141120",
            "authors": [
                "Vandana Singh"
            ],
            "summary": "In a significant development, Microsoft Corp's MSFT CEO, Satya Nadella, has voiced concerns over the competitive landscape of content acquisition essential for training artificial intelligence ( AI ) .",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/10/03/airbnbtoronto5.jpg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.214378"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.538269"
                },
                {
                    "topic": "Real Estate & Construction",
                    "relevance_score": "0.166667"
                }
            ],
            "overall_sentiment_score": 0.058194,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "TGT",
                    "relevance_score": "0.076236",
                    "ticker_sentiment_score": "0.263048",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "GOOG",
                    "relevance_score": "0.189076",
                    "ticker_sentiment_score": "0.273786",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "AAPL",
                    "relevance_score": "0.038162",
                    "ticker_sentiment_score": "0.139139",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SPOT",
                    "relevance_score": "0.076236",
                    "ticker_sentiment_score": "0.144617",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.076236",
                    "ticker_sentiment_score": "0.21709",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.076236",
                    "ticker_sentiment_score": "-0.067693",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MU",
                    "relevance_score": "0.076236",
                    "ticker_sentiment_score": "0.143767",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ABNB",
                    "relevance_score": "0.114137",
                    "ticker_sentiment_score": "-0.017859",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DAL",
                    "relevance_score": "0.076236",
                    "ticker_sentiment_score": "-0.098084",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ASML",
                    "relevance_score": "0.076236",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MSFT",
                    "relevance_score": "0.076236",
                    "ticker_sentiment_score": "0.14478",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AZN",
                    "relevance_score": "0.076236",
                    "ticker_sentiment_score": "-0.038103",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PNT",
                    "relevance_score": "0.076236",
                    "ticker_sentiment_score": "0.179376",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "VTRS",
                    "relevance_score": "0.076236",
                    "ticker_sentiment_score": "0.067102",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.076236",
                    "ticker_sentiment_score": "0.179376",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "ALXO",
                    "relevance_score": "0.076236",
                    "ticker_sentiment_score": "-0.146817",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GME",
                    "relevance_score": "0.114137",
                    "ticker_sentiment_score": "-0.130984",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BA",
                    "relevance_score": "0.076236",
                    "ticker_sentiment_score": "0.021659",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SNY",
                    "relevance_score": "0.114137",
                    "ticker_sentiment_score": "-0.064201",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TAK",
                    "relevance_score": "0.076236",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CRYPTO:NXC",
                    "relevance_score": "0.038162",
                    "ticker_sentiment_score": "-0.036553",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Vericity, POINT Biopharma Global, Oddity Tech And Other Big Stocks Moving Higher On Tuesday - Fiverr Intl  ( NYSE:FVRR ) , Clean Energy Fuels  ( NASDAQ:CLNE ) ",
            "url": "https://www.benzinga.com/news/23/10/35064944/vericity-point-biopharma-global-oddity-tech-and-other-big-stocks-moving-higher-on-tuesday",
            "time_published": "20231003T140934",
            "authors": [
                "Lisa Levin"
            ],
            "summary": "U.S. stocks traded lower, with the Nasdaq Composite falling more than 100 points on Tuesday. Here are some big stocks recording gains in today's session. Vericity, Inc. VERY shares climbed 87% to $11.11 after iA Financial Group announced it will acquire the company. POINT Biopharma Global Inc.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/10/03/vericity_-_logo.jpg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "Trading",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.614606"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Real Estate & Construction",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.2"
                }
            ],
            "overall_sentiment_score": 0.295453,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "FVRR",
                    "relevance_score": "0.405651",
                    "ticker_sentiment_score": "0.340386",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "IAFNF",
                    "relevance_score": "0.140896",
                    "ticker_sentiment_score": "0.217305",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "LNTH",
                    "relevance_score": "0.405651",
                    "ticker_sentiment_score": "-0.020303",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PNT",
                    "relevance_score": "0.405651",
                    "ticker_sentiment_score": "0.546995",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.405651",
                    "ticker_sentiment_score": "0.301297",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "SMR",
                    "relevance_score": "0.277433",
                    "ticker_sentiment_score": "0.616912",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "WRBY",
                    "relevance_score": "0.405651",
                    "ticker_sentiment_score": "0.716185",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "MSC",
                    "relevance_score": "0.277433",
                    "ticker_sentiment_score": "-0.460934",
                    "ticker_sentiment_label": "Bearish"
                },
                {
                    "ticker": "ODD",
                    "relevance_score": "0.277433",
                    "ticker_sentiment_score": "0.371281",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "SYNA",
                    "relevance_score": "0.405651",
                    "ticker_sentiment_score": "-0.293274",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "VERY",
                    "relevance_score": "0.140896",
                    "ticker_sentiment_score": "0.217305",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "CLNE",
                    "relevance_score": "0.405651",
                    "ticker_sentiment_score": "0.747204",
                    "ticker_sentiment_label": "Bullish"
                }
            ]
        },
        {
            "title": "Dow Falls Over 100 Points; McCormick Sales Miss Views - AERWINS Technologies  ( NASDAQ:AWIN ) , Dixie Gr  ( NASDAQ:DXYN ) ",
            "url": "https://www.benzinga.com/news/earnings/23/10/35064200/dow-falls-over-100-points-mccormick-sales-miss-views",
            "time_published": "20231003T134205",
            "authors": [
                "Lisa Levin"
            ],
            "summary": "U.S. stocks traded lower this morning, with the Dow Jones falling more than 100 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.37% to 33,310.99 while the NASDAQ fell 0.58% to 13,230.96. The S&P 500 also fell, dropping, 0.47% to 4,268.18.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/10/03/image21.jpg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "Trading",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Economy - Fiscal",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.108179"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.684621"
                },
                {
                    "topic": "Real Estate & Construction",
                    "relevance_score": "0.2"
                }
            ],
            "overall_sentiment_score": -0.029034,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "SDC",
                    "relevance_score": "0.209365",
                    "ticker_sentiment_score": "0.148236",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AWIN",
                    "relevance_score": "0.209365",
                    "ticker_sentiment_score": "0.22361",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "IAFNF",
                    "relevance_score": "0.070517",
                    "ticker_sentiment_score": "0.169043",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "PNT",
                    "relevance_score": "0.209365",
                    "ticker_sentiment_score": "0.387902",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.140485",
                    "ticker_sentiment_score": "0.302654",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "SPRC",
                    "relevance_score": "0.140485",
                    "ticker_sentiment_score": "0.306305",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "DXYN",
                    "relevance_score": "0.140485",
                    "ticker_sentiment_score": "-0.204669",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "SPGI",
                    "relevance_score": "0.070517",
                    "ticker_sentiment_score": "-0.010088",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "VERY",
                    "relevance_score": "0.070517",
                    "ticker_sentiment_score": "0.169043",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Cancer Specialist Launches 84% On Eli Lilly's $1.4 Billion Deal",
            "url": "https://www.investors.com/news/technology/pnt-stock-launches-on-eli-lilly-takeover/",
            "time_published": "20231003T133000",
            "authors": [
                "ALLISON GATLIN",
                "Investor's Business Daily"
            ],
            "summary": "PNT Stock Launches 84% On Eli Lilly's $1.4 Billion Takeover Investor's Business Daily ...",
            "banner_image": "https://www.investors.com/wp-content/uploads/2018/05/Stock-Lilly-01-Shutterstock.jpg",
            "source": "Investors Business Daily",
            "category_within_source": "n/a",
            "source_domain": "www.investors.com",
            "topics": [
                {
                    "topic": "Real Estate & Construction",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.962106"
                }
            ],
            "overall_sentiment_score": -0.017088,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.612033",
                    "ticker_sentiment_score": "-0.182398",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "SLNO",
                    "relevance_score": "0.170878",
                    "ticker_sentiment_score": "0.022879",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PNT",
                    "relevance_score": "0.719473",
                    "ticker_sentiment_score": "-0.196734",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                }
            ]
        },
        {
            "title": "Why Is Cancer Treatment Focused POINT Biopharma Stock Trading Higher Today? - POINT Biopharma Global  ( NASDAQ:PNT ) ",
            "url": "https://www.benzinga.com/general/biotech/23/10/35060421/why-is-cancer-treatment-focused-point-biopharma-stock-trading-higher-today",
            "time_published": "20231003T130307",
            "authors": [
                "Vandana Singh"
            ],
            "summary": "Eli Lilly And Co LLY agreed to acquire POINT Biopharma Global Inc PNT at $12.50 per share in cash, an aggregate of approximately $1.4 billion. POINT Biopharma is a radiopharmaceutical company with a pipeline of clinical and preclinical-stage radioligand therapies in development for cancer.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/10/03/pnt.png?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Real Estate & Construction",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.214378"
                }
            ],
            "overall_sentiment_score": -0.026276,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.488777",
                    "ticker_sentiment_score": "0.370857",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "PNT",
                    "relevance_score": "0.488777",
                    "ticker_sentiment_score": "0.370857",
                    "ticker_sentiment_label": "Bullish"
                }
            ]
        },
        {
            "title": "Why Cancer-Focused ALX Oncology Stock Gained Over 100% Today? - ALX Oncology Holdings  ( NASDAQ:ALXO ) ",
            "url": "https://www.benzinga.com/general/biotech/23/10/35057455/why-cancer-focused-alx-oncology-stock-gained-over-100-today",
            "time_published": "20231003T125830",
            "authors": [
                "Vandana Singh"
            ],
            "summary": "ALX Oncology Holdings Inc ALXO released prespecified interim Phase 2 data from its ASPEN-06 trial of evorpacept plus trastuzumab, Cyramza ( ramucirumab ) and paclitaxel for HER2-positive gastric/gastroesophageal junction cancer. Cyramza ( ramucirumab ) is owned by Eli Lilly And Co LLY.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/10/03/alxo.png?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "News",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": -0.033284,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "ALXO",
                    "relevance_score": "0.40348",
                    "ticker_sentiment_score": "-0.126347",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.275867",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AZN",
                    "relevance_score": "0.275867",
                    "ticker_sentiment_score": "-0.139155",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Want Better Returns? Don?t Ignore These 2 Medical Stocks Set to Beat Earnings",
            "url": "https://www.zacks.com/stock/news/2159086/want-better-returns-dont-ignore-these-2-medical-stocks-set-to-beat-earnings",
            "time_published": "20231003T125006",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.",
            "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default341.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.999973"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.161647"
                }
            ],
            "overall_sentiment_score": 0.363038,
            "overall_sentiment_label": "Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.390904",
                    "ticker_sentiment_score": "0.418501",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "ZTS",
                    "relevance_score": "0.390904",
                    "ticker_sentiment_score": "0.4042",
                    "ticker_sentiment_label": "Bullish"
                }
            ]
        },
        {
            "title": "Meet The Company Whose Hunger Suppressant Sent Shares Flying 505%",
            "url": "https://www.investors.com/news/technology/slno-stock-meet-soleno-the-company-whose-hunger-suppressant-sent-shares-skyrocketing/",
            "time_published": "20231003T120000",
            "authors": [
                "ALLISON GATLIN",
                "Investor's Business Daily"
            ],
            "summary": "Meet The Company Whose Hunger Suppressant Sent Shares Flying ... Investor's Business Daily ...",
            "banner_image": "https://www.investors.com/wp-content/uploads/2019/06/Stock-Drug-73-adobe.jpg",
            "source": "Investors Business Daily",
            "category_within_source": "n/a",
            "source_domain": "www.investors.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.459462"
                }
            ],
            "overall_sentiment_score": 0.169373,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.170878",
                    "ticker_sentiment_score": "0.13065",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SLNO",
                    "relevance_score": "0.385455",
                    "ticker_sentiment_score": "0.141436",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.114409",
                    "ticker_sentiment_score": "0.127724",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Lilly's  ( LLY )  Eczema Candidate Lebrikizumab Faces FDA Rejection",
            "url": "https://www.zacks.com/stock/news/2159031/lillys-lly-eczema-candidate-lebrikizumab-faces-fda-rejection",
            "time_published": "20231003T114300",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Lilly (LLY) gets a CRL for the eczema candidate, lebrikizumab, based on inspection findings at a third-party manufacturer.",
            "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/52/873.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.682689"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.241153,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.470894",
                    "ticker_sentiment_score": "0.295921",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "CORT",
                    "relevance_score": "0.11123",
                    "ticker_sentiment_score": "0.058093",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AUPH",
                    "relevance_score": "0.273399",
                    "ticker_sentiment_score": "0.146338",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ALPN",
                    "relevance_score": "0.220308",
                    "ticker_sentiment_score": "0.180672",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Lilly to Acquire POINT Biopharma to Expand Oncology Capabilities into Next-Generation Radioligand Therapies",
            "url": "https://markets.businessinsider.com/news/stocks/lilly-to-acquire-point-biopharma-to-expand-oncology-capabilities-into-next-generation-radioligand-therapies-1032673889",
            "time_published": "20231003T104500",
            "authors": [
                "markets.businessinsider.com"
            ],
            "summary": "INDIANAPOLIS, Oct. 3, 2023 /PRNewswire/ -- Eli Lilly and Company ( NYSE: LLY ) and POINT Biopharma Global, Inc. ( NASDAQ: PNT ) today announced a definitive agreement for Lilly to acquire POINT, a radiopharmaceutical company with a pipeline of clinical and preclinical-stage radioligand therapies ...",
            "banner_image": "https://mma.prnewswire.com/media/1756482/Cropped_Lilly_Logo.jpg",
            "source": "Business Insider",
            "category_within_source": "RSS",
            "source_domain": "markets.businessinsider.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.918141"
                },
                {
                    "topic": "Mergers & Acquisitions",
                    "relevance_score": "0.99989"
                },
                {
                    "topic": "Real Estate & Construction",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.25"
                }
            ],
            "overall_sentiment_score": 0.244254,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.423251",
                    "ticker_sentiment_score": "0.364727",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "META",
                    "relevance_score": "0.027828",
                    "ticker_sentiment_score": "0.161364",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "GS",
                    "relevance_score": "0.027828",
                    "ticker_sentiment_score": "0.115903",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LNTH",
                    "relevance_score": "0.027828",
                    "ticker_sentiment_score": "0.113045",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PNT",
                    "relevance_score": "0.110973",
                    "ticker_sentiment_score": "-0.016078",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Lilly to Acquire POINT Biopharma to Expand Oncology Capabilities into Next-Generation Radioligand Therapies - PR Newswire",
            "url": "https://www.prnewswire.com/news-releases/lilly-to-acquire-point-biopharma-to-expand-oncology-capabilities-into-next-generation-radioligand-therapies-301945243.html",
            "time_published": "20231003T104500",
            "authors": [],
            "summary": "Lilly to Acquire POINT Biopharma to Expand Oncology Capabilities into Next-Generation Radioligand Therapies PR ...",
            "banner_image": null,
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.986714"
                },
                {
                    "topic": "Mergers & Acquisitions",
                    "relevance_score": "0.99998"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.108179"
                },
                {
                    "topic": "Real Estate & Construction",
                    "relevance_score": "0.25"
                }
            ],
            "overall_sentiment_score": 0.224114,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.380775",
                    "ticker_sentiment_score": "0.285753",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "META",
                    "relevance_score": "0.020866",
                    "ticker_sentiment_score": "0.156872",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "GS",
                    "relevance_score": "0.020866",
                    "ticker_sentiment_score": "0.111541",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LNTH",
                    "relevance_score": "0.020866",
                    "ticker_sentiment_score": "0.108764",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PNT",
                    "relevance_score": "0.083323",
                    "ticker_sentiment_score": "-0.014694",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Why Shares of Structure Therapeutics Are Up Monday",
            "url": "https://www.fool.com/investing/2023/10/02/why-shares-of-structure-therapeutics-are-up-monday/",
            "time_published": "20231002T194847",
            "authors": [
                "Jim Halley"
            ],
            "summary": "The stock climbed for the second straight day after the company reported positive trial data for its weight-loss therapy drug.",
            "banner_image": "https://g.foolcdn.com/misc-assets/hp-sa-cumulative-growth-chart.png",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.266143"
                }
            ],
            "overall_sentiment_score": 0.29063,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.128822",
                    "ticker_sentiment_score": "0.163951",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "GPCR",
                    "relevance_score": "0.254307",
                    "ticker_sentiment_score": "0.337869",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JEF",
                    "relevance_score": "0.128822",
                    "ticker_sentiment_score": "0.145174",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.128822",
                    "ticker_sentiment_score": "0.163951",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "This fund shows that industry expertise can help you make a lot of money in the stock market",
            "url": "https://www.marketwatch.com/story/this-fund-shows-that-industry-expertise-can-help-you-make-a-lot-of-money-in-the-stock-market-5d104b1d",
            "time_published": "20231002T162800",
            "authors": [
                "Philip van Doorn"
            ],
            "summary": "The managers of the Janus Henderson Global Life Sciences Fund have direct experience to help them separate promising innovators from flashes in the pan.",
            "banner_image": "https://images.mktw.net/im-861100?width=700&height=593",
            "source": "MarketWatch",
            "category_within_source": "Top Stories",
            "source_domain": "www.marketwatch.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.986564"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.310843"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.174392,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "ETNB",
                    "relevance_score": "0.083107",
                    "ticker_sentiment_score": "-0.074703",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.04161",
                    "ticker_sentiment_score": "0.084583",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JHG",
                    "relevance_score": "0.205807",
                    "ticker_sentiment_score": "0.11181",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.083107",
                    "ticker_sentiment_score": "0.089042",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MDGL",
                    "relevance_score": "0.083107",
                    "ticker_sentiment_score": "-0.03668",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AKRO",
                    "relevance_score": "0.083107",
                    "ticker_sentiment_score": "-0.074703",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ISRG",
                    "relevance_score": "0.083107",
                    "ticker_sentiment_score": "0.238236",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "FDA Declines To Approve Eli Lilly's Eczema Drug - Eli Lilly  ( NYSE:LLY ) ",
            "url": "https://www.benzinga.com/general/biotech/23/10/35031584/fda-declines-to-approve-eli-lillys-eczema-drug",
            "time_published": "20231002T154641",
            "authors": [
                "Vandana Singh"
            ],
            "summary": "The U.S. Food and Drug Administration ( FDA ) issued a complete response letter for Eli Lilly And Co's LLY lebrikizumab biologic license application ( BLA ) for the treatment of moderate-to-severe atopic dermatitis ( eczema ) .",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/10/02/aapharma_4.png?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.210329,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.737032",
                    "ticker_sentiment_score": "0.257538",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Stocks off to a choppy start this week, as bond yields push higher",
            "url": "https://www.cnbc.com/2023/10/02/stocks-off-to-a-choppy-start-this-week-as-bond-yields-push-higher.html",
            "time_published": "20231002T150747",
            "authors": [
                "Jeff Marks"
            ],
            "summary": "The Investing Club holds its Morning Meeting every weekday at 10:20 a.m. ET.",
            "banner_image": "https://image.cnbcfm.com/api/v1/image/107310037-1696258414393-1696257499-31430485476-hd.jpg?v=1696260270&w=600&h=300&vtcrop=y",
            "source": "CNBC",
            "category_within_source": "Top News",
            "source_domain": "www.cnbc.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.997902"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.451494"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.137563,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.388879",
                    "ticker_sentiment_score": "0.155401",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "CTRA",
                    "relevance_score": "0.239698",
                    "ticker_sentiment_score": "0.107077",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DHR",
                    "relevance_score": "0.388879",
                    "ticker_sentiment_score": "0.155401",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "ACM Research and Advance Auto Parts have been highlighted as Zacks Bull and Bear of the Day",
            "url": "https://www.zacks.com/stock/news/2158590/acm-research-and-advance-auto-parts-have-been-highlighted-as-zacks-bull-and-bear-of-the-day",
            "time_published": "20231002T122500",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Chicago, IL - October 2, 2023 - Zacks Equity Research shares ACM Research ( ACMR Quick QuoteACMR - ) as the Bull of the Day and Advance Auto Parts ( AAP Quick QuoteAAP - ) as the Bear of the Day.",
            "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/cb/577.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Economy - Macro",
                    "relevance_score": "0.158519"
                }
            ],
            "overall_sentiment_score": 0.152207,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "AAP",
                    "relevance_score": "0.242027",
                    "ticker_sentiment_score": "-0.080033",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.087631",
                    "ticker_sentiment_score": "0.027321",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ACMR",
                    "relevance_score": "0.225224",
                    "ticker_sentiment_score": "0.251365",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "MS",
                    "relevance_score": "0.01756",
                    "ticker_sentiment_score": "0.155341",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.139771",
                    "ticker_sentiment_score": "0.043998",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.105064",
                    "ticker_sentiment_score": "0.040069",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "U.S. Food and Drug Administration Issues Complete Response Letter for Lebrikizumab Based on Inspection Findings at Third-Party Manufacturer",
            "url": "https://www.prnewswire.com/news-releases/us-food-and-drug-administration-issues-complete-response-letter-for-lebrikizumab-based-on-inspection-findings-at-third-party-manufacturer-301943925.html",
            "time_published": "20231002T104500",
            "authors": [
                "Eli Lilly and Company"
            ],
            "summary": "U.S. Food and Drug Administration Issues Complete Response Letter for Lebrikizumab Based on Inspection Findings ... PR ...",
            "banner_image": "https://mma.prnewswire.com/media/133140/eli_lilly_and_company_logo.jpg?p=facebook",
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.310843"
                }
            ],
            "overall_sentiment_score": 0.204257,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.622414",
                    "ticker_sentiment_score": "0.302624",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "META",
                    "relevance_score": "0.07031",
                    "ticker_sentiment_score": "0.170556",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "The Zacks Analyst Blog Highlights AbbVie, Lilly, Sanofi, Merck and J&J",
            "url": "https://www.zacks.com/stock/news/2158561/the-zacks-analyst-blog-highlights-abbvie-lilly-sanofi-merck-and-jj",
            "time_published": "20231002T103100",
            "authors": [
                "Zacks Investment Research"
            ],
            "summary": "AbbVie, Lilly, Sanofi, Merck and J&J are included in this Analyst Blog.",
            "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/7d/1177.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.214378"
                }
            ],
            "overall_sentiment_score": 0.210323,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.149192",
                    "ticker_sentiment_score": "0.022956",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ABBV",
                    "relevance_score": "0.074926",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AZN",
                    "relevance_score": "0.037504",
                    "ticker_sentiment_score": "-0.12063",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ESALF",
                    "relevance_score": "0.074926",
                    "ticker_sentiment_score": "0.113572",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.037504",
                    "ticker_sentiment_score": "-0.11573",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SNY",
                    "relevance_score": "0.074926",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        }
    ]
}